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  ABSTRACT	  
Background	  Coronary	   Allograft	   Vasculopathy	   (CAV)	   is	   the	   leading	   cause	   of	   late	   death	   for	  children	  after	  heart	  transplantation.	  It	  often	  presents	  late	  due	  to	  lack	  of	  ischaemic	  symptoms	   from	   the	   denervated	   allograft	   and	   it	   is	   difficult	   to	   detect	   using	  conventional	  angiography.	  A	  non-­‐invasive	  diagnostic	  tool	  would	  be	  invaluable	  for	  the	  early	  detection	  and	  therefore,	  prevention	  of	  disease.	  MRI	  has	  the	  potential	  to	  achieve	  this	  by	  imaging	  coronary	  lumen,	  vessel	  wall	  and	  central	  vascular	  stiffness	  in	  a	  child-­‐friendly	  free-­‐breathing	  protocol	  lasting	  thirty	  minutes.	  	  	  
Methods	  A	  three-­‐dimensional	  steady-­‐state-­‐free-­‐precession	  (3D	  SSFP)	  imaging	  sequence	  for	  coronary	  artery	  lumen	  imaging	  was	  optimised	  for	  its	  use	  in	  children.	  Patient	  based	  studies	   were	   performed	   to	   show	   the	   clinical	   potential	   for	   this	   approach.	  Furthermore,	  contrast-­‐enhanced	  inversion-­‐prepared	  coronary	  vessel	  wall	  imaging	  was	  investigated	  for	  its	  ability	  to	  detect	  intimal	  disease	  in	  CAV,	  using	  intravascular	  ultrasound	  to	  validate	  the	  findings.	  Finally,	  MRI	  was	  used	  to	  study	  the	  potential	  of	  aortic	  screening	  for	  rapid	  assessment	  of	  CAV.	  	  	  
	   	  
	  
ABSTRACT	  	  
	   	   3	  
	  
Results	  MRI	  coronary	  artery	  lumen	  imaging	  is	  feasible	  in	  children	  and	  reference	  values	  are	  provided.	   Contrast-­‐enhanced	   vessel	   wall	   imaging	   has	   91%	   accuracy	   in	   the	  detection	   of	   significant	   CAV.	   Further	   improvements	   in	   the	   technique	   can	   be	  achieved	   using	   high-­‐field	   MRI	   (3.0	   Tesla)	   or	   sublingual	   nitroglycerin.	   Central	  aortic	   stiffness	   is	   increased	   in	   children	   after	   heart	   transplantation	   and	   a	  relationship	  between	  this	  and	  CAV	  is	  demonstrated.	  	  
	  
Conclusions	  Coronary	  artery	  lumen	  and	  vessel	  wall	  MRI	  can	  be	  used	  to	  follow	  up	  children	  after	  heart	   transplantation.	  Non-­‐invasive	   follow-­‐up	   can	  be	  more	   frequent	   and	  has	   the	  potential	   to	   allow	   early	   prevention.	   From	   this	   research,	   there	   are	   wider	  implications	   for	   congenital	   heart	   disease,	   Kawasaki	   disease	   and	   cardiovascular	  atherosclerosis	  imaging	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INTRODUCTION	  
Translational	   medicine	   has	   been	   defined	   as	   “a	   discipline	   that	   increases	   the	  
efficiency	   of	   determining	   the	   relevance	   of	   novel	   discoveries	   in	   the	   biological	  
sciences	   to	   human	   disease	   and	   helps	   clinical	   researchers	   identify,	   through	  
direct	  human	  observation,	  alternative	  hypotheses	  relevant	  to	  human	  disease.	  
A	   further	   goal	   is	   to	   accelerate	   the	   rational	   transfer	   of	   new	   insights	   and	  
knowledge	   into	  clinical	  practice	   for	   improving	  patients’	  outcomes	  and	  public	  
health.”1	   As	   such,	   it	   has	   been	   identified	   nationally	   as	   one	   of	   the	   key	   research	  strategies	  towards	  delivery	  of	  improved	  patient	  care.2	  	  In	  keeping	  with	  this	  definition,	  this	  thesis	  takes	  basic	  science	  developments	  such	  as	  coronary	  lumen	  imaging,	  vessel	  wall	  imaging,	  vessel	  wall	  delayed	  enhancement	  and	  reduced	  field-­‐of-­‐view	  imaging	  and	  implements	  them	  in	  clinical	  research.	  The	  aim	  is	   to	  use	  these	  techniques	  to	  answer	  specific	  clinical	  questions	   in	  Congenital	  Heart	   Disease,	   Atherosclerosis,	   Coronary	   Allograft	   Vasculopathy	   and	   Kawasaki	  disease.	   Ultimately	   these	   insights	   should	   be	   used	   to	   improve	   the	   care	   of	   these	  patient	  groups.	  	  Among	   the	   important	   factors	   towards	   translation,	   highlighted	   by	   Lord	   and	  Trembath	  when	   setting	  out	   their	   translational	   strategy,	   are	  patient	   involvement,	  industry	   collaboration	   and	   multicentre	   collaboration.	   Planning	   and	   conducting	  this	   research	  has	   involved	   the	  patient	   support	   groups:	   “Evelina	  Children’s	  Heart	  Organisation”	   and	   “Hearts	   for	   Kids”.	   Results	   have	   also	   been	   presented	   to	   these	  patient	   groups.	   Industry	   collaboration	  with	   Philips	  Healthcare	   has	   been	   present	  from	  the	  outset	  with	  partial	  funding	  for	  MR	  imaging	  coming	  from	  them.	  Finally,	  we	  have	  established	   firm	  research	  collaboration	  with	  Great	  Ormond	  Street	  Hospital,	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which	   has	   the	   biggest	   Paediatric	   Heart	   Transplant	   programme	   in	   Europe.	   This	  collaboration	  will	  be	  beneficial	  to	  both	  research	  groups	  and	  ultimately	  for	  patient	  care.	  	  The	  thesis	  revolves	  around	  a	  central	  question:	  “Can	  we	  detect	  and	  grade	  Coronary	  Allograft	  Vasculopathy	  non-­‐invasively	  using	  MRI?”	  	  In	  order	  to	  answer	  this	  question,	  the	  thesis	  takes	  a	  stepwise	  approach:	  Step	  1:	  	   Development	  of	  Coronary	  Lumen	  Imaging	  Step	  2:	  	   Development	  of	  Contrast-­‐Enhanced	  Vessel	  Wall	  Imaging	  Step	  3:	  	   Aortic	  Imaging	  as	  a	  correlate	  for	  Coronary	  Disease	  	  In	   taking	   these	   steps,	   the	   thesis	   introduces	   new	   technologies	   and	   explores	   the	  implications	  for	  other	  type	  of	  cardiovascular	  disease.	  Ultimately,	  the	  thesis	  makes	  important	  contributions	  to	  congenital	  heart	  disease,	  atherosclerotic	  heart	  disease,	  Kawasaki	  disease	  and	  Coronary	  Allograft	  Vasculopathy.	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1. Review	  of	  Imaging	  for	  Coronary	  Allograft	  Vasculopathy	  	  
	  
1.1. Introduction	  Coronary	   Allograft	   Vasculopathy	   remains	   one	   of	   the	   biggest	   challenges	   facing	  heart	   transplant	  medicine.	   It	   is	   a	   progressive	   condition,	   which	   is	   thought	   to	   be	  caused	   largely	   by	   chronic	   autoimmune-­‐mediated	   endothelial	   damage.3	   Damaged	  endothelium	   allows	   cell	   infiltration,	   which	   is	   responsible	   for	   the	   production	   of	  cytokines,	  growth	  factors,	  and	  matrix	  deposition	  (collagen	  I	  and	  fibroblasts).4	  This	  causes	   a	   progressive	   thickening	   of	   the	   intimal	   layer	   of	   the	   coronary	   vessel	  wall.	  The	  end	  results	  are	  allograft	  ischaemia,	  infarction,	  heart	  failure	  and	  sudden	  death.	  	  	  In	  adults,	  CAV,	  along	  with	  malignancy	  is	  the	  biggest	  cause	  of	  late	  death	  after	  heart	  transplantation.5	  In	  paediatric	  series,	  CAV	  alone	  is	  the	  biggest	  cause	  of	  late	  death.6	  Angiographic	   evidence	   of	   CAV	   is	   present	   in	   30	   to	   50%	   of	   heart	   transplant	  survivors	   at	   5	   years,5,	   7	   and	   survival	   is	   significantly	   reduced	   for	   those	   with	  reported	  CAV.5	  In	  children,	  angiographic	  evidence	  of	  severe	  CAV	  is	  associated	  with	  a	  mortality	  or	  retransplantation	  rate	  of	  over	  70%	  at	  4	  years.6	  Accordingly,	  in	  both	  adult	   and	   children,	   detection	   at	   an	   early	   stage	   and	   prevention	   of	   progression	   is	  paramount.	  Detection	  of	  CAV,	  however,	   is	  made	  more	  difficult	  owing	  to	  a	   lack	  of	  ischaemic	   symptoms	   from	   the	   denervated	   heart.	   This	   means	   that	   the	  asymptomatic	  period	  is	  much	  longer	  and	  therefore,	  regular	  imaging	  surveillance	  is	  required.	   This	   review,	   addresses	   issues	   concerning	   different	   imaging	  modalities	  that	   have	   be	   used	   for	   the	   detection	   of	   CAV	   and	   particular	   discussion	   is	   given	  regarding	  points	  pertinent	  to	  imaging	  in	  children.	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1.2. Angiography	  Invasive	  coronary	  angiography	  remains	   the	  mainstay	   for	   the	  diagnosis	  of	  CAV	   in	  many	   heart-­‐transplant	   centres.	   However,	   histological	   evidence	   has	   long	   been	  present	  to	  show	  that	  angiography	  is	  prone	  to	  underestimating	  disease.8	  With	  the	  advent	   of	   intravascular	   ultrasound	   (IVUS),	   the	   relative	   insensitivity	   of	  conventional	   angiography	   as	   a	   screening	   tool	   has	   been	   demonstrated.9-­‐11	   In	   a	  study	   by	   St	   Goar	   at	   al,	   50%	   of	   those	   with	   normal	   coronary	   angiograms	   were	  shown	   to	   have	   moderate	   or	   severe	   intimal	   thickening	   on	   IVUS	   (by	   Stanford	  grading).10	  In	  fact,	  in	  this	  study,	  the	  mean	  intimal	  thickness	  and	  the	  mean	  intimal	  index	  (the	  ratio	  of	  intimal	  area	  to	  the	  sum	  of	  the	  intimal	  and	  lumen	  areas)	  were	  no	  different	   between	   those	   with	   abnormal	   angiograms	   and	   those	   with	   normal	  angiograms	  but	  moderate	  to	  severe	  thickening	  on	  IVUS	  	  (thickness	  0.53+0.35	  mm	  versus	   0.64+0.30	  mm;	   index,	   0.28±0.10	   versus	   0.34±0.10).	   Similarly,	  Tuzcu	  et	  al	  showed	   that	   the	   sensitivity	   of	   angiography	   for	   detection	   of	   CAV	   (defined	   by	  maximal	   intimal	   thickness	   >0.5mm	   on	   IVUS)	  was	   only	   43%	   (specificity	   95%).11	  
Spes	   et	   al,	   in	   a	   study	   of	   56	   heart	   transplant	   recipients	   with	   normal	   coronary	  angiograms,	  demonstrated	  that	  33	  had	  significant	  CAV	  on	  IVUS	  (defined	  as	  mean	  score	  equivalent	  being	  greater	  than	  a	  mean	  intimal	  thickness	  of	  0.3mm).9	  Gregory	  
et	  al	  examined	  122	  coronary	  artery	  segments	  and,	  defining	  disease	  as	  a	  maximal	  intimal	   thickness	   >0.5mm	   on	   IVUS,	   demonstrated	   that	   angiography	   had	   a	  sensitivity	  of	   just	  11%	  (95%	  CI	  4	  to	  23%)	  and	  a	  negative	  predictive	  value	  of	   just	  57%	  (47	  to	  66%).	  12	  Using	  the	  same	  definition	  as	  Spes,	  Störk	  et	  al,	  demonstrated	  an	  even	   lower	  negative	  predictive	  value	  of	  28%	  (14	  to	  46%)	  and	  a	  sensitivity	  of	  44%	  (29	  to	  60%).	  Hence,	  although	  angiography	  is	  highly	  specific	  for	  CAV	  and	  has	  a	  high	  positive	  predictive	   value,	   it	   is	   not	   sensitive	   enough	  and	   it	   has	   low	  negative	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predictive	  value.	  As	  a	  screening	  tool	  for	  the	  early	  detection	  of	  CAV,	  it	  is	  therefore	  flawed.	  It	  should	  be	  stated	  that	  Sharples	  et	  al,	  using	  predictive	  modeling	  to	  assess	  566	  patients	  over	  a	  23	  year	  period	  found	  a	  higher	  sensitivity	  for	  angiography	  but	  this	  study	  did	  not	  have	  histological	  or	  IVUS	  correlation	  for	  comparison.	  13	  	  The	  main	  problem	  with	  angiography	   is	   that	   it	  merely	   images	   the	   lumen	  and	  not	  the	   vessel	  wall,	  which	   is	   the	   region	   of	   pathology.	   CAV	   causes	   intimal	   thickening	  and	  fibrous	  changes	  of	  the	  whole	  vessel	  wall,	   frequently	  including	  the	  media	  and	  adventitia.	  Hence,	  compensatory	  Glagov-­‐type	  dilatory	  remodeling	  of	  the	  artery	  is	  relatively	   inhibited,	   and	   the	   artery	   often	   undergoes	   constriction.14	   CAV,	   unlike	  atherosclerosis,	   tends	   to	   be	   a	   diffuse,	   concentric	   disease	   affecting	   large	   and	  medium	   size	   vessels	   as	   well	   as	   the	   microvasculature.10,	   15	   This	   underlying	  pathophysiology	   tends	   to	   make	   it	   difficult	   to	   detect	   angiographically.	   This	   is	  reflected	   in	   wide	   inter-­‐observer	   agreement	   in	   the	   reporting	   of	   diffuse	   or	   distal	  disease.16	   Angiography,	   however,	   remains	   the	   cornerstone	   of	   clinical	   imaging	   at	  many	  institutions	  due	  to	  the	  ease	  and	  relatively	   inexpensive	  nature	  compared	  to	  IVUS.	  The	  prognostic	  value	  of	  angiography	  has	  been	  clearly	  demonstrated,5	  and	  so	  it	  remains	  important	  to	  use	  the	  recognised	  nomenclature	  for	  reporting	  (Table	  1).17	  The	   introduction	   of	   physiological	   parameters	   to	   this	   nomenclature	   such	   as	   left	  ventricular	   ejection	   fraction	   (LVEF)	   and	   restrictive	   physiology	   adds	   incremental	  value	  to	  the	  risk	  stratification	  but	  is	  another	  indication	  of	  the	  imperfect	  nature	  of	  angiography	  as	  a	  diagnostic	  test.18,	  19	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Table	  1.	  ISHLT	  Consensus	  Grading	  for	  Coronary	  Allograft	  Vasculopathy	  
(Mehra	  et	  al	  2010)	  
For	  children,	  angiography	  is	  clinically	  even	  more	  important	  than	  in	  adults	  because	  intravascular	  ultrasound	   is	   largely	  avoided	   in	  smaller	  children	  due	   to	   the	  size	  of	  the	   coronary	   arteries.	   However,	   in	   children,	   published	   rates	   of	   angiographically	  defined	  CAV	  appear	  substantially	  lower	  than	  adult	  series	  at	  only	  17%	  at	  5	  years.6	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It	   may	   be	   hypothesised	   that	   the	   reason	   for	   this	   is	   that	   there	   is	   less	   donor	  atherosclerosis	   in	   younger	   donors	   and	   less	   recipient	   risk	   factors	   for	  atherosclerosis.	  However,	  this	  fact	  is	  hard	  to	  reconcile	  with	  the	  fact	  that	  CAV	  is	  an	  even	  more	   important	   cause	  of	   death	  or	   graft	   loss	   after	   the	   first	   year	   in	   children	  than	   in	   adults	   (in	   whom	   malignancy	   is	   more	   common).5,	   6	   An	   alternative	  explanation	  is	  that,	  the	  pattern	  of	  disease	  is	  different	  with	  a	  greater	  burden	  due	  to	  concentric	  disease	  with	   less	   focal	  narrowing	   initially	  and	  hence	   it	  becomes	  even	  more	   difficult	   to	   diagnose	   angiographically.	   In	   support	   of	   this	   are	   the	   small	  paediatric	   IVUS	  studies	  showing	  only	  18%	  to	  30%	  sensitivity	   for	  angiography	  to	  detect	  CAV	  in	  children.20,	  21	  	  	  	  
1.3. IVUS	  In	  1995,	  Mehra	  et	  al	   reported	  on	   the	  prognostic	   significance	  of	   IVUS.	  This	   study	  showed	   that,	   even	   in	   the	   presence	   of	   a	   normal	   angiogram,	   cardiac	   endpoints	  (death,	  infarction	  or	  intervention)	  were	  significantly	  more	  likely	  if	  severe	  intimal	  proliferation	  was	  present	  on	  IVUS.22	  This	  finding	  was	  subsequently	  confirmed	  by	  
Rickenbacher	  et	  al	  who	  showed	  that,	  despite	  normal	  angiography,	  a	  mean	  intimal	  thickness	  of	  >0.3mm	  was	  associated	  with	  a	  significantly	  worse	  four-­‐year	  survival	  and	  predicted	  the	  subsequent	  development	  of	  angiographic	  disease.23	  It	  has	  been	  previously	   demonstrated	   that	   it	   is	   not	   merely	   the	   presence	   of	   disease	   but	   the	  timing	   of	   onset	   and	   rate	   of	   progression	   that	   determines	   outcome.24	   Congruent	  with	  this,	  Kobashigawa	  et	  al	  went	  on	  to	  show	  that	  rapid	   intimal	  proliferation	  (as	  evidenced	  by	  an	  increase	  in	  intimal	  thickness	  of	  more	  than	  0.5mm	  in	  the	  first	  year	  after	  heart	  transplantation)	  was	  an	  important	  predictor	  of	  all-­‐cause	  death.	  25	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IVUS	   is	   the	  most	  sensitive	   imaging	  modality	   for	   the	  detection	  of	  CAV,	   it	  has	  high	  image	  resolution	  and	  measures	  of	  intimal	  thickness	  are	  reproducible.	  In	  addition,	  the	   prognostic	   significance	   is	   described	   above.	   For	   these	   reasons,	   most	   large	  multicentre	   trials	   use	   IVUS	   as	   the	   gold	   standard	   to	   assess	   the	   effect	   of	   drug	  treatments	   on	   CAV.	   Despite	   this,	   there	   remain	   a	   number	   of	   concerns	   regarding	  routine	  clinical	  use.	  These	   include	  an	   inability	   to	  draw	  inferences	  on	  the	  state	  of	  the	   microvasculature	   and	   a	   lack	   of	   standardisation	   of	   technique	   and	   of	   image	  analysis.	   Furthermore	   it	   is	   costly	   and	   time-­‐consuming.	   A	   recent	   consensus	  statement	  concludes	  that	  routine	  IVUS	  for	  clinical	  follow-­‐up	  cannot	  be	  advocated	  at	   this	   time	   because	   its	   value	   as	   a	   surrogate	   marker	   remains	   investigational.17	  However,	  this	  consensus	  statement	  does	  go	  some	  way	  into	  establishing	  standards	  for	   carrying	   out	   IVUS.	   Triple	   vessel	   imaging	   is	   preferred	   if	   possible	   with	  preference	  to	  imaging	  of	  the	  left	  anterior	  descending	  artery,	  followed	  by	  the	  right	  coronary	   artery	   and	   finally	   the	   circumflex	   when	   possible.	   It	   further	   advises	   an	  automated	  pullback	   to	   enhance	   consistent	   sampling	   and	   identification	  of	  branch	  vessels	  that	  are	  used	  as	  landmarks	  so	  that	  serial	  investigations	  can	  be	  performed	  and	  compared.	  This	  is	  the	  technique	  that	  we	  use	  at	  our	  institution,	  although,	  due	  to	   time	   constraints,	   imaging	   of	   the	   left	   anterior	   descending	   is	   preformed	   in	  preference.	   The	   consensus	   statement	   falls	   short	   of	   providing	   image	   analysis	  guidance.	  At	  our	   institution,	  we	  aim	   to	  analyse	  30	   cross-­‐sectional	   images	  evenly	  spaced	  (at	  approximately	  1.5mm	  intervals)	  over	  the	  same	  segment	  of	  left	  anterior	  descending	  artery	   identified	  by	  branch	  points.	  Additionally,	   the	   images	  anlaysed	  are	   always	   taken	   during	   the	   mid-­‐diastolic	   rest	   period	   for	   consistency.	   Maximal	  intimal	   thickness,	   mean	   intimal	   thickness,	   mean	   intimal	   index,10	   Stanford	  Grading10	  score	  and	  percent	  atheroma	  volume26	  are	  recorded.	  In	  addition,	  a	  semi-­‐
CHAPTER	  1	  –	  Review	  of	  Imaging	  for	  Coronary	  Allograft	  Vasculopathy	  
	   	   23	  
automatic	   interactive	   edge-­‐detection	   software	   is	   used	   (QIVUS	   Clinical	   Edition,	  Medis	  medical	   imaging	   systems)	   to	   improve	   reproducibility	   of	  measurements.27	  By	   adopting	   a	   standardised	   approach	   to	   performing	   IVUS	   and	   by	   using	   a	  systematic	  consistent	  analysis	  method,	  we	  believe	  that	  the	  clinical	  applicability	  for	  follow-­‐up	  and	  sensitivity	  to	  change	  in	  CAV	  is	  improved.	  In	   young	   children,	   evidence	   to	   support	   the	   use	   of	   IVUS	   is	   lacking.	   Unlike	  angiographically	   demonstrated	   CAV	   in	   children,	   demonstration	   of	   CAV	   by	   IVUS	  has	  not	  yet	  been	  convincingly	  shown	  to	  have	  any	  impact	  on	  prognosis.21	  However,	  this	   may	   be	   explained	   by	   small	   study	   numbers	   and	   inconsistent	   analysis	   and	  reporting	  techniques.	  Technical	  difficulties	  are	  also	  higher	  in	  children	  due	  to	  size	  and	   time	   limitations.	  Reported	   literature	   shows	  possible	  use	  of	   IVUS	   in	   children	  between	  21-­‐79kg,	  although	  the	  reported	  lower	  weight	  limit	  is	  10-­‐25kg.20,	  21	  In	  our	  clinical	  practice,	  we	  generally	  avoid	  use	  of	  IVUS	  below	  10	  years	  of	  age.	  	  	  
1.4. 	  Coronary	  Flow	  Reserve	  CAV	   is	   a	   diffuse	   process	  with	   frequent	   involvement	   of	   large-­‐	   and	  medium-­‐sized	  vessels	  as	  well	  as	  the	  microvasculature.28	  Furthermore,	  microvascular	  disease,	  as	  demonstrated	  by	  histology,	  has	  been	  shown	  to	  be	  a	  predictor	  of	  cardiac	  mortality	  in	  this	  group	  of	  patients,	  independent	  of	  other	  risk	  factors,	  including	  the	  presence	  of	  angiographically	  demonstrated	  epicardial	  disease.29	  Coronary	  microvasculature	  function	  can	  be	  directly	  assessed	  invasively	  by	  Doppler	  wire	  (or	  thermodilution)	  coronary	   artery	   flow	   velocity	   measurements	   before	   and	   after	   direct	  administration	  of	  endothelial-­‐dependent	  vasodilators	  (acetylcholine	  or	  substance	  P)	   and	   endothelial-­‐independent	   vasodilatation	   (nitroglycerine,	   adenosine,	   or	  papaverine).	  The	  Coronary	  Flow	  Reserve	  (CFR)	  is	  defined	  as	  the	  coronary	  artery	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averaged	   peak	   velocity	   during	   administration	   of	   vasodilator	   divided	   by	   the	  averaged	   peak	   velocity	   at	   rest.	   A	   reduction	   in	   CFR	   using	   maximal	   adenosine	  vasodilation,	   in	   the	  context	  of	  a	  normal	   fractional	   flow	  reserve	  (i.e.	  no	  epicardial	  stenosis)	  indicates	  microcirculatory	  dysfunction.30	  The	  Doppler	  wire	  method	  also	  provides	   other	   measures	   of	   microcirculatory	   function	   by	   analysis	   of	   the	   flow	  patterns	  ((e.g.	  diastolic	  deceleration	  time,	  systolic	  flow	  reversal)	  but	  there	  is	   less	  experience	   with	   the	   interpretation	   of	   these	   parameters.	   	   However,	   despite	   the	  proven	  prognostic	  value	  of	  detection	  of	  endothelial	  dysfunction	  using	  CFR	   in	   the	  setting	   of	   atherosclerosis,31,	   32	   its	   significance	   in	   the	   setting	   of	   CAV	   remains	  unclear.	  
Kubrik	   et	   al,	   in	   a	   study	   of	   185	   patients	   showed	   that	   whilst	   microvascular	  dysfunction,	  demonstrated	  by	  CFR,	  was	  a	  predictor	  of	  outcome	  (death	  or	  adverse	  cardiovascular	  event)	  in	  the	  univariate	  analysis,	  it	  did	  not	  predict	  outcome	  in	  the	  multivariate	  analysis.33	  In	  a	  smaller	  study	  of	  73	  patients,	  Hollenberg	  et	  al	  showed	  again	   that	  microvascular	   dysfunction	  was	  more	   common	   in	   the	   group	   suffering	  adverse	  outcomes	  (death	  or	  angiographic	  evidence	  of	  CAV)	  than	  in	  those	  without	  adverse	  outcome.	  There	  was	  no	  multivariate	  analysis	  in	  this	  study.34	  Regarding	   children,	   a	   small	   study	   has	   shown	   that	   occurrence	   of	   microvascular	  disease	   correlates	   with	   length	   of	   time	   since	   transplant.35	   Similarly,	   in	   another	  small	   study,	   CFR	   has	   been	   shown	   to	   be	   significantly	   reduced	   in	   children	   with	  histologically	   demonstrated	   microvasculopathy.36	   However,	   importantly	   this	  study	   was	   not	   able	   to	   demonstrate	   whether	   the	   reduction	   in	   CFR	   was	   due	   to	  epicardial	   or	  microvascular	   coronary	   disease.	   This	   was	   because	   there	   was	   only	  one	  patient	  in	  this	  study	  that	  had	  microvascular	  disease	  on	  histology	  without	  CAV	  demonstrated	  on	  angiogram.	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Although	   prognostic	   value	   of	   detecting	   microvascular	   disease	   by	   histology	   has	  been	   demonstrated,	   the	   incremental	   prognostic	   value	   of	   performing	   CFR	  measurements	   is	   uncertain.	   A	   recent	   study	   comparing	   IVUS	   and	   CFR	  measurements,	   suggests	   that,	   even	   in	   early	   CAV,	   the	   pattern	   of	   involvement	   is	  diffuse	   from	   epicardial	   arteries	   to	  microvasculature	   and	   suggests	   therefore	   that	  IVUS	  alone	  is	  sensitive	  enough	  to	  infer	  microvascular	  involvement.37	  Furthermore,	  the	  invasive	  nature	  of	  CFR	  makes	  it	  unattractive	  for	  diagnostic	  use	  in	  children.	  More	  recently,	  the	  index	  of	  microvascular	  resistance	  (IMR)	  has	  been	  shown	  to	  be	  a	  measure	   which	   is	   more	   independent	   of	   epicardial	   disease	   than	   CFR.38	   It	   is	  measured	  in	  a	  similar	  manner	  and	  defined	  as	  distal	  coronary	  pressure	  multiplied	  by	   the	   hyperaemic	  mean	   transit	   time	   (mmHg	   seconds).39	  One	   study	  has	   already	  demonstrated	   the	   potential	   value	   of	   this	   index	   as	   a	  marker	   for	   CAV	   but	   further	  evaluation	  is	  necessary.15	  	  
1.5. Single	  photon	  emission	  computed	  tomography	  Single	  photon	  emission	  computed	  tomography	  (SPECT)	  is	  well	  established	  in	  the	  detection	  of	   ischaemia	   in	   the	  setting	  of	  coronary	  atherosclerosis	  and	   its	  value	   to	  guide	   management	   in	   this	   setting	   has	   been	   documented.40,	   41	   Ciliberto	   et	   al	  demonstrated	  the	  use	  of	  quantitative	  evaluation	  of	  SPECT	  imaging	  with	  high-­‐dose	  dipyridamole	   stress	   for	   CAV.42	   This	   study	   showed	   that	   if	   rest	   echocardiography	  showed	  no	  wall	  motion	  abnormalities	  and	  SPECT	  did	  not	  show	  the	  presence	  of	  a	  reversible	  perfusion	  defect,	  then	  the	  combined	  negative	  predictive	  value	  of	  this	  for	  any	   significant	   CAV	   was	   100%.	   Significant	   CAV	   is	   defined	   here	   as	   luminal	  narrowing	  >50%	  and/or	  diffuse	  small	  vessel	  narrowing.	  However,	  this	  combined	  approach	  still	  only	  achieves	  60%	  sensitivity	  for	  all	  angiographically	  demonstrated	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CAV.	   Given	   the	   relative	   insensitivity	   of	   angiography,	   as	   discussed	   above,	   there	  would	  be	  significant	  concerns	  regarding	  the	  applicability	  of	  this	  approach	  for	  early	  detection	  and	  prevention	  of	  CAV.	  	  
Wu	  et	  al	  similarly	  showed	  the	  use	  of	  dobutamine	  stress	  perfusion	  with	  SPECT	  but	  again	   used	   angiography	   as	   the	   comparison.43	   Several	   smaller	   studies	   have	   also	  indicated	  the	  potential	  of	  SPECT	  in	  this	  respect44-­‐46.	  	  More	  importantly	  a	  reversible	  stress	  perfusion	  defect	  on	  SPECT	  has	  been	  shown	  to	  be	  an	  independent	  predictor	  of	  mortality	  and	  graft	  loss	  after	  heart	  transplantation	  
42,	  43,	  47,	  48	  and	  two	  small	  studies	  have	  even	  suggested	  that	  stress	  SPECT	  imaging	  at	  1	  year	  post-­‐transplant	  may	  be	  of	  early	  prognostic	  significance.49,	  50	  However,	   the	  use	   of	   SPECT	   still	   needs	   to	   be	   moderated	   by	   concerns	   regarding	   the	   relative	  insensitivity	   to	   detect	   CAV	  when	   compared	   to	   IVUS	   and	   concerns	   regarding	   the	  use	  of	  ionising	  radiation.	  	  The	  experience	  of	   SPECT	   imaging	   in	   children	  with	  CAV	   is	   extremely	   limited	  and	  this	   may	   in	   part	   be	   due	   to	   low	   spatial	   resolution,	   which	   becomes	   particularly	  relevant	  for	  smaller	  hearts.	  	  
1.6. Echocardiography	  Both	   Dobutamine	   Stress	   Echocardiography	   (DSE)	   and	   Tissue	   Doppler	   Imaging	  (TDI)	  have	  been	  evaluated	  with	  respect	  to	  CAV.	  In	  a	  well-­‐structured	  investigation,	  
Spes	   et	   al	   evaluated	   both	   the	   diagnostic	   and	   prognostic	   value	   of	   DSE.51	   This	  showed	   that	   DSE	   has	   a	   poor	   sensitivity	   (47%)	   to	   detect	   progression	   of	   CAV	   as	  demonstrated	   by	   a	   combination	   of	   angiography	   and	   IVUS	   (specificity	   72%,	  positive	   predictive	   value	   74%,	   negative	   predictive	   value	   44%).	   However,	   the	  prognostic	   implications	   of	   serial	   DSE	   testing	   are	   clearly	   shown	   from	   this	   study.	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Serial	  normal	  DSE	  examinations	  had	  a	  96%	  negative	  predictive	  value	  for	  adverse	  cardiac	   outcomes	   (Sensitivity	   82%;	   Specificity	   69%;	   Positive	   Predictive	   Value	  29%).	  Limitations	  of	   this	  study	   include	   the	   fact	   that	  only	  patients	  with	  adequate	  trans-­‐thoracic	   echocardiographic	   windows	   could	   be	   studied.	   Furthermore,	   the	  average	   length	  of	   clinical	   follow-­‐up	  stated	  was	  only	  2.7	  years	  per	  patient	  and	  so	  the	  number	   of	   cardiac	   adverse	   outcomes	  was	   small	   (with	  many	  of	   the	   recorded	  adverse	   events	   being	   coronary	   interventions).	   In	   addition,	   IVUS	   was	   not	  performed	  in	  all	  of	  the	  patients.	  Despite	  these	  limitations,	  it	  is	  interesting	  to	  note	  that	   in	   patients	  with	   abnormal	  DSE,	   90%	  had	   significant	   CAV	   by	   IVUS,	   but	   only	  49%	   by	   angiography.	   This	   confirms	   that	   angiography	   is	   relatively	   insensitive	   in	  detecting	   CAV	   and	   infers	   incremental	   value	   to	   the	   addition	   of	   stress	   testing	   for	  institutions	  following	  only	  a	  policy	  of	  coronary	  luminal	  imaging.	  Furthermore,	  the	  high	   negative	   predictive	   value	   of	   stress	   testing	   with	   respect	   to	   outcome	   may	  suggest	   that	   if	   a	   strict	   DSE	   protocol	   is	   followed,	   a	   selective	   angiography/	   IVUS	  policy	  may	  be	  adopted.	  This	  policy	  would	  be	  supported	  by	  findings	  from	  other	  DSE	  studies.52-­‐54	   Furthermore,	   another	   study	  has	   also	   suggested	   that	   this	   is	   also	   true	  even	   early	   after	   transplantation	   and	   that	   early	   reproducible	   wall	   motion	  abnormalities	   on	   dobutamine	   stress	   are	   predictive	   of	   later	   events.55	   This	   offers	  further	   evidence	   for	   the	   use	   of	   stress	   testing	   to	   reduce	   the	   burden	   of	   invasive	  monitoring	   for	  CAV.	  Recent	  evidence	   suggests	   that	   strain	   rate	   imaging	  may	  be	  a	  useful	   quantitative	   aid	   to	   improve	   upon	   the	   qualitative	   visual	   assessment	   of	  myocardial	  segmental	  contractility	  during	  DSE.56	  	  The	  non-­‐invasive	  nature	  of	  DSE	  and	  the	   familiarity	  with	  echocardiography	  mean	  that	  DSE	  in	  children	  can	  be	  carried	  out	  with	  relative	  ease	  in	  most	  cases	  (with	  use	  of	   sedation	   for	   more	   difficult	   cases).	   This	   makes	   it	   an	   attractive	   modality	   in	  
CHAPTER	  1	  –	  Review	  of	  Imaging	  for	  Coronary	  Allograft	  Vasculopathy	  
	   	   28	  
children	   and	   studies	   in	   children	   have	   shown	   promise	   in	   this	   respect.57-­‐60	  When	  angiography	  is	  used	  as	  the	  standard,	  DSE	  shows	  a	  sensitivity	  for	  the	  detection	  of	  CAV	  in	  children	  of	  35-­‐71%;	  specificity	  of	  80-­‐94%;	  positive	  predictive	  value	  of	  45-­‐71%	  and	  negative	  predictive	   value	  of	   81-­‐92%.57,	  58,	  60	   Furthermore,	   although	   the	  adverse	   event	   rate	   in	   these	   studies	   was	   low	   with	   a	   relatively	   short	   follow-­‐up,	  prognostic	  significance	  of	  DSE	  has	  been	  demonstrated	  in	  children	  with	  a	  negative	  predictive	  value	  of	  95-­‐96%	  with	   respect	   to	  adverse	  events.57,	  58	   	  Although	  utility	  and	  feasibility	  have	  been	  demonstrated,	  DSE	  imaging	  in	  children	  requires	  a	  good	  setup	   to	   ensure	   efficient	   intravenous	   access;	   accurate	   ECG	  monitoring;	   effective	  sedation	   if	   required;	   sonographer	   expertise	   in	   image	   acquisition;	   physician	  expertise	  in	  wall	  motion	  analysis;	  appropriate	  software	  for	  analysis	  and	  a	  specific,	  reproducible	  protocol.	  A	   recent	   small	   study	   has	   shown	   the	   feasibility	   of	   assessing	   CFR	   by	   contrast-­‐enhanced	  trans-­‐thoracic	  echocardiography.61	   It	  showed	  both	  high	  sensitivity	  and	  specificity	   for	   the	   detection	   of	   significant	   CAV	   (as	   defined	   by	   maximal	   intimal	  thickness	   on	   IVUS	   >0.5mm).	   In	   a	   previous	   study	  with	  multivariate	   analysis,	   the	  same	   group	   has	   shown	   the	   prognostic	   value	   of	   this	   technique.62	   Given	   the	  uncertainty	  regarding	  the	  prognostic	  value	  of	  invasive	  CFR	  measurements,	  further	  evaluation	  of	  this	  technique	  is	  required	  to	  demonstrate	  its	  robustness.	  Tissue	  Doppler	  Imaging	  has	  become	  commonplace	  in	  clinical	  cardiology.	  Dandel	  et	  
al	  have	  demonstrated	  the	  utility	  of	  TDI	  for	  the	  detection	  of	  CAV.63	  In	  this	  study	  293	  patients	   underwent	   angiography	   and	   those	  with	   normal	   angiograms	   underwent	  further	   intravascular	   ultrasound	   to	   evaluate	   for	   CAV.	   In	   this	   study,	   systolic	   TDI	  parameters	   at	   the	   basal	   lateral	   LV	  wall	   (mitral	   annulus	   level)	  were	   found	   to	   be	  most	  predictive	  for	  CAV.	  Both	  peak	  systolic	  wall	  motion	  velocity	  (Sm)	  and	  time	  to	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peak	   systole	   (TSm,	   using	   a	   phonogram	   to	   time	   the	   first	   heart	   sound)	   were	  significantly	  different	  between	  those	  with	  CAV	  (even	  if	  only	  detected	  on	  IVUS)	  and	  those	   without	   CAV.	   However,	   only	   the	   negative	   predictive	   value	   of	   TDI	   for	  angiographic	  disease	  is	  quoted,	  with	  more	  complex	  formulae	  required	  to	  exclude	  intravascular	   ultrasound	   or	   angiographic	   disease	   with	   only	   80%	   probability.	  Nevertheless,	  with	  Sm	  >11cm/s	  and	  TSm	  >	  110cm/s2,	  angiographic	  disease	  can	  be	  excluded.	   Furthermore,	   in	   the	   absence	   of	   any	   rejection,	   an	   Sm	   <	   10cm/s	   has	   a	  positive	  predictive	  value	  of	  over	  97%	  for	  CAV	  (detected	  by	  IVUS	  or	  angiography).	  Concerns	   with	   this	   approach	   include	   interobserver	   variability	   of	   measurements	  and	  the	  influence	  of	  bundle	  branch	  block	  on	  individual	  TSm	  measurements.	  Given	  the	  ease	  of	  acquisition	  of	  serial	  measurements,	  TDI	  seems	  to	  be	  sensible	  addition	  to	   routine	   2-­‐dimensional	   echocardiography	   follow-­‐up	   in	   the	   clinic.	   However,	  consistency	  and	  interpretation	  may	  vary	  from	  centre	  to	  centre.	  In	  children,	  the	  applicability	  of	  TDI	  after	  heart	  transplantation	  has	  been	  studied	  in	  53	  children,	  in	  order	  to	  investigate	  the	  progression	  of	  TDI	  indices.	  Only	  8	  children	  had	   pre-­‐terminal	   disease	   but	   the	   study	   did	   show	   that	   both	   tricuspid	   and	  mitral	  annulus	  peak	  velocities	  (systolic	  and	  early	  diastolic)	  are	  reduced	   in	  pre-­‐terminal	  disease.	   Tricuspid	   annular	   velocities	   (systolic	   and	   diastolic)	   were	   shown	   to	   be	  earlier	   predictors	   than	   mitral	   ones.	   However,	   in	   this	   study,	   traditional	  echocardiographic	  measures	  such	  as	  ejection	  fraction	  and	  tricuspid	  regurgitation	  severity	   were	   also	   early	   and	   strong	   predictors	   of	  mortality	   respectively.	   Hence,	  although	   the	   feasibility	   and	   reproducibility	   of	   tricuspid	   annular	   velocities	   in	  children	   has	   been	   shown,64	   the	   incremental	   value	   of	   TDI	   for	   children	   remains	  unclear.	   Furthermore,	   a	   recent	   study	   in	   paediatric	   heart	   transplant	   recipients	  showed	  a	  poor	  correlation	  between	  TDI	  parameters	  and	  invasive	  haemodynamics	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for	   both	   right	   and	   left	   ventricular	   indices.65	   Hence,	   although	   easily	   applied,	  interpretation	   of	   TDI	   indices	   after	   heart	   transplantation	   for	   children	   requires	  further	  study.	  Exercise	   stress	   echocardiography	   has	   been	   evaluated	   in	   heart	   transplant	  recipients	   but	   has	   been	   repeatedly	   found	   to	   have	   an	   unacceptably	   low	  sensitivity.66,	  67	  The	  reason	  for	  this	  may	  be	  the	  relatively	  poor	  heart	  rate	  response	  to	  exercise	  in	  transplant	  recipients.68	  	  
1.7. Pulse	  Wave	  Velocity	  Carotid-­‐Femoral	  pulse	  wave	  velocity	  (PWV)	   is	  easy	  to	  perform	  clinically	  and	   is	  a	  marker	   for	   the	   intrinsic	   stiffness	  of	   the	  aortic	  wall,	  which	  has	  been	  shown	   to	  be	  highly	   predictive	   for	   cardiovascular	   events	   in	   the	   setting	   of	   atherosclerosis.69-­‐74	  The	  explanation	  given	  for	  this	  has	  been	  that	  the	  PWV	  is	  a	  measure	  reflecting	  the	  cumulative	  effect	  of	  cardiovascular	  risk	  factors	  on	  the	  arterial	  wall.75	  Furthermore	  increased	  aortic	   stiffness	  signifies	  adverse	  myocardial	  haemodynamic	  conditions	  including	  an	  increase	  in	  systolic	  blood	  pressure	  and	  pulse	  pressure	  with	  increased	  systolic	   load	  and	  decreased	  myocardial	  perfusion	  pressure.76-­‐78	  The	  relative	  ease	  of	  measurement	  would	  make	  it	  an	  attractive	  adjunct	  to	  the	  clinic	   if	   its	  utility	  can	  be	  shown	  in	  the	  setting	  of	  CAV.	  It	  would	  be	  particularly	  beneficial	  in	  children	  for	  whom	  quick	  non-­‐invasive	  markers	  are	  more	  acceptable.	  However,	   the	  pattern	  of	  blood	  pressure	  increase	  after	  cardiac	  transplantation	  in	  childhood	  is	  not	  typical	  to	  that	  seen	  due	  arterial	  stiffness	  (e.g.	  high	  systolic	  blood	  pressure	  with	  wider	  pulse	  pressure,	  as	  seen	  in	  elderly	  patients).79	  Nevertheless,	  a	  small	  study	  performed	  in	  children	  above	  5	  years	  of	  age	  showed	  a	  significant	  correlation	  between	  length	  of	  time	   since	   transplantation	   and	   PWV.79	   This	   finding	   may	   suggest	   that	   systemic	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inflammatory	   insults	   related	   to	   CAV	   may	   also	   be	   correlated	   to	   PWV.	   Although	  numbers	  were	  too	  small	  for	  a	  meaningful	  multivariate	  analysis,	  the	  utility	  of	  PWV	  in	  these	  patients	  warrants	  further	  attention.	  	  
1.8. Multidetector	  Computed	  Tomography	  In	   the	   setting	   of	   atherosclerosis,	   new	   Multidetector	   Computed	   Tomography	  (MDCT)	  facilities	  have	  been	  proven	  to	  have	  high	  sensitivity	  and	  specificity	  for	  the	  detection	   of	   angiographically	   significant	   coronary	   stenoses.80	   Furthermore,	  coronary	   plaque	   detection	   is	   also	   possible	   using	   MDCT	   and	   attempts	   are	   being	  made	   to	   characterise	   plaque	   using	   this	   imaging	  modality.81,	  82	   In	   line	  with	   these	  findings,	   it	   has	   also	   been	   shown	   that	   MDCT	   is	   accurate	   in	   defining	   coronary	  stenoses	   in	   the	   setting	   of	   CAV.12,	  83	   It	   has	   been	   shown	   that,	   using	   a	   16-­‐detector	  MDCT,	  95%	  of	  coronary	  segments	  >1.5mm	  can	  be	  imaged.83	  Of	  the	  segments	  that	  were	  imaged,	  and	  by	  defining	  a	  significant	  coronary	  stenosis	  as	  >50%,	  MDCT	  was	  shown	  to	  have	  sensitivity,	  specificity,	  and	  positive	  and	  negative	  predictive	  values	  of	  86%,	  99%,	  81%,	  and	  99%,	  respectively,	  when	  compared	  with	  angiography.	  Only	  a	   small	   subsection	   of	   these	   patients	   underwent	   IVUS.	   In	   a	   separate	   study	   of	   20	  patients,	   Gregory	   et	   al	   showed	   that	   in	   comparison	   to	   IVUS	   (defining	   significant	  CAV	   as	   a	   maximal	   intimal	   thickness	   >0.5mm	   for	   a	   given	   segment),	   64-­‐detector	  MDCT	   had	   a	   sensitivity	   of	   70%,	   specificity	   of	   92%,	   positive	   predictive	   value	   of	  89%,	  and	  negative	  predictive	  value	  of	  77%	  for	  the	  detection	  of	  CAV.12	  It	  should	  be	  noted	   that	   in	   this	  study,	  17%	  of	  segments	  (mainly	  distal	  segments)	  could	  not	  be	  analysed	   due	   to	   image	   quality	   and	   authors	   describe	   this	   patient	   group	   as	  challenging	   due	   to	   high	   BMI	   and	   high	   resting	   heart	   rates	   despite	   use	   of	   beta-­‐blockers.	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However,	   the	   introduction	   of	   vessel	   wall	   analysis	   with	   MDCT	   gives	   further	  potential	   strength	   to	   this	   imaging	   technique.84,	  85	  Using	   a	  16-­‐detector	  MDCT	  and	  oral	  beta-­‐blockers	  for	  all	  patients,	  Romeo	  et	  al	  described	  the	  analysis	  of	  lumen	  and	  vessel	   wall	   defining	   three	   groups	   by	   visual	   assessment	   ((i)	   normal;	   (ii)	   wall	  thickening	   without	   significant	   stenosis	   and	   (iii)	   stenosis	   (luminal	   stenosis	  >50%).84	  Again	  complete	  analysis	  of	  coronary	  segments	  was	  not	  possible	  in	  17%	  (9	   of	   53)	   of	   patients.	   A	   further	   2	   patients	   had	   impaired	   analysis	   due	   to	   heavy	  calcification.	   This	   impact	   study	   of	   this	   is	   reduced,	   as	   it	   did	   not	   use	   IVUS	   to	  correlate	  findings	  of	  wall	  thickening.	  Nevertheless,	  the	  sensitivity	  of	  MDCT	  for	  the	  detection	  of	  stenosis	  was	  83%,	  specificity	  95%,	  positive	  predictive	  value	  71%	  and	  negative	   predictive	   value	   95%.	   Another	   small	   study,	   using	   64-­‐detector	   MDCT	  showed	  that	   it	  may	  be	  more	  sensitive	   for	  the	  detection	  of	  CAV	  than	  angiography	  alone	  but	  again,	  no	  IVUS	  was	  preformed	  for	  defining	  vessel	  wall	  disease.85	  	  One	  small	  study	  directly	  compared	  a	  64	  channel	  dual	  source	  CT	  technology	  with	  IVUS.86	   CAV	  was	   defined	   as	   intimal	   thickening	   >0.5mm	  on	   IVUS	   and	   any	   visible	  wall	  thickening	  on	  CT.	  27%	  of	  screened	  patients	  were	  excluded	  from	  the	  study	  due	  to	   impaired	   renal	   function,	  which	   is	   a	   common	   finding	   in	   this	   group	  of	  patients.	  Despite	   a	   high	   mean	   HR	   (80	   bpm,	   range	   60-­‐100	   bpm),	   no	   beta-­‐blockers	   were	  required	   and	   image	   quality	   was	   adequate	   for	   analysis	   in	   96%	   of	   all	   coronary	  segments	   that	  were	   larger	   than	   1.5mm	  diameter	   on	   angiography.	  Using	   IVUS	   to	  define	  CAV,	  dual	   source	  CT	  had	  a	   sensitivity	  of	  85%,	   specificity	  of	  84%,	  positive	  predictive	  value	  of	  76%,	  and	  negative	  predictive	  value	  of	  91%.	  	  In	   summary,	   the	   progress	   in	   equipment,	   such	   as	   increased	   slice	   number,	   use	   of	  dual	  source	  technology,	   increased	  gantry	  rotation	  speed	  and	  so	  on	  has	  made	  the	  MDCT	  examination	  time	  shorter,	  increased	  the	  success	  rate	  of	  examined	  cases	  and	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reduced	   the	   total	   radiation	   exposure.	   The	   use	   of	   MDCT	   as	   a	   screening	   tool	   to	  reduce	  the	  number	  of	  invasive	  procedures	  therefore	  seems	  appropriate,	  although	  concerns	   remain	   regarding	   the	   radiation	   exposure,	   image	   degradation	   due	   to	  vessel	   calcification,	   use	   of	   nephrotoxic	   contrast	   agent,	   image	   acquisition	   at	   high	  heart	   rates	   (which	   appears	   less	   problematic	   with	   the	   latest	   dual	   source	   CT	  technology)	  and	  the	  image	  resolution	  achieved.	  Further,	  although	  comprehensive	  function,	   stress	   testing	   and	  myocardial	   scar	   protocols	   are	   possible	   using	  MDCT,	  the	  radiation	  dose	  involved	  deters	  extensive	  protocols.	  With	  regards	  MDCT	  imaging	  in	  children,	  there	  is	  very	  little	  published	  data.	  Some	  small	   studies	   have	   suggested	   feasibility	   of	   MDCT	   in	   both	   Kawasaki	   disease	   and	  CAV	   but	   issues	   of	   resolution,	   high	   heart	   rates	   and	   radiation	   exposure	   remain	  important	  limitations.87,	  88	  	  
1.9. Cardiac	  Magnetic	  Resonance	  (CMR)	  Coronary	  Magnetic	  Resonance	  Angiography	  (CMRA)	  has	  demonstrated	  feasibility	  for	   the	  detection	  of	   stenoses	   in	   the	   setting	  of	   atherosclerosis,89	   and,	  when	  using	  tailored	   paediatric	   protocols,	   it	   is	   even	   of	   diagnostic	   use	   in	   small	   children	  with	  high	   heart	   rates.90-­‐92	   However,	   most	   authors	   would	   agree	   that	   resolution	   and	  diagnostic	  accuracy	  is	  not	  as	  high	  as	  MDCT	  and	  indeed,	  one	  small	  trial	  looking	  at	  both	   modalities	   in	   the	   setting	   of	   CAV,	   confirms	   this	   statement.93	   However,	   the	  advantage	  of	  CMR	   is	   its	  versatility	   in	   functional	   imaging.	  A	  single	  CMR	  exam	  can	  give	   information	   on	   volumes,	   function,	   wall	   motion,	   myocardial	   scar,	   ischaemia	  and	  coronary	  angiography.	  	  In	  the	  setting	  of	  atherosclerosis,	  adenosine	  stress	  perfusion	  MRI	  has	  shown	  non-­‐inferiority	   to	   SPECT	   for	   the	  detection	  of	  myocardial	   ischaemia	  and	   further	   trials	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are	   underway.94	   Furthermore,	   for	   dobutamine	   stress,	   MRI	   has	   been	   shown	   to	  perform	   better	   than	   echocardiography	   for	   the	   detection	   of	   atherosclerotic	  coronary	  stenoses.95	  Initial	  data	  for	  analysis	  using	  MRI,	  suggests	  that	  MRI	  may	  be	  able	  to	  quantitatively	  assess	  myocardial	  perfusion	  reserve.96	  However,	  this	  study	  used	  CFR	  to	  define	  significant	  CAV	  and	  because	  all	  the	  patients	  in	  the	  group	  with	  significant	  CAV	  had	  severe	  epicardial	  disease,	  microvascular	  disease	  could	  not	  be	  independently	  assessed.	  	  Coronary	   vessel	  wall	   imaging	   and	   analysis	   has	   been	   shown	   to	   be	   feasible	   using	  MRI	  but	  this	  technology	  has	  not	  been	  assessed	  in	  the	  setting	  of	  CAV.	  97-­‐99	  
Steen	   et	   al,	   using	   the	   robust	   clinical	   tool	   of	   myocardial	   late	   gadolinium	  enhancement	  (LGE)	  showed	  that	  84%	  of	  patients	  with	  severe	  CAV	  on	  angiography	  had	   typical	   infarct-­‐pattern	   subendocardial	   late	   gadolinium	   enhancement	   with	   a	  distribution	  consistent	  with	  the	  pattern	  of	  CAV	  on	  angiography.100	  Those	  patients	  with	   infarct-­‐typical	   patterns	   of	   LGE	   had	   also	   showed	   reduced	   left	   ventricular	  ejection	  fractions	  at	  rest.	  There	   are	   promising	   advantages	   of	   using	   CMR	   to	   define	   CAV.	   These	   include	   the	  comprehensive	   assessment	   possible;	   the	   lack	   of	   ionising	   radiation	   and	   the	   non-­‐invasive	   nature.	   However,	   although	   less	   nephrotoxic	   than	   x-­‐ray	   contrast	  media,	  Gadolinium-­‐based	  agents	  remain	  contra-­‐indicated	  in	  end-­‐stage	  renal	  failure	  due	  to	  concerns	  regarding	  nephrogenic	  systemic	  fibrosis	  (NSF).	  Moreover,	  the	  paucity	  of	  data	  for	  CMR	  in	  the	  setting	  of	  CAV	  precludes	  any	  recommendations	  regarding	  its	  use	  at	  the	  current	  stage.	  There	  is	  no	  substantial	  data	  to	  support	  its	  use	  in	  children.	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1.10. Conclusions	  Despite	   advances	   described	   here,	   conventional	   angiography	   remains	   the	   main	  diagnostic	  modality	  of	   choice	   for	   the	   follow-­‐up	  of	  CAV.	  The	  prognostic	   impact	  of	  angiography	  is	  clear	  but	  its	  relative	  insensitivity	  renders	  it	   flawed	  as	  a	  screening	  tool	   to	   detect	   and	   attempt	   to	   treat	   disease	   early.	   IVUS	   is	   currently	   the	   most	  sensitive	  imaging	  modality	  and	  so,	  is	  crucial	  in	  this	  regard	  for	  the	  study	  of	  disease	  and	  prevention.	  It	  is	  therefore	  important	  to	  perform	  and	  analyse/	  report	  the	  IVUS	  in	  a	  thorough	  and	  reproducible	  manner.	  Such	  attention	  to	  detail	  for	  IVUS	  will	  also	  facilitate	  studies	  seeking	  to	  validate	  non-­‐invasive	  imaging	  methods.	  	  Sufficient	  data	  exists	  for	  the	  use	  of	  dobutamine	  stress	  echo	  (DSE)	  or	  SPECT	  stress	  perfusion	  in	  adults	  as	  a	  screening	  tool	  to	  reduce	  the	  burden	  of	  invasive	  testing.	  In	  children,	  DSE	  is	  currently	  preferable.	  CMR	  is	  a	  promising	  modality	  and	  there	  are	  clear	  advantages	  in	  terms	  of	  comprehensive	  single-­‐modality	  assessment;	  in	  terms	  of	   image	  quality	  over	  DSE	  and	   in	   terms	  of	   lack	  of	   radiation	  over	  SPECT	   imaging.	  MDCT	   can	   now	   give	   both	   vessel	   wall	   and	   lumen	   information	   with	   acceptable	  accuracy	   in	   non-­‐calcified	   vessels.	   Therefore,	   this	   modality	   may	   also	   be	   used	   to	  reduce	   the	   amount	  of	   invasive	   testing,	   although	  applicability	   to	   children	  may	  be	  limited	  due	  to	  high	  heart	  rates	  and	  ionising	  radiation.	  The	   choice	   of	   non-­‐invasive	   imaging	   modality	   to	   guide	   a	   selective	   approach	   to	  conventional	  angiography	  and	   IVUS,	   is	   currently	  guided	  by	  centre	  experience.	   In	  particular	   stress	   protocols	  whether	   SPECT,	   DSE	   or	  MRI	  must	   be	   performed	   and	  analysed	   rigorously	   according	   to	   accepted	   criteria.	   Operator	   experience,	   good	  image	   quality	   and	   effective	   patient-­‐friendly	   protocols	   are	   currently	   more	  important	   determinants	   of	   the	   diagnostic	   power	   of	   the	   imaging	   than	   the	   actual	  choice	  of	  imaging	  modality.	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In	  order	   to	   realise	   the	   advantages	  of	  CMR	   for	   coronary	  vasculopathy	   imaging	   in	  children,	   the	   first	   step	   in	   this	   thesis	   is	   to	   develop	   routine	   diagnostic	   quality	  coronary	   lumen	   imaging	   in	   children	   and	   to	   develop	   reference	   values	   for	   CMRA	  lumen	  dimensions.	  The	  next	  step	  is	  to	  investigate	  techniques	  for	  improving	  lumen	  image	  quality	  further.	  Once	  this	  has	  been	  elaborated,	  the	  use	  of	  direct	  imaging	  of	  coronary	   vasculopathy	   using	   contrast-­‐enhanced	   techniques	   can	   be	   applied	   to	  specific	   patient	   groups.	   Finally,	   the	   development	   of	   rapid	   aortic	   imaging	   as	   a	  marker	  for	  coronary	  vasculopathy	  is	  explored.	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2. Coronary	  Lumen	  MRI	  In	  Children	  	  
	  
2.1. Developing	   Coronary	   Lumen	   Imaging	   in	   Children:	   The	   Dual	   Phase	  
approach	  	  
2.1.1. Introduction	  Good	   coronary	   lumen	   imaging	   underpins	   successful	   coronary	   vessel	   wall	  characterisation	  by	  MR.	  The	   technique	  of	   coronary	   imaging	   in	  children	  has	  been	  well	   described	   in	   children	   with	   congenital	   heart	   disease.101	   In	   order	   to	   achieve	  this,	   a	   number	   of	   challenges	   were	   overcome,	   including	   cardiac	   and	   respiratory	  motion,	   and	   the	   proximity	   of	   the	   coronary	   arteries	   to	   epicardial	   fat	   and	  myocardium	   (Figure	   1).	   Cardiac	   motion	   required	   synchronisation	   of	   data	  acquisition	  to	  the	  mid-­‐diastolic	  rest	  period	  of	  the	  heart	  as	  identified	  using	  a	  high	  temporal	  resolution	  4-­‐chamber	  cine.102	  Compensation	  for	  respiratory	  motion	  was	  performed	  using	  an	  MR	  navigator,	  a	  pencil	   like	  beam,	  placed	  on	  the	  dome	  of	   the	  right	   hemi-­‐diaphragm.103	   Data	   is	   accepted	   if	   the	   diaphragm-­‐lung	   interface	   is	  within	  a	  window	  of	  3	  to	  5	  mm	  placed	  in	  end-­‐expiration.	  Suppression	  of	  high	  signal	  from	  the	  epicardial	  fat	  was	  accomplished	  using	  a	  frequency	  selective	  small-­‐banded	  pre-­‐pulse	   that	   saturates	   fat	   signal	   and	   immediately	   precedes	   the	   imaging	  sequence.104	   Myocardial	   suppression	  was	   achieved	   using	   a	   T2	   pre-­‐pulse.105	   The	  combination	   of	   these	   imaging	   advances	   made	   coronary	   imaging	   possible	   in	  children.	   However,	   even	   in	   the	   aforementioned	   study	   by	   Beerbaum	   et	   al,101	  imaging	  of	  children	  less	  than	  6	  years	  of	  age	  was	  unsatisfactory	  due	  to	  vessel	  size	  and	  high	  heart	  rates.	  In	  this	  regard,	  major	  advances	  have	  been	  made	  by	  our	  group	  (detailed	  in	  study	  2.1.2.	  and	  2.1.3.	  below).	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Figure	  1.	  Schematic	  Showing	  Three-­‐Dimensional	  Whole	  Heart	  Sequence	  
Myocardial	   suppression	   was	   achieved	   using	   a	   T2	   pre-­‐pulse	   (T2	   PREP).	  
Compensation	  for	  respiratory	  motion	  was	  performed	  using	  an	  MR	  navigator,	  
a	   pencil	   like	   beam,	   placed	   on	   the	   dome	   of	   the	   right	   hemi-­‐diaphragm	   (2D	  
SELECTIVE	   REALTIME	   NAVIGATOR).	   Suppression	   of	   high	   signal	   from	   the	  
epicardial	   fat	   was	   accomplished	   using	   a	   frequency	   selective	   small-­‐banded	  
pre-­‐pulse	   that	   saturates	   fat	   signal	   and	   immediately	   precedes	   the	   imaging	  
sequence	   (FAT	   SAT).	   The	   imaging	   sequence	   is	   a	   three-­‐dimensional	   steady-­‐
state-­‐free-­‐precession	  acquisition.	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2.1.2. Detection	   of	   Coronary	   Artery	   Anomalies	   in	   Infants	   and	   Young	  
Children	  with	  Congenital	  Heart	  Disease	  Using	  Magnetic	  Resonance	  Imaging,	  
(Tangcharoen	  et	  al)	  	  Dr.	   Hussain’s	   contribution	   to	   this	   work	   was	   data	   analysis	   and	   manuscript	  editing.90	   This	   work	   showed	   that,	   using	   a	   set	   protocol,	   coronary	   imaging	   in	  children	  is	  successful	  beyond	  4	  months	  of	  age	  (88%	  success	  at	  >4	  months	  vs.	  17%	  ≤4	   months,	   p<0.001).	   There	   were	   several	   key	   improvements	   that	   may	   have	  allowed	  this	  improvement	  in	  comparison	  to	  previous	  studies:	  
• In	   younger	  patients	  with	  higher	  heart	   rates,	   the	  mid-­‐diastolic	   rest	   period	  shortened	   whilst	   the	   end	   systolic	   rest	   period	   remained	   almost	   constant.	   As	   a	  consequence	  we	  acquired	  the	  whole-­‐heart	  data	  during	  end	  systole	  in	  most	  of	  our	  young	   children	   and	   achieved	   diagnostic	   image	   quality	   in	   most	   of	   our	   patients.	  Another	   advantage	   of	   end	   systolic	   data	   acquisition	   may	   be	   the	   more	   constant	  duration	  and	  position	  of	  the	  systolic	  rest	  period	  within	  the	  cardiac	  cycle	  compared	  to	  the	  mid-­‐diastolic	  rest	  period.106	  
• General	   anaesthetic	   allowed	   for	   a	   more	   regular	   pattern	   of	   breathing	  compared	   to	   free-­‐breathing	   patients.	   In	   fact	   sequential	   breath	   holds	   in	  combination	   with	   a	   very	   narrow	   navigator	   window	   (3	   mm)	   allowed	   very	  successful	   suppression	   of	   respiratory	   motion.	   The	   use	   of	   remifentanil	   as	   the	  anaesthetic	   agent	   is	   further	   advantageous	   in	   terms	   of	   heart	   rate	   control	   for	  imaging	  
• As	   coronary	   arteries	   in	   children	   are	   small,	   better	   intravascular	   contrast	  may	   have	   been	   achieved	   by	   imaging	   after	   administration	   of	   Gadolinium-­‐based	  contrast	  agent	  as	  observed	  by	  other	  groups.107	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2.1.3. Coronary	  MR	   Angiography	   in	   children	  with	   CHD	  During	   Systole	   and	  
Diastole	  Using	  a	  Dual	  Cardiac	  Phase	  Whole	  Heart	  Scan	  (Uribe	  et	  al)	  Dr.	   Hussain’s	   contribution	   to	   this	  work	   includes	   study	   planning,	   data	   collection,	  analysis	   and	   manuscript	   editing.92	   Given	   our	   previous	   experience	   with	   end-­‐systolic	   imaging	   for	   higher	   heart	   rates,	   we	   sought	   to	   assess	   a	   newly	   developed	  sequence,	   “the	   dual	   phase	   sequence”	   capable	   of	   acquiring	   3D	   data	   during	   both	  end-­‐systolic	  and	  mid-­‐diastolic	  rest	  periods	  within	  each	  cardiac	  cycle.108	  This	  study	  showed	   the	   advantages	   of	   the	   novel	   dual	   phase	   technology.	   As	   outlined	   by	  
Tangcharoen	  et	  al,	  the	  ideal	  rest	  period	  needs	  to	  be	  predicted	  prospectively	  for	  the	  single	   phase	   technology.	   With	   the	   dual	   phase	   technology,	   it	   was	   nicely	  demonstrated	   that	   within	   the	   same	   patient,	   different	   segments	   of	   the	   coronary	  artery	  may	   be	   better	   visualised	   either	   in	   an	   end-­‐systolic	   or	  mid-­‐diastolic	   phase.	  However,	   contrary	   to	  our	   initial	  hypothesis,	   it	  was	  not	  possible	   to	  predict	  which	  rest	  period	  would	  be	  optimal	  for	  a	  given	  segment	  at	  a	  given	  heart	  rate.	  Hence	  it	  is	  hypothesised	  that,	  in	  fact,	  the	  dual	  cardiac	  phase	  offers	  further	  improved	  coronary	  artery	   visualisation	   due	   to	   the	   possibility	   of	   retrospectively	   choosing	   the	   best	  cardiac	  phase	  for	  each	  segment.	  This	  development	  also	  has	  wider	  implications	  for	  patients	   with	   congenital	   heart	   disease	   and	   this	   is	   investigated	   in	   section	   2.1.4	  below.	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2.1.4. 3D	   Dual-­‐Phase	   Whole-­‐Heart	   Magnetic	   Resonance	   Imaging:	   Clinical	  
Implications	  for	  Congenital	  Heart	  Disease	  	  
2.1.4.1. Advances	  in	  Knowledge	  1. A	  recently	  developed	  dual	  cardiac	  phase	  technique	  for	  whole	  heart	  imaging	  is	   able	   to	   image	   in	   both	   systolic	   and	   diastolic	   rest	   periods	   in	   approximately	   the	  same	  time	  as	  a	  standard	  single	  phase	  sequence.	  2. For	   3D	   whole-­‐heart	   steady-­‐state-­‐free-­‐precession	   imaging,	   cardiac	  chambers	  (ventricles	  and	  atria)	  and	  pulmonary	  veins	  are	  better	  imaged	  in	  systole	  whereas	  the	  great	  vessels	  are	  better	  imaged	  in	  diastole.	  3. 3D	  dual	  phase	  whole	  heart	  imaging	  offers	  a	  higher	  rate	  of	  diagnostic	  quality	  imaging	  for	  all	  cardiac	  structures	  in	  congenital	  heart	  disease	  than	  either	  systolic	  or	  diastolic	  imaging	  alone.	  4. 3D	  dual	  phase	  imaging	  is	  able	  to	  depict	  changes	  in	  diameter	  of	  structures	  in	  congenital	  heart	  disease	  through	  the	  cardiac	  cycle	  and	  so	  is	  better	  for	  the	  planning	  of	  interventional	  procedures	  than	  the	  standard	  single	  phase	  technique.	  5. Arterial	   stenoses	   have	   better	   image	   quality	   in	   diastole	   but	   for,	  interventional	  planning,	  should	  be	  measured	  in	  systole	  and	  both	  can	  be	  achieved	  with	  3D	  dual	  phase	  whole-­‐heart	  imaging.	  	  
2.1.4.2. Implications	  for	  Patient	  Care	  1. To	   improve	   rates	   of	   diagnostic	   image	   quality	   and	   to	   allow	   accurate	  measurements	   for	   interventions,	   3D	   angiography	   in	   congenital	   heart	   disease	  should	  be	  performed	  in	  both	  systolic	  and	  diastolic	  rest	  periods.	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2. 	  The	  3D	  dual	  phase	  whole-­‐heart	  technique	  is	  able	  to	  image	  in	  both	  systolic	  and	   diastolic	   rest	   periods	   in	   approximately	   the	   same	   time	   as	   a	   standard	   single	  phase	  sequence.	  
	  
2.1.4.3. ABSTRACT	  Purpose:	   To	   identify	   which	   rest	   phase	   (systolic	   or	   diastolic)	   is	   optimum	   for	  assessing	   or	   measuring	   cardiac	   structures	   in	   the	   setting	   of	   3D	   whole-­‐heart	  imaging	  in	  congenital	  heart	  disease	  (CHD).	  	  Materials	   and	   Methods:	   The	   study	   was	   approved	   by	   the	   Institutional	   Review	  Board	  and	  informed	  consent	  obtained.	  50	  children	  (26	  male)	  underwent	  3D	  dual	  phase	   whole-­‐heart	   imaging.	   Cardiac	   structures	   were	   analysed	   for	   contrast-­‐to-­‐noise	   ratio	   (CNR)	   and	   image	   quality	   (IQ).	   	   Cross-­‐Sectional	   measurements	   were	  taken	   of	   the	   aortic	   arch,	   right	   ventricular	   outflow	   tract	   (RVOT)	   and	   pulmonary	  arteries.	   Normally	   distributed	   variables	   were	   compared	   by	   paired	   t-­‐tests	   and	  categorical	  data	  by	  Wilcoxon	  signed-­‐ranks	  test.	  	  Results:	   CNR	   and	   IQ	   were	   significantly	   (all	   p<0.05)	   greater	   in	   systole	   for	   the	  cardiac	  chambers	  (RA	  (mean	  CNR	  =	  8.9	  vs.	  7.5:	  sum	  of	  IQ	  ranks	  =	  438	  vs.	  91),	  LA	  (CNR	  =	  8.0	  vs.	  5.3:	  IQ	  =	  1006	  vs.	  29),	  RV	  (CNR	  =	  10.6	  vs.	  8.2:	  IQ=131	  vs.	  23)	  &	  LV	  (CNR	  =	  9.4	  vs.	  7.7:	  IQ	  =	  125	  vs.	  28))	  and	  pulmonary	  veins	  (CNR	  =	  6.2	  vs.	  4.9:	  IQ	  =	  914	  vs.	  32).	  Conversely,	  diastolic	  CNR	  was	  significantly	  higher	  in	  the	  Aorta	  (9.2	  vs.	  8.2:	  p=0.013)	  and	  diastolic	  IQ	  was	  higher	  for	  the	  branch	  pulmonary	  arteries	  (LPA	  =	  238	  vs.	  62:	  p=0.007)(RPA	  =	  219	  vs.	  35:	  p<0.001)	  and	  for	  post-­‐arterial	  stenosis	  imaging	   (164	   vs.	   7:p<0.001).	   All	   aortic	   arch	   and	   RVOT	   cross-­‐sectional	  measurements	  were	  significantly	  (p<0.05)	  greater	  in	  systole	  (Narrowest-­‐point-­‐of-­‐arch	  =	  70	  vs.	  53mm2;	  Descending-­‐Aorta=	  71	  vs.	  58mm2;	  Transverse-­‐arch	  =	  293	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vs.	   275mm2;	   valvar-­‐RVOT	   =	   291	   vs.	   268mm2;	   supravalvar-­‐RVOT	   =	   337	   vs.	  280mm2;	   pre-­‐bifurcation-­‐RVOT	   =	   329	   vs.	   259mm2)	   Conclusion:	   Certain	  structures	   in	   CHD	   are	   better	   imaged	   in	   systole	   and	   others	   in	   diastole	   and	  therefore,	   the	   dual	   phase	   approach	   allows	   a	   higher	   overall	   success	   rate.	   This	  approach	  is	  also	  able	  to	  depict	  diameter	  changes	  between	  systole	  and	  diastole	  and	  is	   therefore	   preferable	   to	   standard	   single	   phase	   sequences	   for	   the	   planning	   of	  interventional	  procedures.	  	  
2.1.4.4. Introduction	  A	   single	   phase	   3-­‐dimensional	   (3D)	   steady-­‐state-­‐free	   precession	   (SSFP)	   whole-­‐heart	   approach	   with	   respiratory	   navigator	   gating	   and	   ECG	   triggering	   is	   now	  frequently	   used	   and	   has	   proven	   utility	   for	   diagnostic	   imaging	   in	   children	   with	  congenital	  heart	  disease	  (CHD).101	  It	   is	  common	  practice	  to	  perform	  this	   imaging	  in	  the	  diastolic	  rest	  period.	  	  In	  young	  children	  with	  high	  heart	  rates,	  utilisation	  of	  the	  systolic	  rest	  period	  for	  such	  imaging	  has	  been	  demonstrated	  to	  be	  successful.90	  Recent	  advances	  have	  allowed	  acquisition	  of	  the	  3D	  whole-­‐heart	  data	  set	  in	  both	  end-­‐systole	  and	  mid-­‐diastole,	  in	  a	  single	  free-­‐breathing	  sequence	  in	  approximately	  the	   same	   time	   as	   the	   traditional	   single	   phase	   sequence.	   This	   sequence	  has	   been	  termed	   the	   ‘3D	   dual	   phase	   whole-­‐heart	   sequence’.92	   The	   relevance	   of	   this	  technique	  has	  been	  demonstrated	  for	  coronary	  imaging,	  ventricular	  function	  and	  volumetric	  assessment.92	  However,	   its	  utility	  has	  not	  been	  assessed	   in	   the	  wider	  setting	  of	  congenital	  heart	  disease.	  	  The	  dual	  phase	  3D	  whole-­‐heart	  sequence	  offers	  not	  only	  the	  opportunity	  to	  study	  which	   heart	   phase	   is	   optimum	   for	   each	   structure	   but	   also	   affords	   the	   clinical	  opportunity	  to	  retrospectively	  select	  either	  phase	  for	  the	  assessment	  of	  anatomy.	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An	   important	   parameter	   for	   assessing	   anatomy	   is	   the	   vessel	   sharpness.	   This	   is	  particularly	   relevant	   when	   measuring	   vessel	   size	   for	   planning	   of	   interventions.	  Vessel	   sharpness	   using	   the	   ECG-­‐gated	   3D	  whole-­‐heart	   approach	   at	   end-­‐diastole	  has	   been	   shown	   to	   be	   superior	   compared	   to	   non-­‐gated	   conventional	   magnetic	  resonance	  angiography.109.	  However,	  it	  may	  be	  more	  appropriate	  to	  image	  at	  end-­‐systole	  for	  the	  purposes	  of	  certain	  interventions	  (e.g.	  implantation	  of	  valve	  bearing	  stents),	  because	   this	  gives	   the	  maximum	  arterial	  diameter.110	  The	  3D	  dual	  phase	  approach	   may	   also	   be	   able	   to	   detect	   changes	   in	   diameter	   between	   systole	   and	  diastole	  in	  order	  to	  appropriately	  plan	  intervention.	  The	  purpose	  of	  this	  study	  was	  to	  identify	  which	  rest	  phase	  (systolic	  or	  diastolic)	  is	  optimum	  for	  assessing	  or	  measuring	  cardiac	  structures	  in	  the	  setting	  of	  3D	  whole-­‐heart	  imaging	  in	  congenital	  heart	  disease.	  	  	  
2.1.4.5. Methods	  	  
2.1.4.5.1. Participants	  Children	   undergoing	   3D	   whole-­‐heart	   imaging	   for	   clinical	   reasons	   as	   part	   of	   a	  cardiovascular	  MRI	  were	   included	   in	   the	   study.	   The	   study	  was	   approved	   by	   the	  local	  Institutional	  Review	  Board	  (IRB	  08/H0810/058)	  and	  informed	  consent	  was	  obtained.	   50	   children	   participated	   in	   this	   study.	   The	   mean	   age	   was	   4	   years	   10	  months	  (range	  5	  days	  to	  18	  years)	  and	  this	  was	  not	  different	  between	  male	  (mean	  age	  4.7	  years,	  range	  2	  weeks	  to	  16	  years)	  and	  female	  (mean	  age	  5.1	  years,	  range	  5	  days	   to	   18	   years)	   patients	   (p=0.35	   by	   independent	   samples	   t-­‐test).	   All	   children	  were	  in	  sinus	  rhythm.	  42	  underwent	  imaging	  while	  under	  general	  anesthesia	  with	  use	  of	  an	  anaesthetic	  delivery	  system	  (Aestiva/5;	  Datex-­‐Ohmeda	  (GE	  Healthcare,	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WI,	   USA)	   with	   pressure-­‐controlled	   ventilation	   (routine	   protocol	   for	   young	   or	  uncooperative	  children	  at	  our	  institution).	  After	  gas	  induction,	  general	  anesthesia	  was	   continued	   with	   a	   continuous	   intravenous	   infusion	   of	   remifentanil.	   All	  anaesthetic	  procedures	  were	  completed	  without	  adverse	  effects.	  	  
2.1.4.5.2. MRI	  Protocol	  Cardiac	  MRI	  was	  performed	  using	  a	  1.5	  Tesla	  Achieva	  clinical	  MR	  scanner	  (Philips	  Healthcare,	  Best,	  NL).	  3D	  dual	  phase	  sequence	  was	  used	   for	  all	   cases.108	  As	  with	  standard	  3D	  SSFP	  sequences,101	  the	  dual	  phase	  sequence	  is	  respiratory-­‐gated	  and	  ECG-­‐triggered	  with	  a	  fat	  saturation	  pre-­‐pulse	  to	  null	  fat	  signal	  and	  a	  T2	  pre-­‐pulse	  to	  improve	  the	  myocardium	  to	  blood	  pool	  contrast.108	  Imaging	  was	  acquired	  in	  a	  sagittal	  orientation	  (repetition	  time	  (TR)	  /echo	  time	  (TE)	  =	  3.4/1.7	  ms,	  flip	  angle	  90°,	  60-­‐120	  slices,	  isotropic	  resolution	  of	  1-­‐1.5	  mm3,	  acquisition	  window	  of	  60	  -­‐75	  ms).	   	  For	  children	  below	  3	  years	  of	  age,	  a	   two-­‐element	  coil	  was	  used	  (Flex	  M	  or	  Flex	  S).	  For	  older	  children,	  a	   five-­‐element	  cardiac	  coil	  was	  used.	  Parallel	   imaging	  with	   a	   SENSitivity	   Encoding	   (SENSE)	   acceleration	   factor	   of	   2	   in	   the	   antero-­‐posterior	  direction	  was	  also	  used.	  Trigger	  delays	  were	  set	  for	  end-­‐systole	  and	  mid-­‐diastole.	  The	  cardiac	  rest	  periods	  were	  assessed	  with	  a	  high	  temporal	  resolution,	  balanced	  steady-­‐state	  free	  precession	  (SSFP),	  four-­‐chamber	  cine	  (TR=	  3.1–3.6	  ms,	  TE	  =	  1.6–1.8	  ms,	   flip	   angle	  60°,	   6-­‐mm-­‐thick	   sections,	   240-­‐300	  mm	   field	  of	   view,	  60–80	   phases).	   The	   sequence	   employs	   navigators	   for	   each	   cardiac	   phase	  with	   a	  respiratory	  gating	  window	  of	  3	  mm	  and	  data	  is	  only	  accepted	  if	  both	  navigators,	  in	  any	  given	  cardiac	  cycle,	  fall	  within	  this	  gating	  window.	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2.1.4.5.3. Image	  analysis	  Image	  processing	  and	  reformatting	  were	  performed	  with	  commercially	  available	  analysis	   software	   (View	   Forum;	   Philips	   Healthcare).	   All	   cardiac	   chambers	   and	  great	   vessels	  were	   quantitatively	   analysed	   for	   contrast-­‐to-­‐noise	   ratio	   (CNR)	   and	  qualitatively	  analysed	  for	  image	  quality	  (IQ).	  	  	  
2.1.4.5.3.1. Image	  quality	  measurements	  	  A	   consensus	   reading	   was	   performed	   for	   IQ	   on	   reformatted	   angiograms	   of	   each	  structure	   in	  a	  blinded	  and	  random	  order	  by	  2	  readers	  (TH	  and	  DL:	  both	  with	  >3	  years	  experience	  of	  cardiovascular	  MRI).	  Prior	  to	  the	  analysis,	  a	  trial	  assessment	  of	  five	   angiograms	   was	   performed	   for	   quality	   assurance.	   Study	   images	   were	   first	  reviewed	   independently	   and	   then	   disagreement	   was	   discussed	   before	   the	   final	  grade	  was	  given.	  Image	  quality	  was	  scored	  according	  to	  the	  system	  described	  by	  
McConnell	  et	  al:	   0	   indicates	   that	   the	   structure	  was	  not	  visible;	  1	  visible	  but	  with	  markedly	   blurred	   borders;	   2	   visible	   with	  moderately	   blurred	   borders;	   3	   visible	  with	  mildly	  blurred	  borders	  and	  4	  visible	  with	  sharply	  defined	  borders.111	  Using	  this,	   a	   score	   of	   2	   or	  more	  out	   of	   4	  was	   considered	  diagnostic	   quality	   (definition	  adapted	  from	  Greil	  et	  al).112,	  113	  	  	  
2.1.4.5.3.2. Contrast	  to	  noise	  measurements	  Regions	   of	   interest	   (ROIs)	  were	   defined	   to	   determine	   the	   signal	   (S)	   from	   blood	  (SBlood)	   and	   reference	   tissue	   (SMyocardium).	   ROIs	   were	   drawn	   by	   both	   observers	  independently	  (TH	  &	  DL)	  on	  images	  reformatted	  in	  the	  transverse	  plane.	  Noise	  (N)	  was	   estimated	   by	   the	   standard	   deviation	   in	   both	   of	   these	   respective	   ROIs,	   as	  parallel	   imaging	  was	   used.113	   Blood	  pool	  ROIs	  were	   drawn	   in	   the	   superior	   vena	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cava	  (SVC),	  right	  atrium	  (RA),	  right	  ventricle	  (RV),	  main	  pulmonary	  artery	  (MPA),	  left	   pulmonary	   artery	   (LPA),	   right	   pulmonary	   artery	   (RPA),	   pulmonary	   veins	  (PV’s),	   left	   atrium	  (LA),	   left	   ventricle	   (LV)	  and	  aorta	   (Ao).	   Similarly	  placed	  ROI’s	  were	   positioned	   in	   identically	   reformatted	   systolic	   and	   diastolic	   images.	  Additional	  blood	  pool	  ROI’s	  were	  drawn	  in	  any	  location	  post-­‐arterial	  stenosis	  (e.g.	  post-­‐coarctation	  or	  post	  pulmonary	  artery	  stenosis)	  and	  in	  structures	  pertinent	  to	  specific	   congenital	   defects	   (lateral	   tunnels	   in	   total	   cavo-­‐pulmonary	   connection;	  modified	   Blalock-­‐Taussig	   shunts	   (BT);	   Glenn	   anastomoses	   and	   Damus-­‐Kaye-­‐Stansel	  (DKS)	  anastomoses).	  	  	  CNR	  was	  defined	  by	  using	  the	  following	  equation:	  	  CNR	   =	   (SBlood	   -­‐SMyocardium)/(0.5	   ·	   (NBlood	   +	   NMyocardium)),	   where	   all	   variables	   are	  means.114	  	  
	  
2.1.4.5.3.3. Cross-­‐Sectional	  Measurements	  Measurements	  of	   the	  aortic	  arch,	  branch	  pulmonary	  arteries	  or	   right	  ventricular	  outflow	   tract	   (RVOT)	   were	   performed	   as	   clinically	   indicated.	   These	   cases	   were	  chosen	   to	   in	   order	   to	   answer	   the	   following	   clinically	   pertinent	   question:	   in	   the	  setting	   of	   branch	   pulmonary	   artery	   stenoses,	   repaired	   coarctation	   or	   right-­‐ventricular	   outflow	   tract	   surgery,	   is	   it	   important	   to	  measure	   in	   the	   correct	   rest	  period	  for	  interventional	  planning?	  For	   the	   aortic	   arch,	   cross-­‐sectional	   area	   was	   measured	   at	   the	   narrowest	   point	  (isthmus	  or	  coarctation	  site);	  at	  the	  transverse	  arch	  (between	  left	  common	  carotid	  and	   left	   subclavian)	   and	   at	   the	   descending	   aorta,	   level	   with	   the	   dome	   of	   the	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diaphragm	   (Figure	   2).	   For	   the	   branch	   pulmonary	   arteries,	   measurements	   were	  repeated	   at	   the	   narrowest	   point	   and	   at	   the	   distal	   vessel	   prior	   to	   bifurcation	   (or	  trifurcation)	   (Figure	  2).	  RVOT	  dimensions	  were	  measured	  at	  valvar,	   supravalvar	  and	   pre-­‐bifurcation	   levels.	   In	   all	   cases,	   care	  was	   taken	   to	   ensure	  measurements	  were	  in	  the	  exact	  corresponding	  positions	  in	  both	  systole	  and	  diastole	  (see	  (Figure	  2)).	  
	  
Figure	  2.	  Measurement	  levels	  for	  Dual	  Phase	  Study	  
(i)	   shows	   right	   ventricular	   outflow	   tract	   (RVOT)	   in	   sagittal	   plane	   (RV	   =	  
right	  ventricle;	  LV	  =	  left	  ventricle)	  	  
(ii)	   shows	   right	   ventricular	   outflow	   tract	   in	   coronal	   plane	   (RPA=	   right	  
pulmonary	  artery)	  
(iii)	   shows	  arch	  in	  oblique	  sagittal	  (Ao	  =	  Aorta)	  
(iv)	   shows	   branch	   pulmonary	   arteries	   in	   transverse	   plane	   (MPA	   =	  main	  
pulmonary	  artery;	  LPA	  =	  left	  pulmonary	  artery)	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(v)	   	  shows	  left	  pulmonary	  artery	  in	  sagittal	  plane	  
Dashed	  line	  represent	  levels	  at	  which	  measurements	  were	  taken:	  
A:	  RVOT	  at	  valvar	  level	  
B:	  RVOT	  at	  supravalvar	  level	  
C:	  RVOT	  at	  pre-­‐bifurcation	  level	  
D:	  LPA	  at	  the	  narrowest	  point	  	  
E:	  LPA	  at	  the	  distal	  vessel	  	  
F:	  Aortic	  Arch	  at	  the	  narrowest	  point	  (isthmus	  or	  coarctation	  site)	  
G:	  	  Descending	  aorta,	  level	  with	  the	  dome	  of	  the	  diaphragm	  	  
H:	  Transverse	  arch	  (between	  left	  common	  carotid	  and	  left	  subclavian)	  
	  
2.1.4.5.4. Statistics	  IQ	   scores	   represent	   categorical	   data	   and	   were	   tested	   using	   non-­‐parametric	  statistical	  procedures.	  Remaining	  variables	  were	  visually	  assessed	  with	  histogram	  plots	   and	   formally	   tested	   for	   normality	   using	   Kolmogorov-­‐Smirnov	   tests	   for	  normality.	   Normally	   distributed	   variables	   were	   compared	   by	   paired	   t-­‐tests	   and	  remaining	   variables	   were	   assessed	   by	   Wilcoxon	   signed	   ranks	   test.	   A	   repeated	  measures	  analysis	  of	  variance	  models	  for	  CNR	  was	  constructed	  in	  order	  to	  account	  for	   within-­‐subject	   and	   between-­‐subject	   variability	   arising	   from	   testing	   multiple	  segments	   over	   two	  phases	   in	   each	   patient.	   Levene’s	   test	  was	   used	   to	   assess	   the	  assumption	  for	  homogeneity	  of	  variance.	  Assumptions	  of	  sphericity	  were	  formally	  tested	  using	  Mauchly’s	  test	  but	  rejected.	  Hence,	  results	  given	  use	  the	  Greenhouse-­‐
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Geisser	   model.	   The	   Bonferroni	   correction	   is	   used	   to	   correct	   for	   multiple	  comparisons.	  Statistical	  analysis	  was	  performed	  on	  SPSS	  (version	  19)	  2010.	  	  	  	  As	   we	   are	   unaware	   of	   similar	   data	   from	   previous	   studies,	   prospective	   power	  analysis	  was	  not	  possible.	  However,	  post	  hoc	  analysis	  shows	  that	  for	  a	  significance	  level	  of	  5%	  and	  with	  80%	  power,	  50	  cases	  enables	  us	  to	  be	  able	  to	  detect	  a	  change	  in	   CNR	   of	   approximately	   10%	   in	   the	   aorta.	   A	   10%	   difference	   was	   felt	   to	   be	  appropriate	  from	  a	  clinical	  perspective.	  	  
2.1.4.6. Results	  	  
2.1.4.6.1. Participants	  50	  children	  (26	  male)	  underwent	  3D	  dual	  phase	  SSFP	  imaging.	  The	  mean	  age	  was	  4	  years	  10	  months	  (range	  5	  days	  to	  18	  years)	  and	  this	  was	  not	  different	  between	  male	  (mean	  age	  4.7	  years)	  and	  female	  (mean	  age	  5.1	  years)	  patients	  (p=0.35	  by	  independent	  samples	  t-­‐test).	  Diagnoses	  and	  RV	  volumes	  are	  given	  in	  (Table	  2).	  The	  mean	  HR	  was	  90	  bpm	  (range	  56	  to	  139	  bpm).	  Navigator	  efficiency	  and	  total	  time	  taken	  for	  the	  dual	  phase	  sequence	  are	  given	  in	  (Table	  3).	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Table	  3.	  Time	  Taken	  for	  Dual	  Phase	  Imaging.	  
Values	  given	  as	  mean	  ±	  standard	  deviation.	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2.1.4.6.2. Image	  Quality	  Dual	  phase	  yielded	  diagnostic	  quality	  imaging	  for	  all	  chambers	  and	  great	  vessels	  in	  one	   or	   other	   cardiac	   phase	   in	   38	   out	   of	   50	   patients.	   Systolic	   imaging	   alone	   had	  diagnostic	   image	  quality	   for	  all	  segments	   in	  31	  cases	  and	  diastolic	   imaging	  alone	  had	  diagnostic	  quality	  in	  26	  cases.	  A	  summary	  of	  non-­‐diagnostic	  segments	  is	  given	  in	  (Figure	  3).	  Two	  points	  are	  notable	  from	  this	  figure:	  that	  end-­‐systole	  was	  more	  successful	  for	  the	  imaging	  of	  the	  LA	  and	  PV’s	  and	  that	  the	  combination	  of	  the	  two	  phases	   is	   clearly	  more	   successful	   from	  a	   segment	   to	   segment	  basis	   compared	   to	  either	  phase	  alone.	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Figure	  3.	  Summary	  of	  segments	  with	  non-­‐diagnostic	  IQ	  
Using	   the	  Wilcoxon	  Signed	  Ranks	   test,	   IQ	  was	   significantly	  greater	   in	   systole	   for	  the	  four	  cardiac	  chambers	  (RA,	  LA,	  RV	  &	  LV)	  and	  for	  the	  PV’s.	  Conversely,	  diastolic	  IQ	   was	   significantly	   greater	   for	   the	   branch	   pulmonary	   arteries	   and	   for	   post-­‐arterial	   stenosis	   imaging.	  Mean	   rank	   values	   and	  p-­‐values	   are	   given	   in	   (Table	  4).	  Clearly,	  RVOT	  obstruction	  and	  pulmonary	  arterial	  stenosis	  may	  influence	  IQ	  of	  the	  branch	  pulmonary	  arteries	  but	  the	  relationship	  between	  superior	  image	  quality	  in	  diastole	   and	   the	   branch	   pulmonary	   arteries,	   remains	   true	   even	   if	   RVOT	  obstruction	   and	   pulmonary	   arterial	   stenosis	   cases	   are	   excluded	   (p=0.02	   by	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Wilcoxon	  Signed	  Rank	   test	   for	  RPA	   IQ	  between	  systole	  and	  diastole)	  but	  not	   for	  the	   LPA	   (p=0.13	   by	   Wilcoxon	   Signed	   Rank	   test	   for	   IQ	   between	   systole	   and	  diastole).	  
	  
Table	  4.	  Image	  Quality	  of	  Cardiac	  segments	  for	  Dual	  Phase	  Congenital	  Heart	  
Disease	  Study	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2.1.4.6.3. Contrast-­‐to-­‐noise	  Ratio	  All	  CNR	  measurements	  were	  normally	  distributed	  using	  Kolmogorov-­‐Smirnov	  tests	  for	  normality.	  Similar	  to	  the	  pattern	  for	  IQ,	  CNR	  was	  also	  significantly	  higher	  in	  systole	  for	  cardiac	  chambers	  (LA,	  RA,	  LV	  and	  RV)	  and	  for	  the	  PV’s.	  Diastolic	  CNR	  was	  significantly	  higher	  in	  the	  Aorta	  and	  for	  the	  Glenn	  anastomosis.	  However	  it	  should	  be	  noted	  that	  the	  number	  of	  Glenn	  anastomoses	  was	  small	  (n=5).	  CNR	  results	  are	  given	  in	  (Table	  5).	  There	  were	  no	  significant	  differences	  for	  the	  CNR	  at	  arterial	  post-­‐stenosis	  sites	  between	  systolic	  and	  diastolic	  images.	  Similarly,	  exclusion	  of	  arterial	  stenosis	  cases	  from	  the	  analysis	  does	  not	  influence	  the	  given	  results	  for	  branch	  pulmonary	  arteries.	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Table	  5.	   CNR	  of	  Cardiac	   segments	   for	  Dual	  Phase	  Congenital	  Heart	  Disease	  
Study	  
Only	  major	  segments	  (SVC,	  RA,	  RV,	  LPA,	  RPA,	  PV’s,	  LA,	  LV	  and	  Ao)	  are	  included	  in	  the	  repeated	  measures	  ANOVA	  model,	  in	  order	  to	  have	  adequate	  (n=33)	  numbers	  with	   complete	   segmental	   analyses.	   The	   model	   is	   constructed	   using	   CNR	   as	   a	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measure	   (which	   has	   been	   already	   formally	   tested	   to	   pass	   assumptions	   of	  normality)	  and	  within-­‐subject	  variables	  are	  given	  as	  segment	   (SVC,	  RA,	  RV,	  LPA,	  RPA,	  PV’s,	  LA,	  LV	  and	  Ao)	  and	  heart	  phase	  (systole	  or	  diastole).	  Between	  subjects,	  the	  heart	  rate	  variable	  is	  tested	  by	  grouping	  heart	  rates	  (three	  groups	  <80;	  80	  to	  100	   &	   >100	   bpm).	   All	   data	   passes	   Levene’s	   test	   of	   Homogeneity	   of	   Variance,	  showing	   that	   this	   assumption	   is	  met.	   Assumptions	   of	   sphericity	   have	   also	   been	  formally	   tested	   and	   rejected	   (Mauchly’s	   test).	   Hence	   results	   given	   use	   the	  Greenhouse-­‐Geisser	   model.	   The	   Bonferroni	   correction	   is	   used	   to	   correct	   for	  multiple	  comparisons.	  The	   model	   demonstrates	   that	   the	   systolic	   CNR	   (mean	   7.2)	   is	   higher	   than	   the	  diastolic	   CNR	   (mean	   6.3)	   (p=0.007).	   There	   is	   no	   interaction	   between	   this	  relationship	  and	  HR	  (p=0.10).	  As	  described	  in	  the	  univariate	  analysis,	  the	  ANOVA	  model	   confirms	   that	   this	   relationship	   between	   the	   CNR	   and	   heart	   phase	   is	  significantly	  altered	  according	  to	  the	  segment	  imaged	  (p<0.001).	  	  	  
2.1.4.7. Cross-­‐Sectional	  Measurements	  In	  16	  cases,	  right	  ventricular	  outflow	  tract	  measurements	  were	  clinically	  indicated.	  This	  included	  8	  cases	  of	  repaired	  tetralogy	  of	  Fallot;	  5	  cases	  of	  pulmonary	  atresia	  and	  ventricular	  septal	  defect	  (VSD)	  repaired	  with	  homograft;	  1	  transposition,	  VSD,	  pulmonary	  stenosis	  (PS)	  after	  Rastelli	  procedure;	  1	  repaired	  truncus	  arteriosus	  and	  one	  mixed	  valvar	  and	  supravalvar	  PS.	  Systolic	  RVOT	  areas	  were	  shown	  to	  be	  significantly	  greater	  than	  diastolic	  areas	  (mean	  at	  valvar	  level	  2.91	  vs.	  2.68	  cm2	  (p=0.01);	  supravalvar	  level	  3.37	  vs.	  2.80	  cm2	  (p<0.001);	  pre-­‐bifurcation	  3.29	  vs.	  2.59	  cm2	  (p=0.003))	  (see	  (Table	  6)).	  In	  10	  cases,	  the	  aortic	  arch	  measurements	  were	  clinically	  important	  (previous	  arch	  repairs).	  At	  all	  levels,	  systolic	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measurements	  were	  greater	  than	  diastolic	  (mean	  in	  systole	  vs.	  diastole	  =	  0.70	  vs.	  0.53	  cm2	  at	  narrowest	  point	  (p=0.009);	  0.71	  vs.	  0.58	  cm2	  at	  diaphragm	  (p=0.023)	  and	  2.93	  vs.	  2.75	  cm2	  at	  transverse	  arch	  (p=0.016)	  (see	  (Table	  6)	  15	  cases	  had	  branch	  pulmonary	  artery	  stenoses	  of	  varying	  severity.	  Although	  mean	  areas	  were	  slightly	  higher	  in	  systole	  both	  at	  the	  narrowing	  (0.57	  vs.	  0.49	  cm2	  in	  diastole)	  and	  distally	  (0.75	  vs.	  0.68	  cm2	  in	  diastole),	  this	  did	  not	  reach	  significance	  (p=0.30	  and	  0.21	  respectively)	  (see	  (Table	  6)).	  
	  
Table	  6.	  Cross-­‐Sectional	  Measurements	  of	  Cardiac	  segments	  for	  Dual	  Phase	  
Congenital	  Heart	  Disease	  Study	  	  
! "#!
Table 4 – Cross-Sectional Measurements 





Systole 10 70.34 34.79 0.009* 
  Diastole 10 52.60 24.57  
 Descending 
Aorta 
Systole 10 70.71 49.36 0.023* 
  Diastole 10 57.93 36.31  
 Transverse 
arch 
Systole 10 293.13 514.80 0.016* 





Systole 15 56.79 56.45 0.213 
  Diastole 15 49.25 47.29  
 Distal Vessel Systole 15 75.01 54.28 0.307 
  Diastole 15 68.16 40.80  
RVOT Valvar level Systole 16 291.44 119.58 0.01* 
  Diastole 16 268.04 111.56  
 Supravalvar Systole 16 336.56 167.65 <0.001* 
  Diastole 16 279.75 150.04  
 Pre-
bifurcation 
Systole 16 328.56 265.58 0.003* 
  Diastole 16 259.25 214.45  
  
* denotes statistically significant differences using paired t-test to compare 
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2.1.4.8. Discussion	  The	  original	   approach	   to	  3D	  whole-­‐heart	   imaging	   in	   children	   to	   image	   coronary	  arteries,	   as	   suggested	   by	  Tangcharoen	  et	  al,	   is	   to	   use	   the	   systolic	   rest	   period	   at	  higher	   heart	   rates	   when	   assessed	   to	   be	   longer	   than	   the	   diastolic	   rest	   period.90	  However,	   this	   approach	   does	   not	   acknowledge	   that	   certain	   structures	   may	   be	  inherently	  better	  imaged	  at	  a	  specific	  cardiac	  phase.	  We	   have	   shown	   that	   regardless	   of	   heart	   rate,	   systole	   offers	   better	   imaging	   for	  many	   cardiac	   segments	   in	   congenital	   heart	   disease.	   In	   particular,	   cardiac	  chambers	   (RA,	   RV,	   LA	  &	   LV)	   and	   pulmonary	   veins	   had	   both	   higher	   CNR	   and	   IQ	  scores	  at	  end-­‐systole	  (see	  (Figure	  4)).	  The	  reason	  for	  this	  may	  be	  due	  to	  different	  blood	   exchange	   rates	   during	   the	   two	   rest	   periods.	   For	   example,	   in	   healthy	  individuals,	   the	   systolic	   flow	   rate	   (and	   waveform)	   is	   of	   higher	   amplitude	   than	  diastole	  in	  the	  pulmonary	  veins.	  
	  
Figure	  4.	  A	  6-­‐yr-­‐old	  patient,	  status	  post	  repair	  of	  Tetralogy	  of	  Fallot.	  	  
Identical	  formatting	  showing	  thick	  slab	  (1.6	  cm)	  depicting	  pulmonary	  veins.	  
Systolic	  pulmonary	  vein	  imaging	  (A)	  has	  superior	  IQ	  (grade	  2	  vs.	  1)	  and	  CNR	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(5.3	  vs.	  4.9)	  to	  the	  diastolic	  image	  (B).	  (RUPV	  –	  right	  upper	  pulmonary	  vein;	  
RLPV	  –	  right	   lower	  pulmonary	  vein;	  LUPV	  –	   left	   lower	  pulmonary	  vein	  and	  
LLPV	  –	  left	  lower	  pulmonary	  vein).	  
However,	   diastolic	   imaging	   appears	   preferable	   for	   arterial	   imaging	   with	   higher	  CNR	  values	  for	  the	  Aorta	  and	  higher	  IQ	  scores	  for	  the	  branch	  pulmonary	  arteries	  (see	  (Figure	  5)).	  The	  reason	  for	  this	  may	  be	  simply	  that,	  although	  end-­‐systole	  is	  a	  cardiac	   rest	   period,	   arterial	  motion	   is	   still	   present	  whereas	  mid-­‐diastole	   offers	   a	  more	  stable	  combined	  arterial	  and	  cardiac	  rest	  period.	  
	  
Figure	  5.	  A	  4-­‐year-­‐old	  patient,	  after	  repair	  of	  tetralogy	  of	  Fallot.	  	  
Identical	   formatting	   to	   demonstrate	   pulmonary	   artery	   and	   branches	  
(arrows).	   	  This	  is	  only	  appreciated	  in	  the	  diastolic	  image	  (B)	  and	  not	  in	  the	  
systolic	   image	   (A),	  which	   shows	   image	  disturbance	  due	   to	   flow	   turbulence	  
(asterix).	   (RPA	   –	   right	   pulmonary	   artery;	   LPA	   –	   left	   pulmonary	   artery	   and	  
MPA	  –	  main	  pulmonary	  artery)	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Furthermore,	  to	  support	  this,	  we	  were	  able	  to	  show	  that	  the	  dual	  phase	  approach	  was	   advantageous	   in	   demonstrating	   a	   higher	   rate	   of	   diagnostic	   quality	   imaging	  than	  either	  phase	  alone.	  	  The	   issue	   of	   imaging	   arterial	   stenosis	   is	   best	   considered	   separately.	   We	  demonstrated	  superior	  image	  quality	  in	  diastole	  for	  imaging	  arterial	  stenoses	  (e.g.	  Coarctation:	   see	   (Figure	   6)).	   However,	   x-­‐ray	   angiographic	   measurements	   are	  typically	  done	  in	  systole	  for	  two	  reasons:	  (i)	  Contrast	  medium	  from	  the	  injection	  fills	  the	  artery	  in	  systole	  (ii)	  the	  wider	  systolic	  diameter	  is	  taken	  for	  intervention	  so	   that	  stent	  sizes	  are	  not	  under-­‐estimated	   leading	   to	  possible	  embolisation.	  For	  these	   purposes,	   we	   have	   further	   shown	   the	   ability	   of	   dual	   phase	   imaging	   to	  demonstrate	   the	   deformations	   of	   the	   RVOT	   and	   aortic	   arch	   though	   the	   cardiac	  cycle,	   using	   similar	   definitions	   as	   recently	   used	   to	   illustrate	   four-­‐dimensional	  computed	  tomography.110	  Although	  systolic	  mean	  areas	  were	  higher	  for	  stenosed	  branch	  pulmonary	  arteries	  (both	  at	  the	  narrowing	  and	  distally),	  we	  were	  not	  able	  to	   demonstrate	   a	   significant	   difference.	   This	   can	   be	   explained	   by	   a	   number	   of	  factors.	   First,	   amongst	   our	   15	   branch	   pulmonary	   artery	   stenoses,	   there	   were	   3	  with	  venous	   flow	   (cavopulmonary	   connections)	   and	  2	  with	   continuous	   flow	   (BT	  shunts).	  Branch	  pulmonary	  arteries	  with	   such	  venous	  or	   continuous	   flow	  would	  not	   be	   subject	   to	   the	   same	   systolic	   deformation.	   Furthermore,	   in	   the	   setting	   of	  significant	   branch	   stenosis	   (at	   least	   3	   further	   cases),	   pulmonary	   arterial	   flow	   is	  known	   to	   be	   redistributed	   to	   the	   unaffected	   artery	   and,	   in	   the	   stenotic	   artery,	  pulsatility	  is	  reduced.	  In	  short,	  we	  were	  underpowered	  in	  this	  study	  to	  be	  able	  to	  demonstrate	   the	   ability	   of	   dual	   phase	   imaging	   to	   depict	   deformation	   of	   stenotic	  branch	  pulmonary	  arteries.	  Despite	  this,	  dual	  phase	  imaging	  has	  clear	  advantages	  for	   interventional	   planning	   over	   standard	   3D	   single	   phase	   sequences,	   because	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diastolic	  images,	  with	  superior	  image	  quality,	  can	  be	  used	  for	  diagnostic	  purposes	  and	  systolic	  images	  can	  be	  used	  for	  measurements.	  
	  
Figure	  6.	  A	  1-­‐year	  old	  patient	  with	  a	  coarctation.	  	  
The	  asterix	  depicts	  the	  site	  of	  narrowing.	  The	  systolic	  image	  (A)	  is	  of	  lower	  
quality	  than	  the	  diastolic	  image	  (B)	  with	  depiction	  of	  the	  stenotic	  flow	  jet	  in	  
systole.	  
Magnetic	   resonance	  contrast	  angiography	  measurements	  are	  now	  routinely	  used	  for	   the	   planning	   of	   both	   surgical	   and	   trans-­‐catheter	   intervention.	   It	   has	   been	  shown	   recently	   that	   the	   accuracy	   of	   these	   measurements	   may	   be	   improved	   by	  using	   identical	   angulations	   for	   formatting	   the	   MRI	   data,	   as	   used	   in	   the	   x-­‐ray	  angiography.115	  However,	  this	  approach	  is	  still	  limited	  in	  accuracy	  compared	  to	  3D	  whole-­‐heart	  imaging,	  because	  standard	  MR	  contrast	  angiography	  is	  not	  ECG-­‐gated	  and	   therefore	   subject	   to	   blurring	   due	   to	   cardiac	  motion.109	   As	   demonstrated	   by	  
Potthast	   et	   al,	   routine	   clinical	   3D	   whole-­‐heart	   imaging	   is	   done	   in	   diastole.109	   In	  some	   ways,	   our	   study	   lends	   support	   to	   this	   because	   we	   show	   that	   diastole	   has	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superior	  arterial	  image	  quality.	  However,	  systolic	  imaging	  is	  vital,	  especially	  when	  considering	   interventions	   of	   the	   RVOT.110	   3D	   whole-­‐heart	   imaging	   is	   time-­‐consuming	   and	   the	   disparity	   between	   this	   and	   prior	   statements	   can	   only	   be	  resolved	  by	  use	  of	  dual	  phase	  imaging.	  Using	  this	  sequence,	  we	  can	  provide	  ECG-­‐gated	   3D	   imaging	   in	   both	   cardiac	   rest	   periods	   in	   a	   single	   sequence	   taking	  approximately	  the	  same	  time	  as	  the	  standard	  single	  phase	  approach.	  We	  can	  then	  also	  format	  the	  systolic	  images	  using	  approximated	  equivalents	  for	  subsequent	  x-­‐ray	  angiography,	  as	  suggested	  by	  Valverde	  et	  al.115	  Although,	  we	  have	  described	  findings	  in	  arterial	  stenosis,	  we	  only	  had	  one	  patient	  with	   an	   aneurysmal	   segment.	   The	   suggestion	   from	   this	   case	   (Figure	   7)	   is	   that	  systole	  may	  provide	  better	  image	  quality,	  perhaps	  due	  to	  more	  disordered	  flow	  in	  diastole	  (swirling).	  
	  	  
Figure	   7.	   A	   right	   ventricular	   outflow	   tract	   aneurysm	   (*)	   is	   shown	   in	   a	   9	  
months	  old	  patient	  after	  trans-­‐annular	  patch	  repair	  of	  Tetralogy	  of	  Fallot.	  	  
Systole	  A;	  Diastole	  B	  
The	   superiority	   of	   systolic	   image	   quality	   (A)	   is	   clear.	   This	   may	   be	   due	   to	  
diastolic	   blood	   (B)	   swirling	   in	   the	   aneurysm,	   perhaps	   heightened	   by	  
pulmonary	  regurgitation.	  (RPA	  –	  right	  pulmonary	  artery)	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The	  effect	  of	  blood	  flow	  velocities	  on	  image	  quality	  may	  be	  partially	  explained	  by	  the	   use	   of	   a	   Cartesian	   readout	   for	   3D	   whole-­‐heart	   imaging.	   The	   dual	   phase	  sequence	  that	  is	  described	  here	  did	  not	  benefit	  from	  flow	  compensation	  gradients.	  Perhaps,	   other	   trajectories	  with	   fully	   velocity	   compensate	   gradients	  may	   reduce	  the	  IQ	  and	  CNR	  differences	  between	  systole	  and	  diastole.116-­‐118	  As	  mentioned	  previously,119	  another	  theoretical	  limitation	  of	  dual	  phase	  imaging	  is	  the	  possible	  reduction	  of	  signal-­‐to-­‐noise	  ratio	  due	  to	  the	  acquisition	  of	  two	  cardiac	  phases	  during	  a	  single	  cardiac	  cycle	  when	  compared	  with	  the	  signal-­‐to-­‐noise	  ratio	  obtained	  with	  a	  single	  phase	  whole-­‐heart	  sequence.	  In	  addition,	  the	  application	  of	  two	   T2	   preparation	   pulses	   may	   also	   influence	   the	   contrast	   to	   some	   extent.	  However,	  these	  effects	  are	  likely	  to	  affect	  both	  cardiac	  phases	  similarly.	  This	   study	  does	  not	   include	   a	  direct	   comparison	  between	   single	  phase	   and	  dual	  phase	   approaches.	   However,	   dual	   phase	   imaging	   is	   now	   part	   of	   the	   routine	  protocol	   at	   our	   institution	   and	   we	   have	   not	   noted	   any	   image	   degradation	   in	  comparison	   to	   the	  previous	  single	  phase	  approach.	  This	  experience	   is	  supported	  by	  comparison	  of	  two	  recent	  publications	  using	  3D	  whole-­‐heart	  SSFP.	  Uribe	  et	  al,	  using	   3D	   dual	   phase	   whole-­‐heart	   SSFP	   imaging	   measured	   image	   quality	  quantitatively	   (by	  vessel	   sharpness)	   for	   the	   left	   (LCA)	   and	   right	   coronary	  artery	  (RCA)	  systems.92	  Values	  for	  the	  best	  phase	  were	  40%	  ±	  10%	  for	  the	  LCA	  and	  40%	  ±	  10%	  for	  the	  RCA.	  Thirty	  children	  (28	  under	  general	  anaesthesia)	  were	  studied	  with	  a	  mean	  age	  of	  5	  years	  (range	  0-­‐16	  years).	  Using	  a	  very	  similar	  protocol	  but	  using	  a	  single	  phase	  approach	  (using	  the	  phase	  with	  the	  longest	  user-­‐defined	  rest	  period),	  Tangcharoen	  et	  al	  imaged	  100	  children	  under	  general	  anaesthesia.90	  This	  data	   is	   divided	   into	   age	   groups	   and	   the	   oldest	   group	   (range	   5-­‐11	   years)	   is	  comparable	  and	  comprised	  32	  children.	  The	  mean	  vessel	  sharpness	  for	  LCA	  (32%	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±	   0.24)	  was	   not	   significantly	   different	   to	   data	   from	  Uribe	   et	   al	   (p=0.09	   by	   two-­‐tailed	   independent	   samples	   t-­‐test).	   Similarly,	   there	  was	   no	   significant	   difference	  for	  RCA	   vessel	   sharpness	   (41%	  ±	   18%;	   p=0.79).	   The	   combination	   of	   experience	  and	  quantitative	  analyses	  from	  these	  studies	  leads	  us	  to	  believe	  that,	  although	  SNR	  may	  be	  theoretically	  reduced,	  image	  quality	  is	  not	  significantly	  different	  between	  dual	  phase	  imaging	  and	  each	  of	  the	  corresponding	  single	  phase	  acquisitions.	  In	  summary,	  the	  dual	  phase	  sequence	  should	  become	  the	  routine	  3D	  whole-­‐heart	  sequence	   for	   children	  with	   congenital	   heart	  disease.	  The	  utility	   of	   this	   sequence	  has	  already	  ben	  shown	  for	  the	  imaging	  of	  coronary	  arteries.119	  We	  demonstrate	  
here	   that	   the	   dual	   phase	   sequence	   improves	   the	   overall	   success	   rate	   in	  
achieving	   diagnostic	   image	   quality,	   and	   is	   particularly	   useful	   for	  
interventional	  planning.	  Similar	  results	  can	  be	  achieved	  using	  time-­‐resolved	  3D	  computed	  tomography110	  but	  this	  would	  further	  increase	  the	  amount	  of	  radiation	  used	   compared	   to	   single	   rest-­‐period	   multi-­‐detector	   computed	   tomography	   and	  would	   result	   in	   inferior	   diagnostic	   physiological	   information	   with	   respect	   to	  cardiovascular	  MRI.	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2.2. Coronary	   artery	   size	   and	   origin	   imaging	   in	   children:	   a	   comparative	  
study	  of	  MRI	  and	  trans-­‐thoracic	  echocardiography	  	  	  
2.2.1. Introduction	  In	   infants,	   it	   is	   appreciated	   that	   currently,	   echocardiography	   is	   the	   first	   line	  imaging	  method	  for	  delineation	  of	  the	  origin	  and	  course	  of	  the	  proximal	  portion	  of	  the	   coronary	   arteries.120	   However,	   echocardiographic	   imaging	   becomes	  progressively	  more	   difficult	   in	   children	   and	   adolescents	   due	   to	   size	   and	   poorer	  transthoracic	  ultrasound	  windows.	  	  	  Normal	   values	   exist	   for	   coronary	   dimensions	   using	   echocardiography,121,	  122	   but	  no	   such	   references	   exist	   for	   coronary	  magnetic	   resonance	   angiography	   (CMRA).	  The	   difficulty	   exists	   in	   producing	   normal	   MRI	   data	   is	   that	   young	   children	   and	  infants	  would	  require	  sedation	  or	  general	  anaesthesia.	  This	  information,	  however,	  may	  be	  gained	  by	  cross-­‐referencing	  MRI	  and	  echo	  data,	  so	  that	  MR	  dimensions	  can	  be	   validated	   systematically	   against	   echo-­‐derived	   dimensions.	   This	   will	   be	  important	   for	   clinical	   settings,	   such	   as	   Kawasaki	   disease	   (or	   coronary	   allograft	  vasculopathy),	  where	  MRI	  is	  used	  for	  longitudinal	  follow	  up	  of	  coronary	  arteries.	  	  In	   the	  setting	  of	  aneurysmal	  coronary	  segments	  and	   larger	  coronary	  arteries	   (in	  adults,	   >3mm),	   it	   has	   already	   been	   shown	   that	   CMRA	   is	   very	   accurate.91	   The	  purpose	   here	   is	   to	   be	   able	   to	   develop	   a	   reference	   for	   coronary	   dimensions	   in	  children	  to	  be	  able	  to	  identify	  whether	  the	  segment	  in	  question	  is	  indeed	  dilated.	  This	   is	   particularly	   important	   for	   longitudinal	   follow-­‐up	   and	   when	  echocardiographic	  windows	  are	  poor.	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2.2.2. Methods	  Institutional	   Review	   Board	   approval	   was	   obtained	   for	   this	   study	   (reference	  07/Q0704/3).	   The	   inclusion	   criterion	   was	   any	   patient	   undergoing	   a	   clinical	  cardiovascular	  MRI	  with	  3d-­‐whole	  heart	  acquisition	  under	  general	  anaesthesia	  at	  our	   institution.	   Written,	   informed	   consent	   was	   obtained	   appropriately	   in	   each	  case.	   Enrolled	   patients	   underwent	   dual	   phase	   whole-­‐heart	   3D	   balanced	   steady	  state	   free	   precession	   (SSFP)	   imaging	   and	   echocardiography	   under	   general	  anaesthesia.	  	  
2.2.2.1. MRI	  Cardiac	  MRI	  was	  performed	  using	  a	  1.5	  Tesla	  Achieva	  clinical	  MR	  scanner	  (Philips	  Healthcare,	   Best,	   NL).	   The	   3d	   whole	   heart	   approach,	   described	   by	   Beerbaum	   et	  
al101	  was	  implemented	  with	  noticeable	  changes.	  It	  has	  been	  recently	  demonstrated	  that	   dual	   phase	   imaging	   (end-­‐systole	   and	   mid-­‐diastole)	   can	   improve	   coronary	  imaging	  by	  providing	  the	  ability	  to	  retrospectively	  select	  the	  optimum	  phase	  to	  be	  used	  for	  analysis.92	  Hence	  this	  approach	  was	  used	  for	  this	  study.	  	  As	  with	  standard	  3D	  SSFP	  sequences,	  the	  dual	  phase	  sequence	  is	  respiratory-­‐gated	  and	  ECG-­‐triggered	  with	  a	   fat	  saturation	  pre-­‐pulse	   to	  null	   fat	  signal	  and	  a	  T2	  pre-­‐pulse	  to	  improve	  the	  myocardium	  to	  blood	  pool	  contrast.123	  Imaging	  was	  acquired	  in	   a	   sagittal	   orientation	   (repetition	   time	   (TR)	   /echo	   time	   (TE)	  =	  3.4/1.7	  ms,	   flip	  angle	  90°,	  60-­‐120	  slices,	  isotropic	  resolution	  of	  1-­‐1.5	  mm3,	  acquisition	  window	  of	  60	  -­‐75	  ms).	  	  For	  children	  below	  3	  years	  of	  age,	  a	  two-­‐element	  coil	  was	  used	  (Flex	  M	   or	   Flex	   S).	   For	   older	   children,	   a	   five-­‐element	   cardiac	   coil	   was	   used.	   Parallel	  imaging	   with	   a	   SENSitivity	   Encoding	   (SENSE)	   acceleration	   factor	   of	   2	   in	   the	  antero-­‐posterior	  direction	  was	  also	  used.	  Trigger	  delays	  were	  set	   for	  end-­‐systole	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and	  mid-­‐diastole.	   The	   cardiac	   rest	   periods	   were	   assessed	  with	   a	   high	   temporal	  resolution,	  balanced	  steady-­‐state	  free	  precession	  (SSFP),	  four-­‐chamber	  cine	  (TR=	  3.1–3.6	  ms,	  TE	  =	  1.6–1.8	  ms,	  no.	  of	   lines	  acquired	  per	  heart	  beat	   	  =	  8	   to	  20,	   flip	  angle	   60°,	   6-­‐mm-­‐thick	   sections,	   240-­‐300	  mm	   field	   of	   view,	   60–80	   phases).	   The	  dual	  phase	  sequence	  employs	  navigators	  for	  each	  cardiac	  phase	  with	  a	  respiratory	  gating	  window	  of	  3	  mm	  and	  data	  is	  only	  accepted	  if	  both	  navigators,	  in	  any	  given	  cardiac	  cycle,	  fall	  within	  this	  gating	  window.	  	  In	  addition,	   it	  has	  been	  shown	  that	  an	  automated	  programme	  is	  capable	  of	  more	  accurate	   definitions	   of	   cardiac	   rest	   periods	   than	   visual	   inspection.124	   It	   was	  therefore	  hoped	  that	  clearer	  definitions	  for	  cardiac	  rest-­‐periods	  would	  produce	  a	  similar	  effect.	  The	  mid-­‐diastolic	  period	  was	  taken	  from	  cessation	  of	  movement	  of	  RCA	   (i.e.	   pause	   in	   visible	   filling	   of	   RV)	   to	   the	   beginning	   of	   atrial	   systole.	   This	  stringent	  definition	   covers	  both	  RCA	  and	  LAD	  diastolic	   rest	  periods.102	  The	  end-­‐systolic	  period	  was	  taken	  from	  cessation	  of	  movement	  of	  the	  RCA	  (corresponding	  to	  lowest	  RV	  volume)	  to	  just	  before	  the	  beginning	  of	  opening	  of	  the	  tricuspid	  valve.	  Coronary	   dimensions	   were	   assessed	   manually	   at	   the	   same	   points	   as	   the	  echocardiographic	  measurements.	  The	  number	  of	  proximal	  LAD	  branches	  imaged	  was	  also	  recorded	  in	  order	  to	  give	  an	  estimate	  of	  distal	  coronary	  tree	  visualisation.	  Coronary	  origins	  were	  classified	  as	  abnormal	  if	  there	  was	  operator	  certainty	  from	  both	  echo	  and	  MRI.	   In	   the	  case	  where	  modalities	  disagreed,	  reference	  was	  made	  either	  to	  earlier	  diagnostic	  catheterisation	  or	  to	  previous	  surgical	  notes.	  	  
2.2.2.2. Echocardiography	  The	  Washington	  protocol	  for	  coronary	  dimensions	  was	  followed.122	  This	  protocol	  was	  chosen	  in	  preference	  as	  the	  measurement	  process	  is	  clearly	  defined.	  Images	  of	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the	  proximal	  coronary	  arteries	   (right	  coronary	  artery	   (RCA),	   left	  mainstem	  (LM)	  and	  left	  anterior	  descending	  (LAD))	  were	  recorded	  as	  digital	  cines	  using	  short	  axis	  (in	  preference	  but	  alternatively,	  modified	  superiorly-­‐tilted	  long-­‐axis	  view	  for	  LAD	  was	   used).	   Operator	   assessment	   of	   coronary	   origins	   was	   recorded	   and	   stored	  cines	  were	  used	  to	  assess	  coronary	  dimensions.	  	  Measurements	  of	  the	  RCA,	  LAD	  and	  LM	  were	  made	  from	  inner	  edge	  to	  inner	  edge,	  excluding	  points	  of	  branching.125	  LM	  was	  measured	  at	  its	  mid-­‐point	  and	  the	  LAD/	  RCA	  will	  be	  measured	  0.2	  to	  0.5	  mm	  from	  its	  origin.122	  Measurements	  and	  imaging	  were	  performed	  by	  three	  experienced	  operators	  (SM,	  AB	  and	  KB,	  all	  with	  >5	  years	  experience	  in	  coronary	  echocardiography	  in	  congenital	  heart	  disease).	  Current	   echocardiographic	   data	   does	   not	   specify	   the	   point	   of	   the	   cardiac	   cycle	  (systole	  or	  diastole)	  over	  which	  measurements	  should	  be	  taken.122	  Therefore,	  for	  each	   coronary	   measurement,	   it	   was	   also	   recorded	   as	   to	   which	   phase	   the	  measurement	   was	   taken,	   in	   order	   to	   compare	   fairly	   to	   MRI.	   The	   number	   of	  proximal	  LAD	  branches	  imaged	  was	  also	  recorded	  in	  order	  to	  give	  an	  estimate	  of	  distal	  coronary	  tree	  visualisation.	  	  
2.2.2.3. Statistical	  Methods	  First,	   bland-­‐Altman	   plots	   were	   used	   to	   assess	   agreement	   between	   MRI	   and	  echocardiography	   for	   coronary	  dimensions.	  Using	   information	  gleaned	   from	   this	  analysis,	   a	   regression	   analysis	   was	   carried	   out	   in	   order	   to	   describe	   the	   exact	  relationship	   between	   MRI	   and	   echocardiographic	   measurements.	   Best	   curve	   fit	  estimation,	   using	   scatter	   plot	   and	   comparison	   of	   root	   mean	   squared	   error	   of	  model	  estimates,	  was	  performed	  to	  choose	  the	  most	  appropriate	  model.	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Distal	  coronary	  visualisation,	  assessed	  by	  number	  of	  LAD	  branches	  visualised,	  was	  compared	  between	  modalities	  using	  Wilcoxon	  Signed	  Ranks	  test.	  A	   repeated	  measures	   analysis	   of	   variance	  models	   for	   coronary	   dimensions	   was	  constructed	   in	  order	  to	  assess	   if	   the	  coronary	  distensibility	   in	  children	  results	   in	  different	  dimensions	  according	  to	  cardiac	  phase.	  A	  repeated	  measures	  model	  was	  used	  in	  order	  to	  account	  for	  within-­‐subject	  and	  between-­‐subject	  variability	  arising	  from	  testing	  multiple	  segments	  over	   two	  phases	   in	  each	  patient.	  Assumptions	  of	  sphericity	   were	   formally	   tested,	   and	   accepted,	   using	   Mauchly’s	   test.	   The	  Bonferroni	  correction	  is	  used	  to	  correct	  for	  multiple	  comparisons.	  	  Statistical	   analyses	   were	   performed	   on	   SPSS	   (version	   19)	   2010.	   Variables	   are	  described	  using	  mean	  ±	  standard	  deviation	  (SD)	  	  
2.2.3. Results	  
	  
2.2.3.1. Subjects	  50	  children	  participated	  in	  this	  study	  with	  a	  mean	  age	  of	  4	  ±	  4.4	  years	  (range	  18	  days	  to	  18	  years).	  This	   included	  24	  boys	  (mean	  age	  4.5	  ±	  4.6	  years)	  and	  26	  girls	  (mean	  age	  3.6	  ±	  4.3	  years;	  no	  significant	  age	  difference	  according	  to	  sex,	  p=0.46	  by	  independent	  samples	  t-­‐test).	  Mean	  weight	  was	  15.47	  ±	  11.6	  kg	  (range	  3.7	  to	  52	  kg)	  and	  mean	  height	  was	  94	  ±	  29	  cm.	  48	  children	  underwent	  imaging	  for	  follow-­‐up	  of	  congenital	  heart	  disease,	  1	  child	  for	  cardiomyopathy	  and	  1	  for	  resolved	  Kawasaki	  disease.	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2.2.3.2. Reference	  Values	  Bland-­‐Altman	  plots	   (Figure	  8)(Figure	  9)	   and	   (Figure	  10)	   and	   show	  a	   systematic	  bias	   between	   echocardiographic	   and	   MRI	   measurements	   for	   all	   coronary	  measurements	  (i.e.	  as	  the	  coronary	  artery	  gets	  larger,	  the	  greater	  the	  discrepancy	  between	  echocardiography	  and	  MRI).	  	  
	  
Figure	   8.	   Bland	   Altman	   Mean	   vs.	   Difference	   plots	   for	   Echo	   and	   MRI	   LM	  
measurements	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Figure	   9.	   Bland	   Altman	   Mean	   vs.	   Difference	   plots	   for	   Echo	   and	   MRI	   RCA	  
measurements	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Figure	   10.	   Bland	   Altman	   Mean	   vs.	   Difference	   plots	   for	   Echo	   and	   MRI	   LAD	  
measurements	  
Regression	   analyses	   show	   significant	   linear	   associations	   for	   the	   relationship	  between	  MRI	  and	  echocardiography	  dimensions.	   (R2	   for	  RCA	  was	  0.44,	  p=0.007;	  for	   LM	   R2	   was	   0.58,	   p<0.001	   and	   for	   LAD,	   R2	   was	   0.21,	   p=0.005).	   Regression	  equations	   to	   calculate	   echo	   values	   from	   MRI	   are	   given	   below	   with	   confidence	  intervals	  for	  coefficients	  given	  below	  the	  equations.	  (Table	  7)	  shows	  the	  range	  of	  MRI	  values	  over	  which	  these	  reference	  equations	  have	  been	  calculated.	  
Table	  7.	  Summary	  of	  CMRA	  coronary	  measurements	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  RCA	   Echo	  diameter	  =	   0.6	  (MRI	  diameter)	  +	  	   1	  	   	   	   	   (0.2,	  1)	   	   	   (0.2,	  1.7)	  	  LM	   Echo	  diameter	  =	   1x	  (MRI	  diameter)	  +	  	  0.3	  	   	   	   	   (0.7,	  1.2)	   	   	   (-­‐0.3,	  0.8)	  	  LAD	   Echo	  diameter	  =	   0.5	  x	  (MRI	  diameter)	  +	  	   0.8	  	   	   	   	   (0.3,	  1.3)	   	   	   (-­‐0.5,	  1.5)	  	  However,	  this	  may	  be	  more	  usefully	  summarised	  by	  ignoring	  the	  segment	  imaged,	  removing	  outliers	  and	  pooling	  data.	  If	  this	  is	  done	  we	  get	  a	  simple	  message:	  there	  is	   indeed	  a	   systematic	  bias	   for	  CMRA	  dimensions	  between	  1	  and	  2.5mm.	  This	   is	  demonstrated	   on	   the	   Bland-­‐Altman	   plot	   (Figure	   11)	   and	   on	   the	   regression	  analysis,	  which	  shows	  a	  significant	  linear	  relationship	  (R2	  =0.12,	  p<0.001):	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Figure	   11.	   Bland	   Altman	   Mean	   vs.	   Difference	   plots	   for	   all	   Echo	   and	   MRI	  
measurements	  with	  outliers	  excluded	  
	  Echo	  diameter	  =	   0.6	  x	  (MRI	  diameter)	  +	  	   0.8	  	   	   	   	   (0.3,	  1.4)	   	   	   (0.3,	  1)	  Quadratic	   and	   cubic	   regression	   analyses	  were	   also	   performed	   but	   these	   did	   not	  improve	  the	  root	  mean	  squared	  error	  of	  the	  model	  estimates	  and	  hence,	  the	  linear	  relationship	  is	  presented	  here.	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CMRA	  evaluation	  Operator	  certainty	  regarding	  the	  origin	  of	  the	  three	  main	  coronary	  arteries	  (RCA,	  LAD	  and	   left	   circumflex	   (LCx))	  was	   achieved	   in	   47	  out	   of	   50	   cases	   for	  MRI.	   The	  three	  uncertain	  cases	  were	  infant	  below	  a	  year	  of	  age	  (3	  months,	  9	  months	  and	  11	  months)	  and	  with	  heart	  rates	  >100	  bpm.	  In	  comparison,	  certainty	  was	  achieved	  in	  41	   out	   of	   50	   cases	   for	   echo.	   The	   uncertain	   cases	  were	   older	   patients	   (mean	   4.8	  years,	   range	  9	  months	   to	  18	  years).	   In	   two	  cases,	  MRI	  detected	  abnormalities	   in	  coronary	   origin	   classified	   as	   normal	   on	   echocardiography.	   These	   two	   cases	   had	  confirmed	  abnormalities	  on	  surgery.	  Both	  were	  slightly	  older	  children	  (13	  months	  and	  8	  years	  age	  respectively).	  In	  total,	  there	  were	  6	  abnormal	  coronary	  origins.	  5	  out	  of	  6	  were	  identified	  by	  MRI	  ((Figure	  12)(Figure	  13)(Figure	  14)(Figure	  15)	  and	  (Figure	  16))	  and	  the	  remaining	  one	   was	   classified	   as	   unsure.	   	   4	   out	   of	   6	   were	   correctly	   identified	   on	  echocardiogram	   with	   the	   remaining	   two,	   incorrectly	   classified	   as	   normal	   as	  described	  above.	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Figure	  12.	  3	  month	  old	  with	  Ventriculo-­‐Arterial	  discordance	  and	  RCA	  arises	  
from	  LAD	  
Also	  seen	  on	  echocardiogram	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Figure	   13.	   3year	   old	   girl	   with	   Dextrocardia	   and	   Tricuspid	   Atresia.	   Single	  
Coronary	  artery.	  
Also	  seen	  on	  echocardiogram	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Figure	   14.	   8	   year	   old	   boy	   with	   ventriculo-­‐arterial	   discordance	   showing	  
single	  coronary	  artery.	  
Not	  seen	  on	  echocardiogram.	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Figure	  15.	  7	  year	  old	  girl	  with	   repaired	  pulmonary	  atresia	  and	  ventricular	  
septal	  defect.	  RCA	  arises	  from	  posterior	  non-­‐coronary	  cusp	  
Also	  seen	  on	  echocardiogram	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Figure	  16.	  13	  months	  old	  boy	  showing	  LCx	  arising	  from	  RCA.	  
Not	  seen	  on	  echocardiography.	  
Overall,	   CMRA	   performed	   better	   than	   echocardiography	   in	   terms	   of	   distal	  visualisation	  of	  the	  coronary	  tree,	  as	  defined	  by	  number	  of	  proximal	  LAD	  branches	  imaged	   (p	  =	   0.001	  by	  Wilcoxon	   Signed	  Ranks	   test).	   The	  median	  number	   of	   LAD	  branches	   on	   MRI	   was	   1	   (interquartile	   range	   0	   to	   2)	   and	   on	   echo	   was	   0	  (interquartile	  range	  0	  to	  1).	  CMRA	  measurements	  did	  vary	  according	  to	  cardiac	  phase.	  The	  repeated	  measures	  model	   demonstrates	   that	   the	   systolic	   coronary	   dimension	   (estimated	   marginal	  mean	   1.90	   ±	   0.05	   mm)	   is	   greater	   than	   the	   diastolic	   measurement	   (estimated	  marginal	  mean	  1.84	  ±	  0.05	  mm	  (p=0.002).	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2.2.3.3. Discussion	  This	   study	   has	   important	   implications	   for	   the	   follow-­‐up	   of	   Kawasaki	   disease	   in	  particular.	  It	  is	  demonstrated	  here	  that	  CMRA	  measurements	  between	  1	  to	  2.5mm	  have	  a	  systematic	  bias	  when	  compared	   to	  echocardiographic	  measurements.	  We	  can	  now	  correct	  for	  this	  by	  using	  the	  regression	  equation	  given	  above	  and	  so	  we	  are	   able	   to	   use	   published	   z-­‐score	   values	   for	   echocardiography.122	   MRI	   is	  particularly	   useful	   for	   follow-­‐up	   of	   Kawasaki	   Disease	   and	   Coronary	   Allograft	  Vasculopathy	  as	  anatomic	  evaluation	  can	  be	  combined	  with	  functional	  evaluation	  with	  pharmacological	  stress	   testing.	  Hence,	   this	  study	  now	  allows	   full	  evaluation	  by	   including	   coronary	   reference	   values.	   In	   the	   past,	   clinicians	   have	   merely	  assumed	   that	   dimensions	   were	   normal	   on	   CMRA	   if	   they	   equated	   to	   normal	  published	   echocardiographic	   z-­‐scores.	   This	   study	   shows	   that	   this	   assumption	   is	  erroneous,	  as	  may	  be	  expected	  because	  echocardiography	  relies	  on	  high	  contrast	  in	   the	  vessel	  wall	  and	   low	  contrast	   in	   the	   lumen,	  whereas	  CMRA	  is	   the	  opposite.	  Although	   ‘black-­‐blood’	   coronary	   MRI	   exists97	   and	   contrast-­‐enhanced	  echocardiography	  exists,	  the	  purpose	  of	  this	  study	  was	  to	  evaluate	  the	  commonly	  used	  clinical	  echocardiographic	  and	  MRI	  techniques.	  Bland-­‐Altman	  analysis	  with	  outliers	   included	   (Figure	  17),	   show	  a	   trend	   towards	  greater	   accuracy	   with	   measurements	   above	   2.5mm.	   This	   is	   supported	   by	   a	  previous	  in	  adults	  and	  adolescents	  with	  coronary	  aneurysms	  showing	  good	  CMRA	  accuracy	   for	   coronary	   measurements	   above	   3mm.91	   The	   figure	   also	   shows	   a	  systematic	   bias	   for	   values	   below	   2.5mm.	   A	   trend	   is	   shown	   for	   greater	  underestimation	   of	   diameter	   by	   MRI	   with	   respect	   to	   echo	   as	   the	   diameter	  increases	   (as	   described	   above	   for	   Figure	   11).	   Hence,	   it	   is	   suggested	   that	   only	  measurements	  below	  2.5mm	  should	  be	  corrected	  currently.	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Figure	   17.	   Bland	   Altman	   Mean	   vs.	   Difference	   plots	   for	   all	   Echo	   and	   MRI	  
measurements	  
In	  keeping	  with	  previous	  studies,	  this	  study	  shows	  an	  excellent	  (94%)	  success	  rate	  for	   CMRA	   detection	   of	   coronary	   origins	   in	   children.90,	  92	   Infants	  with	   high	   heart	  rates	  remain	  challenging	  and	  echocardiography	  remains	  the	  modality	  of	  choice	  for	  this	  age	  group.	  This	  study	  also	  shows	  that	  distal	  coronary	  tree	  imaging	  in	  children	  is	  superior	  with	  CMRA	  in	  comparison	  to	  echocardiography.	  This	  is	  another	  useful	  point	  of	  note	  from	  this	  study	  for	  clinical	  follow	  up	  of	  coronary	  disease	  in	  children.	  Unfortunately,	   coronary	   distensibility	   in	   children	   has	   been	   largely	   neglected.	  Although	   an	   important	   recognised	   variable	   in	   adults,126	   this	   factor	   has	   been	  ignored	   when	   generating	   echocardiographic	   normal	   values	   for	   coronary	  dimensions	   in	   children.	   The	   given	   reference	   study,122	  was	   chosen	   specifically	   as	  precise	  details	  are	  given	  regarding	  how	  the	  measurements	  were	  taken.	  Even	  this	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study	  neglected	  to	  mention	  whether	  values	  are	  to	  be	  taken	  in	  systole	  or	  diastole.	  From	   clinical	   experience,	   it	   is	   usually	   difficult	   to	   get	   clear	   pictures	   for	   each	  segment	   in	   both	   phases	   and	   so	   it	   is	   understandable	   that	   this	   is	   not	   stressed.	  However,	   our	   data	   from	   the	   dual	   phase	   CMRA	   measurements	   shows	   that	  dimensions	   do	   indeed	   vary	   according	   to	   phase.	   Future	   normal	   values	   for	  echocardiography	  in	  children	  should	  note	  this	  finding	  and	  provide	  phase-­‐specific	  references.	  Intra-­‐	   and	   inter-­‐observer	   error	   for	  both	  echocardiography	  and	  CMRA	  have	  been	  previously	   investigated	   and	   shown	   to	   be	   low	   in	   these	   studies.92,	   122	   Both	  techniques	   are	   reliable	   and	   it	   is	   hoped	   that,	   in	   the	   future,	   specific	   normative	  coronary	   dimensions	   for	   CMRA	   are	   available.	   The	   difficulty	   imaging	   normal	  volunteers	   in	   this	   age	   group	   has	   precluded	   this	   to	   date.	   Hence,	   until	   such	   data	  becomes	   available,	   the	   regression	   equation	   given	   should	   be	   used	   to	   correct	  measurements	  when	  using	  echocardiographic	  data	  to	  derive	  z-­‐scores.	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3. Studies	  Relevant	  to	  Coronary	  Magnetic	  Resonance	  Angiography	  
	  As	  detailed	  in	  chapter	  2,	  good	  coronary	  lumen	  imaging	  underpins	  successful	  coronary	  vessel	  wall	  characterisation	  by	  MR.	  The	  dual	  phase	  approach	  is	  clearly	  an	  important	  development	  in	  this	  respect.	  This	  chapter	  explores	  two	  potential	  further	  improvements:	  use	  of	  3.0	  Tesla	  field	  strength	  (chapter	  3.1)	  and	  use	  of	  sublingual	  nitroglycerin	  (chapter	  3.2).	  	  
3.1. Coronary	   Magnetic	   Resonance	   Angiography:	   In	   vivo	   comparison	   of	  
image	   quality	   at	   1.5	   Tesla	   versus	   3.0	   Tesla	   with	   Parallel	   Radiofrequency	  
Transmission.	  
	  
3.1.1. Abstract	  Background:	  Coronary	  plaque	  and	  thrombus	  characterisation	  at	  3	  Tesla	  (T)	  holds	  great	   potential	   for	   clinical	   benefit	   but	   problems	   still	   exist	   with	   coronary	   lumen	  image	   quality	   at	   3T.	   Parallel	   radiofrequency	   transmission	   (Tx)	   can	   improve	   B1	  field	  homogeneity	  and	  reduce	  B1	  attenuation	  artefacts.	  The	  purpose	  of	  this	  study	  is	   to	   investigate	   if,	   in	   comparison	   to	   1.5T	   imaging,	   balanced	   steady-­‐state	   free	  precession	   (SSFP)	   coronary	   magnetic	   resonance	   angiography	   (CMRA)	   image	  quality	  at	  3T	  can	  be	  maintained	  by	  use	  of	  Tx.	  	  Methods:	  Ten	  subjects	  (7	  male)	  underwent	  balanced-­‐SSFP	  CMRA	  at	  3T	  and	  1.5T.	  Targeted	  CMRA	  of	   the	   left	   coronary	  system	  was	  performed	  using	   free-­‐breathing,	  cardiac-­‐triggered,	   T2-­‐prepared,	   3d	   balanced-­‐SSFP.	   At	   3.0T,	   a	   B1	   volume	   shim,	  utilising	  Tx	   technology,	  was	  applied.	  Proximal	  vessel	  diameter;	  SNR;	  CNR;	  vessel	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sharpness;	   vessel	   length;	   number	   of	   proximal	   left	   anterior	   descending	   (LAD)	  branches	   visualised;	   number	   of	   left	   coronary	   artery	   segments	   visualised	   and	  qualitative	   image	  quality	   (IQ)	   scores	   (0	   to	  4)	  were	   recorded.	  Paired	   t-­‐tests	  were	  used	   for	   comparisons	   but	   categorical	   variables	   were	   compared	   using	  Wilcoxon	  Signed	  Ranks	  Test.	  	  Results:	   As	   expected,	   SNR	   values	   were	   significantly	   higher	   at	   3T	   (33	   vs.	   23;	  p=0.01)	   and	   there	   was	   a	   trend	   towards	   higher	   CNR	   (17	   vs.	   14;	   p=0.06).	   This	  resulted	  in	  better	  distal	  visualisation	  with	  a	  greater	  visualised	  length	  of	  LAD	  at	  3T	  (8.4	   vs.	   7.1cm;	   p=0.03).	   It	   also	   resulted	   in	   non-­‐inferiority	   when	   compared	  with	  1.5T	  for	  visualisation	  of	  first-­‐order	  branches	  (median	  2.5	  at	  3.0T	  and	  2.0	  at	  1.5T;	  p=0.92)	  and	  of	  coronary	  segments	  (median	  for	  both	  =	  10;	  p=0.86).	  However,	   vessel	   sharpness	   was	   reduced	   at	   3T	   (37%	   vs.	   43%;	   p=0.011)	   and	   IQ	  scores	  were	  worse	  (median	  3.0	  vs.	  4.0;	  p=0.011).	  The	  reduction	   in	   image	  quality	  resulted	  in	  an	  overestimation	  of	  vessel	  size	  at	  3T	  in	  comparison	  to	  1.5T	  (mean	  bias	  =	  0.2mm;	  p=0.049).	  	  Conclusions:	   This	   study	   shows	   that,	   despite	   implementation	   of	   parallel	   transmit	  technology,	   balanced-­‐SSFP	   CMRA	   at	   3T	   is	   still	   inferior	   to	   1.5T	   imaging.	   Parallel	  transmit	  should	  be	  combined	  with	  other	  recent	  technological	  advances	  to	  achieve	  superior	  imaging	  at	  3T.	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3.1.2. Introduction	  Despite	  many	  medical	  advances	  in	  the	  last	  twenty	  years,	  atherosclerosis	  remains	  the	   leading	   cause	   of	   mortality	   in	   developed	   nations.127,	   128	   Coronary	   magnetic	  resonance	  angiography	  (CMRA)	  is	  a	  valuable	  tool	  for	  the	  non-­‐invasive	  detection	  of	  significant	  proximal	  or	  mid	  coronary	  artery	  disease.129	  However,	  the	  real	  strength	  behind	   cardiac	   magnetic	   resonance	   imaging	   currently,	   does	   not	   lie	   in	   coronary	  lumen	   angiography	   but	   in	   the	   functional	   and	   pathophysiological	   assessment	   of	  coronary	  disease.130	  Furthermore,	  coronary	  lumen	  imaging	  to	  detect	  stenoses	  is	  a	  poor	   predictor	   of	   future	   coronary	   events.131	   Approximately	   60-­‐70%	   of	   acute	  coronary	   syndromes	   are	   caused	   by	   stenosis	   of	   less	   than	   50%	   of	   the	   luminal	  diameter	   due	   to	   compensatory	   positive	   vessel	   wall	   remodeling.132	   Hence,	   non-­‐invasive	  coronary	  vessel	  wall	  imaging	  has	  the	  potential	  to	  identify	  the	  true	  disease	  burden	   and	   become	   the	   next	   big	   clinical	   development	   for	   cardiac	   magnetic	  resonance	  imaging.97-­‐99	  T1	  weighted	  imaging	  and	  late	  gadolinium	  enhancement	  on	  MRI	  have	  already	  been	  proven	  to	  demonstrate	  symptomatic	  carotid	  plaques	  with	  intra-­‐plaque	   hemorrhage	   or	   thin	   fibrous	   cap	   respectively.133	   Late	   gadolinium	  enhancement	  and	  T1	  weighted	  imaging	  for	  coronary	  vessel	  wall	  disease	  therefore	  have	  great	  potential	  and	  have	  already	  been	  shown	  to	  be	   feasible	  with	   important	  clinical	   implications.134-­‐136	   These	   techniques	   do,	   however,	   rely	   on	   high	   SNR	   and	  high	  image	  resolution.	  Therefore,	  the	  advantages	  of	  high-­‐field	  imaging	  at	  3.0	  Tesla	  may	   benefit	   these	   approaches.	   Feasibility	   studies	   for	   coronary	   plaque	   and	  thrombus	   characterisation	   at	   3.0	   Tesla	   have	   already	   been	   demonstrated.134,	   137	  Good	  quality	   luminal	   imaging	   is,	  however,	  a	  pre-­‐requisite	  both	  as	  a	  roadmap	   for	  coronary	  vessel	  wall	  imaging	  and	  for	  stenosis	  quantification.133-­‐137	  	  
Chapter	  3	  –	  Studies	  Relevant	  to	  Coronary	  Magnetic	  Resonance	  Angiography	  
	   	   90	  
Current	   limitations	  of	  CMRA	   lumen	   imaging	  at	  1.5	  Tesla	   include	  residual	  motion	  and	   signal-­‐to-­‐noise	   (SNR)	   constraints.	   Since	   SNR	   is	   proportional	   to	   the	   static	  magnetic	   field	   (B0),	   imaging	   at	   3	   T	   should	   theoretically	   increase	   SNR.	   Although	  
Stuber	  et	  al,	  found	  an	  increase	  in	  SNR	  and	  CNR	  in	  CMRA	  images	  at	  3T,	  there	  was	  no	  clinically	  meaningful	   increase	   in	   image	  quality,	  measured	  as	  vessel	  sharpness,	  or	  in	  distal	  coronary	  artery	  imaging,	  measured	  by	  length	  of	  vessel	  visualised.138	  One	  possible	   explanation	   is	   the	   difficulty	   in	   achieving	   uniform	   radiofrequency	   (RF)	  excitation	  over	  the	  entire	  field	  of	  view	  (FOV)	  at	  higher	  field	  strengths	  resulting	  in	  a	  reduction	  of	  image	  quality	  (e.g.	  B1	  attenuation	  artefacts).	  	  	  Balanced	  steady-­‐state	  free	  precession	  (SSFP)	  sequences	  have	  been	  demonstrated	  to	  give	  superior	  CNR	  and	  SNR	  values	  compared	  with	  gradient-­‐echo	  sequences.139	  More	  recently,	   imaging	  at	  3T	  using	  balanced-­‐SSFP	  was	   found	  to	   increase	  SNR	  by	  over	   50%.140	   However,	   this	   study	   also	   found	   inconsistent	   image	   quality	   at	   3.0	  Tesla	   due	   to	   off-­‐resonance	   artefacts.	   The	   issue	   arises	   because	   higher	   field	  strengths	   are	   associated	   with	   increased	   susceptibility-­‐induced	   resonance	  frequency	  shifts	  to	  which	  balanced-­‐SSFP	  sequences	  are	  particularly	  susceptible.141	  	  Multi-­‐channel	   RF	   transmission	   (Tx)	   can	   be	   used	   to	   improve	   the	   RF	   (B1	   field)	  homogeneity	   in	  high-­‐field	  MRI.142	  More	  accurate	  knowledge	  of	   the	   local	  B1	   field	  also	  allows	  for	  improved	  management	  of	  the	  local	  specific	  absorption	  rate	  (SAR),	  thereby	   enabling	   shorter	   repetition	   times	   (TR)	   to	   be	   employed.143	   This	   may	  improve	   image	  quality	  by	  reducing	  artefact	   levels,	  as	  demonstrated	  recently	   in	  a	  small	   study	   comparing	   balanced-­‐SSFP	   cine	   images	   with	   and	   without	   the	   use	   of	  Tx.144	  
Chapter	  3	  –	  Studies	  Relevant	  to	  Coronary	  Magnetic	  Resonance	  Angiography	  
	   	   91	  
The	  purpose	  of	  this	  study	  is	  to	  investigate	  if	  balanced-­‐SSFP	  CMRA	  image	  quality	  is	  maintained	  by	  use	  of	  Tx	  when	  moving	  to	  3.0	  Tesla	  imaging	  in	  order	  to	  ultimately	  realise	  the	  potential	  advantages	  of	  high	  field	  MRI	  for	  coronary	  lumen	  imaging.	  	  
3.1.3. Methods	  
	  
3.1.3.1. Image	  Acquisition	  	  Ten	   (7	   male)	   healthy	   volunteers	   were	   first	   imaged	   in	   supine	   position	   on	   a	   3T	  Achieva	   clinical	   scanner	   (Philips	   Healthcare,	   Best,	   Netherlands;	   gradient	  amplitude	   30	  mT/m	   and	   slew	   rate	   200	  mT/m/sec)	   using	   a	   32-­‐element	   cardiac	  phased-­‐array	  receiver	  coil.	   Imaging	  was	  then	  repeated	  on	  a	  1.5T	  Achieva	  clinical	  scanner	  (Philips	  Healthcare,	  Best,	  Netherlands;	  gradient	  amplitude	  30	  mT/m	  and	  slew	   rate	   150	   mT/m/sec)	   using	   a	   similar	   32-­‐element	   cardiac	   phased-­‐array	  receiver	  coil.	  At	  both	  scanners,	  an	  initial	  survey	  and	  reference	  scan	  was	  acquired	  to	   obtain	   coil	   sensitivity	   maps.	   At	   the	   3.0	   Tesla	   scanner,	   an	   additional	   B1	  calibration	  scan	  was	  performed	  between	  the	  survey	  and	  reference	  scans	  in	  order	  to	   calculate	   the	   patient-­‐specific	   absorption	   rate	   and	   allow	   for	   B1	   volume	  shimming.	   Following	   this,	   the	   cardiac	   rest	   period	   was	   ascertained	   using	   a	   high	  temporal	  resolution,	  balanced-­‐SSFP,	  two-­‐dimensional	  cine	  MR	  sequence	  in	  a	  four-­‐chamber	   view	   orientation.	   (Imaging	   parameters	   included:	   repetition	   time	   =	   2.4	  ms,	   echo	   time	  =	  1.2	  ms,	   flip	   angle	  =	  60°	   at	   1.5T	   and	  40°	   at	   3T,	   slice	   thickness	  =	  10mm,	  FOV	  =	  300-­‐350	  mm,	  80	  cardiac	  phases,	  echo	  train	  length	  =	  11	  at	  1.5T	  and	  22	   at	   3.0T,	   temporal	   resolution	   =	   10	   to	   16	   ms/	   frame).	   The	   mid-­‐diastolic	   rest	  period,	   ascertained	   from	   the	   cine	   images,	   was	   used	   to	   define	   the	   acquisition	  window	  for	  the	  subsequent	  CMRA.	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First,	  a	  rapid	  whole-­‐heart	  CMRA	  was	  performed	  as	  a	  roadmap	  for	  a	  subsequent	  3-­‐point	   plan-­‐scan	   for	   a	   targeted	   double-­‐oblique	   CMRA	   parallel	   to	   the	   native	   left	  coronary	   artery	   system.145	   It	   was	   performed	   with	   a	   previously	   described	  navigator-­‐gated	   free-­‐breathing	   and	   cardiac-­‐triggered	   T2-­‐prepared	   three-­‐dimensional	   (3D)	  balanced-­‐SSFP	  sequence	  allowing	  visualisation	  of	   the	  anatomy	  of	   the	   coronary	   artery	   lumen.146	   At	   3.0	   Tesla,	   a	   volume	   B1	   shim	   was	   applied	  utilising	   the	   parallel	   RF	   transmit	   technology.	   Imaging	   parameters	   included	   the	  following:	  FOV	  =	  270x270	  mm,	  matrix	  =	  216x216,	  acquired	  in-­‐plane	  resolution	  =	  1.25x1.25	  mm	  (reconstructed	  0.75x0.75	  mm),	  reconstructed	  slice	  thickness	  =	  1.5	  mm	  (acquired	  thickness	  =	  3	  mm	  overcontiguous	  slices),	  acquisition	  window	  =	  80	  to	  100	  ms,	  repetition	  time	  (TR)	  /echo	  time	  (TE)	  =	  5.2	  ms/2.6	  ms,	  flip	  angle	  =	  90°	  at	   1.5T	   and	   70°	   at	   3.0T;	   start-­‐up	   cycles	   =	   5,	   and	   number	   of	   slices	   =	   20.	   Parallel	  imaging	  techniques	  such	  as	  sensitivity	  encoding	  (SENSE)	  were	  not	  used	  to	  allow	  for	  SNR	  measurements.	  	  
3.1.3.2. Image	  analysis	  For	  quantitative	  analysis,	   the	   targeted	   left	  CMRA	  images	  were	  reformatted	  along	  the	  major	  axis	  of	  the	  left	  coronary	  artery	  system	  and	  analysed	  using	  “Soap-­‐Bubble”	  software	   (Release	  5.0,	   Philips	  Healthcare,	  Best,	  Netherlands).147	  Using	   this	   semi-­‐automatic	   software,	   proximal	   vessel	   diameter	   of	   the	   combined	   left	   main	   and	  anterior	   descending	   artery;	   SNR;	   Contrast-­‐to-­‐Noise	   Ratio	   (CNR)	   and	   vessel	  sharpness	   were	   measured.	   The	   local	   vessel	   sharpness	   was	   calculated	   as	   a	  percentage	  by	  normalising	  the	  magnitude	  of	  the	  local	  change	  in	  signal	  intensity	  at	  the	  selected	  vessel	  border	   to	   the	  average	  signal	   intensity	  of	   the	  centerline	  of	   the	  selected	  vessel	  by	  using	  a	  Deriche	  algorithm.148	  The	  SNR	  was	  calculated	  as:	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SNR	  =	  (SIBlood)	  /	  (SDAir)	  where	   SIBlood	   is	   the	   mean	   signal	   intensity	   in	   a	   user-­‐specified	   region	   of	   interest	  (ROI)	  in	  the	  ascending	  aorta	  and	  SDAir	   is	  the	  standard	  deviation	  of	  the	  signal	  in	  a	  ROI	  defined	  anterior	  to	  the	  chest	  wall.138	  Subsequently,	   the	  CNR	  between	  blood	   in	   the	  ascending	  aorta	   (at	   the	   level	  of	   the	  coronary	  ostia)	  and	  muscle	  was	  calculated	  as:	  	  CNR	  =	  (SIBlood	  -­‐	  SIMuscle)/SDAir	  Where	   SIMuscle	   is	   the	   signal	   intensity	   in	   a	   ROI	   defined	   in	   the	   muscle	   of	   the	   left	  ventricular	  free	  wall.138	  In	   order	   to	   measure	   distal	   coverage	   and	   branches,	   the	   length	   of	   left	   anterior	  descending	   artery	   (LAD),	   the	   number	   of	   proximal	   first-­‐order	   LAD	   branches	   and	  the	  number	  of	  left	  coronary	  artery	  segments	  visualised	  were	  recorded.	  Segments	  were	  defined	  as	  11	  left	  coronary	  system	  segments	  using	  the	  modified	  16-­‐segment	  American	   Heart	   Association	   (AHA)	   coronary	   tree	   classification	   (Figure	   18).149	  Segments	  were	   defined	   as	   having	   been	   visualised	   if	   the	   proximal	   portions	  were	  seen.	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Figure	   18.	   Segmental	   anatomy	   of	   the	   left	   coronary	   artery	   system	   using	   a	  
modified	  AHA	  classification.	  	  
5=main	   stem;	  6=LAD	  proximal;	  7=LAD	  mid;	  8=LAD	  distal;	  9=first	  diagonal;	  
10=second	  diagonal;	  11=LCX	  proximal;	  12=obtuse	  marginal;	  13=LCX	  distal;	  
14=LCX	  posterolateral	  branch;	  15=LCX	  posterodescendens	  branch;	  (LCX=left	  
circumflex	  artery;	  LAD=left	  anterior	  descending	  coronary	  artery)	  	  
	  
Finally,	  a	  qualitative	  analysis	  was	  undertaken	  by	  means	  of	  a	  consensus	  reading	  for	  image	  quality	  scoring	  on	  all	  the	  angiograms	  in	  a	  blinded	  and	  random	  order	  by	  two	  readers	  (T.H.	  and	  G.F.G.	  (>3	  years	  and	  10	  years	  respectively	  of	  CMRA	  experience)).	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The	   two	  readers	   first	   reviewed	   the	   images	   independently	  and	  any	  disagreement	  was	  then	  discussed	  before	  the	  final	  grade	  was	  given.	  The	  following	  scoring	  system	  was	  used:	  0	  indicates	  that	  the	  coronary	  artery	  was	  not	  visible;	  1	  visible	  but	  with	  markedly	   blurred	   borders;	   2	   visible	   with	  moderately	   blurred	   borders;	   3	   visible	  with	  mildly	  blurred	  borders	  and	  4	  visible	  with	  sharply	  defined	  borders.111	  	  	  
3.1.3.3. Data	  analysis	  Variables	   were	   visually	   assessed	   on	   frequency	   plots	   for	   normality	   and	   then	  formally	   assessed	   for	   normality	   of	   distribution	   using	   the	   Kolmogorov-­‐Smirnov	  test.	  Image	  quality	  scores	  (IQ);	  number	  of	  first-­‐order	  LAD	  branches	  and	  number	  of	  left	   coronary	   segments	   imaged	   were	   assumed	   to	   have	   a	   non-­‐parametric	  distribution.	  Measurements	  were	  compared	  by	  paired	   t-­‐test	  analysis	   for	  normally	  distributed	  variables	  and	  Wilcoxon	  signed	  rank	  tests	  for	  categorical	  variables	  (p	  values	  <	  0.05	  indicated	  rejection	  of	   the	  null	  hypothesis).	  Agreement	  between	  3.0	  Tesla	  and	  1.5	  Tesla	  CMRA	  for	  proximal	  LAD	  diameter	  was	  assessed	  using	  Bland-­‐Altman	  analysis.	  Using	  an	  80%	  power	   level,	  a	  2-­‐tailed	  significance	   level	  of	  5%	  and	  an	  SD	  of	  7	   for	  vessel	  wall	  sharpness	  from	  previous	  data,138	  to	  show	  a	  significant	  change	  of	  vessel	  sharpness	  of	  15%,	  10	  paired	  cases	  are	  required.	  Statistical	   analysis	   was	   performed	   on	   SPSS	   version	   19	   (Release	   19.0.0,	   IBM	  Software	  Group,	  New	  York,	  USA).	  	  
3.1.4. Results	  All	  ten	  healthy	  subjects	  (7	  male)	  underwent	  CMRA	  at	  both	  scanners.	  Mean	  age	  was	  32	   years	   (range	   25	   to	   39),	   mean	   weight	   was	   71kg	   (range	   48	   to	   90)	   and	  mean	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height	  was	  170	  cm	  (range	  154	  to	  193).	  The	  mean	  time	  between	  scans	  was	  23	  days	  (range	  1	  to	  70	  days).	  There	  was	  no	  difference	   in	  mean	  heart	  rate	  between	  scans	  (mean	  63	  bpm	  at	  3.0	  Tesla	  and	  62	  bpm	  at	  1.5	  Tesla;	  p=	  0.65	  by	  paired	  t-­‐test)	  Vessel	   sharpness;	   proximal	   vessel	   diameter;	   LAD	   length	   imaged;	   SNR	   and	   CNR	  were	  assessed	  visually	  with	  frequency	  plots	  and	  were	  further	  formally	  tested	  for	  normality	   using	   the	   Kolmogorov-­‐Smirnov	   test	   (p>0.2	   for	   all).	   Based	   on	   this	  assessment,	  all	  five	  variables	  were	  assumed	  to	  be	  normally	  distributed.	  As	  expected	  SNR	  values	  were	  significantly	  higher	  at	  3.0	  Tesla	  (33	  vs.	  23;	  p=0.008	  by	  paired	  t-­‐test)	  and	  there	  was	  a	  trend	  towards	  higher	  CNR	  (17	  at	  3.0T	  vs.	  14	  at	  1.5T;	   p=0.060).	   This	   resulted	   in	   better	   distal	   visualisation	   as	   given	   by	   a	   slightly	  greater	   visualised	   length	   of	   LAD	   at	   3.0	   T	   (8.4	   cm	   vs.	   7.1	   cm;	   p=0.03).	   It	   also	  resulted	   in	   non-­‐inferiority	  when	   compared	  with	   1.5	  Tesla	   for	   first-­‐order	   branch	  visualisation	  (median	  at	  3.0	  Tesla,	  2.5	  branches	  seen	  and	  median	  at	  1.5	  Tesla,	  2.0	  branches	   seen;	   p=0.92	   by	   Wilcoxon	   Signed	   Ranks	   Test)	   and	   for	   number	   of	  segments	  seen	  (median	  at	  both	  field	  strengths	  =	  10	  segments;	  p=0.86	  by	  Wilcoxon	  Signed	  Ranks	  Test).	  However,	  vessel	  sharpness	  was	   found	  to	  be	   inferior	  at	  3T	  (37%	  at	  3.0	  Tesla	  and	  43%	   at	   1.5	   Tesla;	   p=0.011	   by	   paired	   t-­‐test).	   Qualitative	   IQ	   scores	   were	   also	  inferior	  (median	  3.0	  at	  3.0	  Tesla	  and	  4.0	  at	  1.5	  Tesla;	  p=0.011	  by	  Wilcoxon	  Signed	  Ranks	  Test).	  This	  resulted	  in	  an	  overestimation	  of	  vessel	  size	  at	  3T	  compared	  with	  1.5	   T	   (mean	   bias	   =	   0.2mm;	   p=0.049;	   95%	   limits	   of	   agreement	   on	   Bland-­‐Altman	  analysis	  were	  0.35	  to	  -­‐0.75mm)	  (Figure	  19).	  Results	  are	  summarised	  in	  (Table	  8)	  and	  (Table	  9).	  Sample	  images	  are	  shown	  in	  (Figure	  20)	  and	  (Figure	  21).	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Table	  8.	  Normally	  distributed	  variables	  for	  1.5T	  vs.	  3T	  study.	  




Table	  9.	  Non-­‐parametric	  tests	  for	  1.5T	  vs.	  3T	  study.	  
P-­‐values	  are	  given	  for	  paired	  differences	  using	  Wilcoxon	  Signed	  Ranks	  Test.	  
*denotes	  a	  significant	  difference	  (p<0.05)	  
Measure	  
3.0	  Tesla	  median	  
(interquartile	  range)	  
1.5	  Tesla	  median	  
(interquartile	  range)	  
p-­‐value	  
Number	  of	  left	  coronary	  
segments	  imaged	  
10	  (8.25	  to	  11)	   10	  (8.75	  to	  10)	   0.86	  
Number	  of	  first-­‐order	  LAD	  
branches	  imaged	  
2.5	  (1	  to	  3.25)	   2.0	  (1.75	  to	  3.25)	   0.92	  
Image	  Quality	  Score	   3.0	  (2	  to	  3.25)	   4.0	  (3.75	  to	  4)	   0.011*	  	  
Measure	   3.0	  Tesla	  (mean	  ±	  SD)	   1.5	  Tesla	  	  (mean	  ±	  SD)	   p-­‐value	  
Vessel	  Sharpness	  (%)	   37	  ±	  6	   43	  ±	  6	   0.011*	  
Vessel	  Length	  (cm)	   8.4	  ±	  1.2	   7.1	  ±	  1.7	   0.027*	  
CNR	   17	  ±	  4	   14	  ±	  6	   0.060	  
SNR	   33	  ±	  7	   23	  ±	  10	   0.008*	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Figure	   19.	   Bland-­‐Altman	   Plots	   for	   agreement	   between	   vessel	   diameter	  
measurement	  at	  3.0	  Tesla	  and	  1.5	  Tesla.	  	  
Dashed	   line	   represents	   95%	   level	   of	   agreement	   and	   solid	   line	   centre-­‐line	  
represents	   the	   mean	   bias.	   There	   is	   a	   significant	   mean	   bias	   of	   0.2mm	  
(p=0.049)	  toward	  overestimation	  of	  vessel	  diameter.	  This	  may	  be	  explained	  
by	   a	   lower	   image	   quality	   and	   vessel	   sharpness	   at	   3.0	   Tesla	   leading	   to	  
problems	   with	   partial-­‐volume	   effects	   which	   result	   in	   overestimation	   of	  
vessel	  diameter	  
	  
Figure	  20.	  Sample	  Images	  showing	  left	  coronary	  system	  of	  same	  volunteer	  at	  
1.5	  Tesla	  (T)	  on	  left	  and	  3.0	  T	  on	  right.	  	  
Images	  have	  been	  reformatted	  using	  “Soap-­‐Bubble”.	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Figure	   21.	   Further	   sample	   Images	   showing	   left	   coronary	   system	   of	   same	  
volunteer	  at	  1.5	  Tesla	  (T)	  on	  left	  and	  3.0	  T	  on	  right.	  	  
Images	  have	  been	  reformatted	  using	  “Soap-­‐Bubble”.	  	  	  
3.1.5. Discussion	  Congruent	   with	   previous	   studies,	   we	   have	   shown	   that	   the	   SNR	   of	   CMRA	   is	  increased	   at	   3.0	  Tesla	   compared	  with	   1.5	  Tesla.138,	  150	  We	  have	   further	   shown	   a	  trend	  towards	   increase	   in	  CNR.	   In	   this	  preliminary	  study	  of	  healthy	  subjects,	   the	  use	  of	  balanced-­‐SSFP	  at	  3.0T	  using	  parallel	  transmit	  technology	  allowed	  improved	  visualisation	  of	  the	  more	  distal	  coronary	  tree	  compared	  with	  1.5	  Tesla	  (length	  of	  LAD	  visualised	  8.4	  cm	  vs.	  7.1cm).	  	  However,	   improvements	   in	   B1	   homogeneity	   afforded	   by	   parallel	   transmit	  technology	  did	  not	  result	  in	  better	  image	  quality.	  Qualitative	  (IQ)	  and	  quantitative	  (vessel	   sharpness)	  measures	   of	   image	   quality	  were	   in	   fact	   reduced	   at	   3.0	   Tesla	  compared	   with	   1.5	   Tesla	   imaging.	   More	   worryingly,	   this	   results	   in	   a	   small	   but	  significant	  overestimation	  of	  lumen	  size	  (mean	  bias	  0.2mm).	  This	  is	  likely	  to	  be	  the	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result	   of	   partial	   volume	   effects	   (intra-­‐voxel	   dephasing)	   that	   occurs	   due	   to	   a	  reduction	  in	  vessel	  sharpness	  as	  demonstrated	  in	  (Figure	  20)	  and	  (Figure	  21).	  	  This	   study	   is	   important	   as	   it	   shows	   that,	   despite	   advantages	   in	   T1	   weighted	  imaging	   and	   late	   gadolinium	   enhancement	   imaging	   at	   3.0	   Tesla,134,	   137	   the	   pre-­‐requisite	  of	  good	  lumen	  imaging	  is	  not	  being	  adequately	  met.	  	  Overall,	   our	   findings	   suggest	   that	   parallel	   transmit	   technology	   alone	   is	   not	  sufficient	   to	  achieve	  balanced-­‐SSFP	  CMRA	   image	  quality	  at	  3.0	  Tesla	  comparable	  with	  1.5	  Tesla.	  We	  can,	  however,	  only	  draw	  conclusions	  from	  the	  specific	  sequence	  tested.	  Sequences	  are	  being	  developed	  such	  as	  the	  method	  to	  alternate	  repetition	  times	  resulting	   in	  an	  alteration	  of	   the	  spectral	  response	  of	  SSFP.151	  Hence,	  wider	  band	  spacing	  can	  be	  achieved,	   relaxing	   the	  TR	   limitation.	  This	  approach,	   termed	  ‘wideband	   SSFP’	   has	   already	   been	   shown	   to	   suppress	   off-­‐resonance	   related	  banding	  artefacts	  and	  hence	  improve	  image	  quality.	  The	  combination	  with	  parallel	  transmit	  technology	  may	  achieve	  the	  full	  potential	  of	  SSFP	  CMRA	  at	  3.0	  Tesla.	  This	  could	  ultimately	  be	  combined	  with	  improved	  motion	  compensation.	  Novel	  2D	  and	  3D	  self-­‐navigator	  techniques	  have	  recently	  been	  described	  and	  have	  already	  been	  shown	  to	  improve	  CMRA	  image	  quality	  and	  even	  shorten	  the	  scan	  duration.152,	  153	  It	   seems	   probable	   that	   a	   combination	   of	   these	   approaches	   will	   soon	   achieve	  improved	  CMRA	   image	  quality	  at	  3.0	  Tesla	  compared	  with	   lower	   field	  strengths.	  We	   have	   shown	   that	   parallel	   transmit	   technology	   is	   only	   one	   step	   towards	   that	  goal.	  	  
3.1.6. Conclusion	  This	   study	   shows	   that	   despite	   implementation	   of	   parallel	   transmit	   technology,	  balanced-­‐SSFP	   CMRA	   image	   quality	   at	   3.0	   Tesla	   is	   still	   inferior	   to	   1.5	   Tesla	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imaging.	  Parallel	  transmit	  combined	  with	  other	  recent	  technological	  advances	  may	  allow	  superior	  imaging	  at	  3.0	  Tesla.	  	  
3.2. Combined	   Coronary	   Lumen	   and	   Vessel	   Wall	   Magnetic	   Resonance	  
Imaging	  with	  i-­‐T2prep:	  Influence	  of	  Nitroglycerin	  	  
3.2.1. Abstract	  Background:	   It	   has	   been	   shown	   that	   sublingual	   nitroglycerin	   (NTG)	   improves	  image	  quality	  of	  coronary	  lumen	  magnetic	  resonance	  angiography.	  The	  purpose	  of	  the	   study	  was	   to	   investigate	   the	   influence	  of	   sublingual	  NTG	  on	   coronary	   lumen	  and	   vessel	   wall	   image	   quality	   using	   a	   combined,	   single	   sequence	   approach	   (i-­‐T2prep),	  which	   is	  able	   to	   image	  both	  coronary	   lumen	  and	  vessel	  wall	  within	   the	  known	  time-­‐frame	  of	  action	  of	  sublingual	  NTG	  Methods:	   Ten	   healthy	   volunteers	   underwent	   right	   coronary	   artery	   (RCA)	   lumen	  and	   vessel	   wall	   imaging	   using	   the	   i-­‐T2prep	   sequence	   before	   and	   after	  administration	   of	   NTG.	   Lumen	   and	   vessel	   wall	   image	   quality	   was	   assessed	  qualitatively	   (scale	   0	   to	   4:	   0	   being	   not	   visible	   and	   4	   being	   visible	   without	   any	  blurring)	  and	  quantitatively	  (using	  vessel	  wall	  sharpness).	  Vessel	  lumen	  and	  wall	  diameters	   and	   length	   were	   also	   measured	   using	   dedicated	   semi-­‐automatic	  software,	   “Soap-­‐Bubble”.	   Normally	   distributed	   variables	   were	   assessed	   using	  paired	  t-­‐tests	  and	  remaining	  variables	  were	  assessed	  using	  Wilcoxon	  signed	  ranks	  test.	  Results:	   NTG	   induced	   coronary	   vasodilatation	   (RCA	   lumen	   diameter	   increased	  from	  2.16	  ±	  0.32	   to	  2.52	  ±	  0.59mm;	  p=0.036).	  As	  a	   result,	   visualised	  RCA	   lumen	  length	  (9.8	  ±	  2.6	   to	  11.4	  ±	  3.3	  cm;	  p=0.025)	  and	  qualitative	   lumen	   image	  quality	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(median	  3	  (interquartile	  range	  2	  -­‐	  3.25)	  vs.	  median	  3	  (interquartile	  range	  3	  –	  4);	  p=0.046)	   both	   improved.	   Vessel	   wall	   imaging	   also	   demonstrated	   a	   significant	  improvement	  in	  vessel	  wall	  sharpness	  after	  NTG	  (24.8	  vs.	  27.3%;	  p=0.036).	  	  Conclusions:	  This	  study	  demonstrates	  the	  benefits	  of	  NTG	  for	  coronary	  lumen	  and	  vessel	   wall	   imaging	   using	   a	   combined	   sequence,	   i-­‐T2prep.	   The	   methodology	  described	  here	  has	  great	  potential	  for	  future	  pathophysiological	  studies.	  	  
3.2.2. Introduction	  Sublingual	   nitroglycerin	   (NTG)	   has	   been	   recently	   shown	   to	   improve	   subjective	  image	   quality	   for	   coronary	   magnetic	   resonance	   angiography	   (CMRA)	   without	  influencing	   signal-­‐to-­‐noise	   or	   contrast-­‐to-­‐noise	   ratios.154	   Increase	   in	   luminal	  diameter	  is	  thought	  to	  result	  in	  a	  better	  delineation	  of	  the	  coronary	  arteries	  and	  a	  reduction	   of	   artefacts.	   Such	   improvements	   are	   welcome	   because	   CMRA	   is	   a	  valuable	   tool	   for	   the	   non-­‐invasive	   and	   radiation-­‐free	   detection	   of	   significant	  proximal	  or	  mid	  coronary	  artery	  disease.89	  However,	  coronary	   lumen	   imaging	  to	  detect	   stenoses	   is	   a	   poor	   predictor	   of	   future	   coronary	   events.131	   Approximately	  60-­‐70%	  of	  acute	  coronary	  syndromes	  are	  caused	  by	  stenosis	  of	   less	  than	  50%	  of	  the	   luminal	   diameter	   due	   to	   compensatory	   positive	   vessel	   wall	   remodeling.132	  Hence,	   coronary	   vessel	   wall	   imaging	   is	   required	   to	   provide	   the	   true	   disease	  burden	  and	  such	  screening	  has	  been	  demonstrated	  using	  non-­‐invasive	  black-­‐blood	  MRI.97-­‐99	   In	   this	   study,	   we	   sought	   to	   investigate	   the	   influence	   of	   NTG	   on	   a	  combined	  protocol,	  i-­‐T2prep	  (interleaved	  T2prep),	  for	  coronary	  lumen	  and	  vessel	  wall	  imaging.	  The	  pharmacodynamics	  of	  NTG	  suggests	  that	  peak	  blood	  levels	  are	  reached	  by	  2	  minutes	  of	  administration,	  that	  this	   level	   falls	  to	  50%	  by	  7	  minutes	  and	  that	   it	   is	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barely	   detectable	   by	   20	   minutes.155	   This	   timing	   means	   that	   it	   is	   impractical	   to	  utilise	  effects	  for	  both	  coronary	  lumen	  and	  vessel	  wall	  imaging	  given	  the	  relatively	  long	   imaging	   times	   for	   these	   free-­‐breathing	   sequences.	   Therefore,	   we	   used	   a	  coronary	  vessel	  wall	   sequence	  based	  on	   the	  differences	   in	  T2	   relaxation	   time	  of	  arterial	  blood	  and	  surrounding	  tissues.	  The	  technique	  is	  based	  on	  the	  acquisition	  and	  weighted	  subtraction	  of	  two	  3D	  coronary	  steady-­‐state	  free-­‐precession	  (SSFP)	  data	   sets,	   one	   obtained	   with	   a	   T2	   preparation	   prepulse	   (T2prep-­‐ON)	   and	   the	  second	  without	  (T2prep-­‐OFF).	  The	  weighted	  subtraction	  allows	  for	  nulling	  of	  the	  signal	  of	  arterial	  blood	  while	  maintaining	  the	  signal	  of	  myocardium	  and	  the	  vessel	  wall.156	   The	   two	   acquisitions	   are	   interleaved	   over	   2	   heartbeats.	   Data	   are	   only	  accepted	   if	   both	   the	   T2prep-­‐ON	   and	   T2prep-­‐OFF	   acquisition	   were	   within	   the	  gating	  window	  thus	  allowing	  for	  identical	  positions	  and	  reducing	  misregistration	  artefacts.	  The	  resulting	  sequence	  (i-­‐T2prep)	  is	  ideal	  for	  the	  purposes	  of	  our	  study	  allowing	   identical	   influence	   of	   NTG	   on	   both	   CMRA	   (using	   the	   acquisition	   with	  T2prep-­‐ON)	   and	   vessel	   wall	   (using	   the	   i-­‐T2prep	   weighted	   subtraction).	  Additionally,	   having	   a	   single	   sequence	   that	   can	   be	   completed	   within	   the	   time	  frame	  of	  action	  of	  sublingual	  NTG,	  eases	  the	  practicalities	  of	  administration.	  The	   purpose	   of	   the	   study	  was	   to	   investigate	   the	   influence	   of	   sublingual	  NTG	   on	  coronary	   lumen	  and	  vessel	  wall	   imaging	  using	   the	   combined,	   single	   sequence,	   i-­‐T2prep	  approach.	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3.2.3. Methods	  
	  
3.2.3.1. Subjects	  Institutional	  Review	  Board	  (IRB)	  approval	  was	  obtained	  prior	  to	  commencement	  of	   recruitment	   (IRB	   reference	   number	   07/Q0702/62).	   Ten	   healthy	   volunteers	  took	  part	  in	  the	  study	  after	  written,	  informed	  consent	  was	  obtained.	  i-­‐T2prep	  MRI	  was	   performed	   before	   and	   directly	   after	   administration	   of	   800	   micrograms	   of	  sublingual	  NTG.	  	  
3.2.3.2. MRI	  Cardiac	   MRI	   was	   performed	   using	   a	   1.5	   Tesla	   (T)	   Achieva	   clinical	   MR	   scanner	  (Philips	  Healthcare,	   Best,	  NL)	   equipped	  with	   a	   32-­‐element	   cardiac	   phased-­‐array	  receiver	   coil.	   An	   initial	   survey	   and	   reference	   scan	  was	   acquired	   for	   subsequent	  positioning	  of	  the	  imaging	  volume	  &	  navigator	  and	  to	  obtain	  coil	  sensitivity	  maps.	  Following	  this,	  the	  mid-­‐diastolic	  cardiac	  rest	  period	  was	  ascertained	  using	  a	  high	  temporal	  resolution,	  balanced-­‐SSFP,	  two-­‐dimensional	  cine	  MR	  sequence	  in	  a	  four-­‐chamber	   view	   orientation.	   (Imaging	   parameters	   included:	   repetition	   time	   =	   2.4	  ms,	  echo	  time	  =	  1.2	  ms,	  flip	  angle	  =	  60°	  at	  1.5T,	  slice	  thickness	  =	  10mm,	  FOV	  =	  300-­‐350	  mm,	  80	  cardiac	  phases,	  temporal	  resolution	  =	  10	  to	  16	  ms/	  frame).	  The	  mid-­‐diastolic	   rest	   period,	   ascertained	   from	   the	   cine	   images,	   was	   used	   to	   define	   the	  acquisition	  window	  for	  the	  subsequent	  CMRA.	  First,	  a	  rapid	  whole-­‐heart	  CMRA	  was	  performed	  as	  a	  roadmap	  for	  a	  subsequent	  3-­‐point	   plan-­‐scan	   to	   set	   a	   targeted	   double-­‐oblique	   geometry	   parallel	   to	   the	   native	  right	  coronary	  artery	  (RCA)	  system.	  RCA	  geometry	  was	  used	  for	  the	  ECG-­‐triggered	  and	  navigator-­‐gated	  i-­‐T2prep	  3D	  SSFP	  gradient	  echo	  sequence.	  Imaging	  parameters	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included	   flip	   angle	   =	   70°;	   TE/TR	   =	   2.7/5.4	   ms;	   acquired	   matrix	   =	   280x280;	   slice	  thickness	   =	   2	   mm;	   20	   slices	   acquired;	   acquired	   resolution	   =	   1x1	   mm	   and	  reconstructed	  resolution	  =	  0.3x0.3	  mm.	  The	  acquisition	  window	  and	  trigger	  delay	  were	   defined	   as	   assessed	   using	   the	   4-­‐chamber	   cine.	   A	   diaphragmatic	   1D	  respiratory	  navigator157,	  158	  and	  a	  fat	  suppression	  pre-­‐pulse	  preceded	  the	  imaging	  sequence.	   A	   7	   mm	   respiratory	   navigator	   window	   was	   used	   but	   data	   was	   only	  accepted	  if	  consecutive	  T2prep-­‐ON	  and	  T2prep-­‐OFF	  acquisitions	  were	  both	  within	  the	   window.	   The	   T2	   preparation	   pre-­‐pulse105	   had	   a	   duration	   of	   80	   ms	   and	  consisted	  of	  2	  non-­‐selective,	  adiabatic,	  180°	  refocusing	  pulses.	  	  The	   i-­‐T2prep	   sequence	  was	   repeated,	   starting	   exactly	   1	  minute	   and	   45	   seconds	  after	  the	  administration	  of	  800	  micrograms	  of	  sublingual	  NTG.	  Vessel	  wall	  images	  were	   obtained	   by	   subtraction	   of	   T2prep-­‐ON	   from	   T2prep-­‐OFF	   images	   using	  custom-­‐made	   software	   implemented	   in	   Matlab	   (Release	   2009b,	   version	   7.9,	  Mathworks,	  Natick,	  MA,	  USA).	  A	  multiplication	  factor	  of	  1.28	  was	  used	  for	  T2prep-­‐ON	  images	  to	  achieve	  consistent	  blood	  signal	  subtraction.	  	  	  
3.2.3.3. Image	  Analysis	  For	   quantitative	   analysis,	   the	   targeted	   RCA	   lumen	   and	   vessel	   wall	   images	  were	  reformatted	   along	   the	  major	   axis	   of	   the	   RCA	   and	   analysed	   using	   “Soap-­‐Bubble”	  software	   (Release	  5.0,	   Philips	  Healthcare,	  Best,	  Netherlands).147	  Using	   this	   semi-­‐automatic	  software,	  length	  of	  RCA	  lumen	  visualised,	  proximal	  vessel	  diameter,	  and	  vessel	   sharpness	   were	   measured.	   The	   local	   vessel	   sharpness	   was	   calculated	   by	  “Soap-­‐Bubble”	  as	  a	  percentage	  by	  normalising	  the	  magnitude	  of	  the	  local	  change	  in	  signal	  intensity	  at	  the	  selected	  vessel	  border	  to	  the	  average	  signal	  intensity	  of	  the	  centerline	  of	  the	  selected	  vessel	  by	  using	  a	  Deriche	  algorithm.148	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Similarly,	  images	  reformatted	  in	  the	  RCA	  plane	  were	  used	  to	  measure	  anterior	  and	  posterior	   vessel	   wall	   length,	   vessel	   wall	   sharpness	   and	   vessel	   wall	   thickness.	  Combined	   anterior	   and	   posterior	  wall	   length,	  mean	   anterior	   and	   posterior	  wall	  sharpness	  and	  mean	  wall	  thickness	  was	  used	  for	  analysis.	  Finally,	  a	  qualitative	  analysis	  was	  undertaken	  by	  means	  of	  a	  consensus	  reading	  for	  image	   quality	   scoring	   on	   all	   the	   reformatted	   lumen	   and	   vessel	  wall	   images	   in	   a	  blinded	  and	  random	  order	  by	  two	  readers	  (T.H.	  and	  G.F.G.	  (>3years	  &	  >10	  years	  of	  CMRA	   experience	   respectively).	   The	   two	   readers	   first	   reviewed	   the	   images	  independently	   and	   any	   disagreement	  was	   then	   discussed	   before	   the	   final	   grade	  was	  given.	  The	   following	  scoring	  system	  was	  used:	  0	   indicates	   that	   the	  coronary	  artery	  was	  not	  visible;	  1	  visible	  but	  with	  markedly	  blurred	  borders;	  2	  visible	  with	  moderately	   blurred	  borders;	   3	   visible	  with	  mildly	   blurred	  borders	   and	  4	   visible	  with	  sharply	  defined	  borders.111	  	  	  
3.2.3.4. Statistical	  Methods	  Variables	   were	   visually	   assessed	   on	   frequency	   plots	   for	   normality	   and	   then	  formally	   assessed	   for	   normality	   of	   distribution	   using	   the	   Kolmogorov-­‐Smirnov	  test.	  Normally	  distributed	  variables	  are	  described	  in	  the	  format	  mean	  ±	  standard	  deviation	   (SD).	   It	  was	   assumed	   that	   image	   quality	   scores	   (IQ),	   being	   categorical	  data,	  were	  not	  normally	  distributed.	  Measurements	  were	  compared	  by	  paired	   t-­‐test	  analysis	   for	  normally	  distributed	  variables	  and	  Wilcoxon	  signed	  rank	  tests	  for	  remaining	  variables.	  p	  values	  <	  0.05	  indicated	  rejection	  of	  the	  null	  hypothesis.	  	  There	  was	  little	  data	  regarding	  the	  i-­‐T2prep	  sequence,	  around	  which	  to	  plan	  study	  numbers.	  However,	  post-­‐hoc	   testing	  was	  performed	  using	  a	  2-­‐tailed	   significance	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3.2.4.1. Subjects	  Ten	  subjects	  (5	  male)	  successfully	  participated	   in	   the	  study	  without	  any	  adverse	  events.	  Mean	  age	  was	  38.7	  ±	  6.8	  years	  and	  mean	  weight	  was	  71.4	  ±	  11.4	  kg.	  Mean	  total	   time	   taken	   for	   i-­‐T2prep	  acquisition	  was	  7.5	  ±	  1.5	  minutes	   (mean	  navigator	  efficiency	   =	   47	   ±	   10%).	   All	   post-­‐NTG	   i-­‐T2prep	   acquisitions	   were	   started	   at	   1	  minute	  and	  45	  seconds	  after	  administration	  and	  all	  were	  finished	  by	  12	  minutes.	  Mean	   heart	   rate	   at	   rest	   was	   63	   bpm	   and,	   as	   expected,	   there	   was	   a	   small	   but	  significant	  rise	  to	  69	  bpm	  with	  NTG	  (p=0.002).	  	  	  
3.2.4.2. Image	  analysis	  Vessel	   sharpness,	   proximal	   vessel	   diameter,	   RCA	   length	   imaged,	   vessel	   wall	  sharpness,	  vessel	  wall	  length	  and	  vessel	  wall	  diameter	  were	  assessed	  visually	  with	  frequency	   plots	   and	   were	   further	   formally	   tested	   for	   normality	   using	   the	  Kolmogorov-­‐Smirnov	  test	  (p>0.2	  for	  all).	  Based	  on	  this	  assessment,	  these	  variables	  were	  assumed	  to	  be	  normally	  distributed.	  After	  NTG	  administration,	  coronary	  lumen	  imaging	  demonstrated	  a	  significant	  increase	  in	  RCA	  diameter	  (2.16	  ±	  0.32	  to	  2.52	  ±	  0.59mm;	  p=0.036),	  RCA	  length	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visualised	  (9.8	  ±	  2.6	  to	  11.4	  ±	  3.3	  cm;	  p=0.025)	  and	  qualitative	  image	  quality	  (median	  3	  (interquartile	  range	  2	  –	  3.25)	  vs.	  median	  3	  (interquartile	  range	  3	  –	  4);	  p=0.046).	  There	  was	  no	  difference	  in	  vessel	  sharpness	  (see	  (Table	  10)	  and	  (Table	  11)	  and	  (Figure	  22)).	  	  
	  
Table	  10.	  NTG	  Summary	  Statistics	  for	  normally	  distributed	  variables	  	  
Tested	   using	   2-­‐tailed	   paired	   t-­‐tests.	   *	   denotes	   significant	   differences	  
(p<0.05)	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Table	  11.	  NTG	  Study	  Summary	  of	  Categorical	  Variables.	  	  
P-­‐values	  are	  given	  for	  paired	  differences	  using	  Wilcoxon	  Signed	  Ranks	  Test.	  
*denotes	  a	  significant	  difference	  (p<0.05)	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Figure	  22.	  Linear	  correlation	  of	  vessel	  lumen	  parameters	  	  
Linear	  correlation	  of	  vessel	  lumen	  parameters	  before	  and	  after	  NTG	  
administration.	  Dotted	  line	  is	  the	  line	  of	  equivalence,	  whereas	  the	  solid	  line	  
Chapter	  3	  –	  Studies	  Relevant	  to	  Coronary	  Magnetic	  Resonance	  Angiography	  
	   	   111	  
plot	  is	  the	  regression	  line	  of	  best	  fit.	  Corresponding	  Bland-­‐Altman	  agreement	  
plots	  are	  shown	  on	  the	  right.	  After	  NTG	  administration,	  coronary	  lumen	  
imaging	  demonstrated	  significant	  increase	  in	  RCA	  diameter	  (2.16	  ±	  0.32	  to	  
2.52	  ±	  0.59mm;	  p=0.036)	  and	  RCA	  length	  visualised	  (9.8	  ±	  2.6	  to	  11.4	  ±	  3.3	  
cm;	  p=0.025).	  This	  is	  demonstrated	  with	  a	  separate	  regression	  lines	  above	  
the	  line	  of	  equivalence.	  It	  is	  also	  shown	  in	  the	  agreement	  plot	  with	  the	  mean	  
bias	  being	  clearly	  above	  0.	  There	  was	  no	  significant	  difference	  in	  vessel	  
lumen	  sharpness.	  
Vessel	  wall	  imaging	  demonstrated	  a	  significant	  improvement	  in	  vessel	  wall	  sharpness	  after	  NTG	  (24.8	  to	  27.3%;	  p=0.036).	  Vessel	  wall	  length	  visualised,	  vessel	  wall	  thickness	  and	  vessel	  wall	  image	  quality	  score	  showed	  no	  differences	  after	  NTG	  administration	  (see	  (Table	  10)	  and	  (Table	  11)	  and	  (Figure	  23)).	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Figure	  23.	  Linear	  correlation	  of	  vessel	  wall	  parameters	  	  
Linear	  correlation	  of	  vessel	  wall	  parameters	  before	  and	  after	  NTG	  
administration.	  Dotted	  line	  is	  the	  line	  of	  equivalence,	  whereas	  the	  solid	  line	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plot	  is	  the	  regression	  line	  of	  best	  fit.	  Corresponding	  Bland-­‐Altman	  agreement	  
plots	  are	  shown	  on	  the	  right.	  Vessel	  wall	  imaging	  demonstrated	  a	  significant	  
improvement	  in	  vessel	  wall	  sharpness	  after	  NTG	  (24.8	  to	  27.3%;	  p=0.036).	  
This	  is	  demonstrated	  with	  a	  separate	  regression	  line	  above	  the	  line	  of	  
equivalence.	  It	  is	  also	  shown	  in	  the	  agreement	  plot	  with	  the	  mean	  bias	  being	  
clearly	  above	  0.	  Vessel	  wall	  length	  visualised	  and	  vessel	  wall	  diameter	  
showed	  no	  significant	  differences	  after	  NTG	  administration.	  
Interestingly,	  4	  subjects	  showed	  little	  change	  in	  vessel	  diameter	  (<5%)	  with	  NTG.	  These	  four	  subjects	  showed	  a	  mean	  increase	  in	  vessel	  wall	  sharpness	  of	  only	  2.7%	  compared	  to	  20.8%	  for	  subjects	  that	  had	  >5%	  increase	  in	  vessel	  diameter.	  	  All	  study	  images	  are	  shown	  in	  (Figure	  24)	  and	  (Figure	  25).	  Mean	  vessel	  wall	  thickness	  with	  GTN	  was	  almost	  identical	  to	  previously	  published	  MRI	  black-­‐blood	  values	  for	  healthy	  individuals	  (1.0	  ±	  0.2	  mm	  using	  i-­‐T2prep	  and	  1.0	  ±	  0.2mm	  for	  previous	  black-­‐blood	  sequence).99	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Figure	  24.	  NTG	  Volunteer	  Images	  
Rows	   1	   to	   6	   represent	   individual	   volunteers.	   Images	   are	   reformatted	   to	  
show	   the	   major	   axis	   of	   the	   RCA.	   Column	   A	   represents	   RCA	   lumen	   CMRA.	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Column	   B	   is	   the	   repeated	   lumen	   CMRA	   using	   NTG.	   Column	   C	   represents	  
subtraction	   RCA	   vessel	   wall	   images.	   Column	   D	   represents	   the	   repeat	  
subtraction	  image	  using	  NTG.	  
	  
	  	  	  
Figure	  25.	  Further	  NTG	  Volunteer	  Images	  
Rows	   7	   to	   10	   represent	   individual	   volunteers.	   Images	   are	   reformatted	   to	  
show	   the	   major	   axis	   of	   the	   RCA.	   Column	   A	   represents	   RCA	   lumen	   CMRA.	  
Column	   B	   is	   the	   repeated	   lumen	   CMRA	   using	   NTG.	   Column	   C	   represents	  
subtraction	   RCA	   vessel	   wall	   images.	   Column	   D	   represents	   the	   repeat	  
subtraction	  image	  using	  NTG.	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3.2.5. Discussion	  We	  have	  shown	  that	  NTG	  improves	  qualitative	  image	  quality	  for	  coronary	  lumen	  imaging.	   This	   is	   congruent	   with	   the	   experience	   of	   other	   investigators.154	  Qualitative	   CMRA	   lumen	   image	   quality	   using	   i-­‐T2prep	   sequences	   is	   similar	   to	  previous	  CMRA	  sequences	  that	  have	  a	  proven	  value	  in	  the	  detection	  of	  proximal	  or	  mid	  vessel	  stenosis.89	  Vessel	  sharpness	  with	  the	  i-­‐T2prep	  sequence	  was	  47	  ±	  9%	  compared	   to	   46	   ±	   10%	   for	   the	   previous	   study.89	   Furthermore,	  we	  were	   able	   to	  show	  a	  mean	  increase	  in	  vessel	  diameter	  of	  16.7%	  using	  NTG.	  We	  believe	  that	  this	  was	  responsible	   for	  a	  greater	  visualised	   length	  of	  RCA	  (mean	  11.4cm	  vs.	  9.8cm).	  This	  is	  important	  as	  it	  allows	  for	  detection	  of	  more	  distal	  stenoses.	  In	  regard	  to	  vessel	  wall	  imaging,	  we	  have	  shown	  that	  the	  quantitative	  measure	  of	  image	  quality	  (vessel	  wall	  sharpness)	  is	  increased	  by	  10%.	  This	  is	  likely	  due	  to	  the	  increase	   in	  vessel	  diameter,	  which	   results	   in	  better	   separation	  between	  anterior	  and	  posterior	  vessel	  walls.	  This	   is	  supported	  by	  the	  data	  showing	  no	  meaningful	  mean	  increase	  in	  vessel	  wall	  sharpness	  in	  those	  individuals	  showing	  no	  significant	  increase	  in	  vessel	  diameter	  after	  NTG.	  Volunteers	  were	  in	  supine	  position	  during	  the	  entire	  period	  of	  peak	  action	  of	  NTG.	  This,	  no	  doubt,	  contributed	  to	  very	  few	  reported	  symptoms	  but	  there	  remained	  a	  small	  but	  significant	  reflex	  increase	  in	  heart	  rate	  due	  to	  NTG.	  This	  is	  one	  limitation	  of	  the	  study	  as	  heart	  rate	  increase	  is	  not	  desirable	  in	  the	  context	  of	  coronary	  imaging.	  Hence,	  a	  combination	  with	  a	  beta-­‐receptor	  antagonist	  would	  be	  preferable	  for	  future	  studies.	  Furthermore,	  although	  successful	  vessel	  wall	  imaging	  has	  been	  demonstrated,	  this	  study	  included	  healthy	  volunteers	  and	  future	  studies	  using	  the	  i-­‐T2prep	  sequence	  will	  need	  to	  focus	  on	  the	  quantification	  of	  coronary	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plaque.	  However,	  (Figure	  24)	  and	  (Figure	  25),	  suggest	  that	  the	  sequence	  is	  robust	  enough	  for	  this	  purpose.	  	  One	  limitation	  is	  that	  the	  subtraction	  algorithm	  may	  unduly	  influence	  the	  resulting	  vessel	   wall	   thickness.	   On	   practical	   terms,	   ensuring	   complete	   arterial	   blood	  suppression	   minimizes	   this	   potential	   error.	   Arterial	   blood	   suppression	   using	   a	  simulation	   for	   this	   sequence	   has	   been	   performed	   previously	   and	   the	   optimum	  value	   shown	   to	   lie	   between	   1.2	   and	   1.3.159	   Validation	   of	   this	   sequence	   and	   this	  subtraction	  weighting	   value	   has	   also	   been	   performed	   on	   the	   Aortic	   vessel	   wall.	  
Andia	   et	   al	   showed	   excellent	   agreement	   between	   vessel	   wall	   measures	   using	   a	  previously	   validated	   dual-­‐inversion	   recovery	   black-­‐blood	   turbo-­‐spin-­‐echo	  sequence	  and	  this	  novel	  i-­‐T2prep	  sequence.	  Hence,	  in	  this	  study	  a	  weighting	  factor	  was	  used	  of	  1.28,	  which	  achieved	  consistent	  arterial	  blood	  suppression	  for	  all	  our	  cases.	  Additionally,	  the	  vessel	  wall	  thickness	  obtained	  using	  i-­‐T2prep	  in	  this	  study	  of	  healthy	  volunteers	  was	  identical	  to	  a	  previous	  black-­‐blood	  coronary	  vessel	  wall	  imaging	   sequence,	   which	   has	   been	   validated	   to	   be	   able	   to	   show	   vessel	   wall	  disease.99,	  160	  In	  the	  long	  term,	  further	  validation	  with	  invasive	  imaging	  would	  lend	  further	  credence	  to	   this	   type	  of	  coronary	  vessel	  wall	   imaging.	  Another	   limitation	  was	  that,	  as	  an	  exploratory	  study	  of	  this	  sequence,	  there	  was	  insufficient	  published	  data	   to	  prospectively	   select	   the	   sample-­‐size	   required.	  However,	  we	  were	  able	   to	  show	  a	  meaningful	  10%	  increase	  in	  vessel	  wall	  sharpness	  with	  our	  given	  sample	  size.	  The	   methodology	   of	   this	   study	   is	   important.	   Like	   the	   previous	   study,154	   the	  imaging	  in	  this	  study	  was	  started	  at	  the	  known	  time	  for	  peak	  blood	  concentrations	  of	  NTG.	  This	  enabled	  both	  vessel	  lumen	  and	  vessel	  wall	  imaging	  to	  be	  performed	  within	  the	  window	  of	  action	  of	  sublingual	  NTG.	  The	  study	  sequence,	  i-­‐T2prep	  was	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also	   ideal	   for	   these	   purposes,	   with	   the	   interleaving	   allowing	   identical	   timing	   of	  effect	   for	   both	   lumen	   and	   vessel	   wall	   imaging.	   The	  methodology	   used	   here	   has	  great	  potential	   for	   the	  pathophysiological	  assessment	  of	   coronary	  disease.	   It	  has	  been	   previously	   shown	   that	   impaired	   NTG-­‐induced	   coronary	   vasodilatation	   is	  associated	  with	  advanced	  atherosclerosis	  in	  an	  asymptomatic	  older	  population.161	  The	  protocol	  described	  would	  allow	  us	  to	  identify	  the	  influence	  of	  atherosclerotic	  plaque	   on	   endothelium-­‐independent	   vasodilatation	   on	   a	   segment-­‐to-­‐segment	  basis.	  Combining	  the	  protocol	  with	  methods	  to	  quantify	  calcification	  would	  allow	  us	  to	  answer	  whether	  calcified	  or	  soft	  plaques	  differ	  in	  their	  effects	  on	  this	  type	  of	  vasodilatation.162	   Moreover,	   impairment	   of	   endothelial-­‐dependent	   coronary	  vasodilatation	   has	   been	   shown	   to	   be	   an	   early	   marker	   of	   atherosclerosis.31	   The	  relationship	   between	   endothelium	   dependent	   vasodilatation	   and	   NTG-­‐induced	  direct	  vasodilatation	  is	  not	  entirely	  clear	  but	  this	  could	  be	  assessed	  further	  using	  this	  protocol	  and	  thereby	  directly	  relating	  it	  to	  vessel	  wall	  disease.	  In	  conclusion,	  we	  have	  demonstrated	  the	  benefits	  of	  NTG	  for	  coronary	  lumen	  and	  vessel	   wall	   imaging	   using	   a	   combined	   sequence,	   i-­‐T2prep.	   The	   methodology	  described	   here	   has	   great	   potential	   for	   future	   pathophysiological	   studies	   of	  coronary	  artery	  disease.	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4. Contrast-­‐Enhanced	  Inversion	  Prepared	  Coronary	  Vessel	  Wall	  Imaging	  
for	  Coronary	  Vasculopathy	  
	  
4.1. Detection	  and	  Grading	  of	  Coronary	  Allograft	  Vasculopathy	  in	  Children	  




Background:	   Coronary	   Allograft	   Vasculopathy	   (CAV)	   is	   the	   leading	   cause	   of	   late	  death	  after	  heart	  transplantation	  in	  children.	  It	  is	  poorly	  detected	  by	  conventional	  angiography.	  Intravascular	  ultrasound	  (IVUS)	  is	  invasive	  and	  costly.	  The	  purpose	  here	   is	   to	   show	   that	   MRI	   late	   gadolinium	   enhancement	   (LGE)	   of	   the	   coronary	  vessel	  wall	  can	  detect	  and	  grade	  CAV.	  
Methods	   and	   Results:	   12	   children	   (5	   male,	   mean	   age	   15.1	   years	   (range	   12-­‐17))	  underwent	  coronary	  angiography,	  IVUS	  and	  MRI.	  Maximal	  intimal	  thickness	  (MIT)	  and	   mean	   intimal	   index	   (MII)	   were	   recorded.	   MRI	   included	   coronary	   magnetic	  resonance	   angiogram	   (CMRA)	   and	   LGE	   vessel	   wall	   imaging.	   Mean	   time	   post-­‐transplant	  was	  4.5	  years	  (range	  0.5-­‐12).	  No	  patient	  had	  angiographic	  disease.	  Two	  patients	  had	  Stanford	  grade	  4	  CAV	  on	  IVUS.	  MIT	  was	  0.50	  ±	  0.29mm	  and	  MII	  was	  17.5	  ±	   5.7%.	  On	  MRI,	  mean	  diameter	   of	   enhancement	   of	   vessel	  wall	  was	   5.38	  ±	  2.39	  mm	  and	  mean	  enhancement	  index	  (indexed	  to	  vessel	  lumen	  size)	  was	  0.53	  ±	  0.42.	  Correlation	  of	  LGE	  with	  MIT	  using	  Pearson's	  coefficient	  was	  0.81	  (p=0.001)	  and	  with	  MII	  was	  0.62	   (p=0.03).	   If	   disease	  on	  MRI	  was	  defined	  as	   enhancement	  diameter	  >	  7.5mm,	  sensitivity	  and	  specificity	  values	  of	  100%	  are	  obtained	  for	  the	  detection	  of	  significant	  CAV.	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Conclusion:	   This	   study	   has	   shown	   that	   imaging	   CAV	   with	   MRI	   is	   possible	   in	  paediatric	   transplant	   recipients.	   The	   late	   gadolinium	   enhancement	   scores	  correlate	  well	  with	   traditional	   IVUS	  measures.	   These	   promising	   results	  warrant	  larger	   studies	   to	   confirm	   the	  utility	  of	   this	   technique.	  This	  approach	  may	  enable	  closer	  follow-­‐up	  and	  better	  prevention	  of	  CAV	  in	  children.	  	  
	  
4.1.2. Introduction	  Coronary	  Allograft	  Vasculopathy	  (CAV)	   is	  the	   leading	  cause	  of	   late	  death	  or	  graft	  loss	  after	  heart	  transplantation	  in	  children.6	  It	  is	  a	  progressive	  condition,	  which	  is	  thought	   to	   be	   caused	   largely	   by	   chronic	   autoimmune-­‐mediated	   endothelial	  damage.3	   Damaged	   endothelium	   allows	   cell	   infiltration,	  which	   is	   responsible	   for	  the	  production	  of	  cytokines,	  growth	  factors,	  and	  matrix	  deposition	  (collagen	  I	  and	  fibroblasts).4	  This	  results	  in	  a	  progressive	  thickening	  of	  the	  intima,	  which	  is	  poorly	  detected	  by	  conventional	  angiography.8	  Rapid	  progression	   is	   the	  most	   important	  predictor	   for	   all-­‐cause	   death	   in	   this	   patient	   group25	   and	   warrants	   a	   change	   in	  treatment.	   Intravascular	   ultrasound	   (IVUS)	   is	   a	   much	   more	   sensitive	   imaging	  modality	  and	  is	  therefore	  desirable	  for	  the	  early	  detection	  of	  CAV.9-­‐11	  However,	  it	  is	   invasive,	   costly	   and	   it	   is	   not	   technically	   feasible	   in	   small	   children.	   This	   limits	  how	  closely	  CAV	  can	  be	  monitored,	  especially	  in	  children.	  Gadolinium	  DTPA	  is	  a	  paramagnetic	  contrast	  agent	  used	  for	  MRI,	  which	  is	  known	  to	   be	   deposited	   in	   diseased	   tissue	   with	   abundant	   fibrosis	   and	   extracellular	  matrix.163-­‐165	  It	   is	  this	  property	  of	  Gadolinium	  that	  has	  previously	  been	  shown	  to	  be	   useful	   to	   demonstrate	   coronary	   vessel	   wall	   disease.135	   In	   this	   study,	   we	  examine	  the	  utility	  of	  late	  gadolinium	  enhancement	  for	  the	  non-­‐invasive	  detection	  and	  grading	  of	  CAV.	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4.1.3. Methods	   	  Institutional	  Review	  Board	  approval	  was	  obtained	  prior	  to	  commencing	  the	  study	  (Research	  Ethics	  Committee	  reference	  number	  09/H0713/53).	  Written,	  informed	  consent	  was	  obtained	  from	  the	  patient	  and/or	  parent	  accordingly.	  Patients	  older	  than	   10	   years	   undergoing	   annual	   review	   after	   orthotopic	   heart	   transplantation	  were	   invited	   to	   take	   part	   in	   the	   study.	   Participants	   underwent	   cardiac	   MRI	  followed	  by	  their	  routine	  conventional	  X-­‐ray	  angiography	  and	  IVUS,	  one	  day	  later.	  Additionally,	   10	   volunteers	   undergoing	   cardiac	   MRI	   for	   clinical	   purposes	   also	  underwent	   coronary	   delayed	   enhancement	   to	   serve	   as	   a	   control	   group.	   These	  volunteers	   were	   young	   adults	   and	   adolescents	   without	   any	   history	   of	   coronary	  disease	   or	   any	   major	   cardiovascular	   risk	   factors	   (i.e.	   smoking,	   hypertension,	  dyslipidaemia,	  diabetes	  or	  family	  history	  of	  early	  disease).	  These	  volunteers	  were	  referred	  either	  for	  the	  exclusion	  of	  hereditary	  cardiomyopathy	  or	  for	  follow-­‐up	  of	  surgically	   corrected	   congenital	   heart	   disease.	   Volunteers	  were	   excluded	   if	   there	  was	   any	   evidence	   of	   cardiomyopathy,	   reduced	   ventricular	   function,	   significant	  residual	   lesion,	   prior	   history	   of	   coarctation	   repair	   or	   history	   of	   arterial	   switch	  procedure.	   Separate	   Institutional	   Review	   Board	   approval	   and	  written,	   informed	  consent	  was	  obtained	  for	  these	  volunteers	  (Research	  Ethics	  Committee	  reference	  number	  09/H0802/078).	  	  
4.1.3.1. MRI	  Sequences	  Cardiac	  Magnetic	  Resonance	  was	  performed	  using	  a	  1.5	  Tesla	  Achieva	  clinical	  MR	  scanner	  (Philips	  Healthcare,	  Best,	  NL).	   Images	  were	  obtained	  using	  a	  32-­‐element	  cardiac	  phased-­‐array	  receiver	  coil.	  Prior	  to	  entering	  the	  scan	  room,	  0.2	  mmol/kg	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body	  weight	   of	   a	   Gadolinium-­‐based	   contrast	  medium	   (Gadovist,	   Bayer	   Schering,	  Berlin,	  Germany)	  was	  administered	  intravenously.	  Subsequently,	  an	  initial	  survey	  and	  reference	  scan	  were	  acquired	   to	  obtain	  coil	   sensitivity	  maps.	  Following	   this,	  the	   cardiac	   rest	   periods	   were	   ascertained	   using	   a	   high	   temporal	   resolution,	  balanced	  steady-­‐state	  free	  precession	  (SSFP),	  two-­‐dimensional	  cine	  MR	  sequence	  in	  a	  four-­‐chamber	  view	  orientation.	  (Imaging	  parameters	  included:	  repetition	  time	  =	  2.4	  ms,	  echo	  time	  =	  1.2	  ms,	  flip	  angle	  =	  60°,	  slice	  thickness	  =	  10mm,	  field-­‐of-­‐view	  =	  300-­‐350	  mm,	  80	  cardiac	  phases,	  TFE	   factor	  =	  6,	   temporal	  resolution	  =	  8	   to	  11	  ms/	   frame).	  The	  mid-­‐diastolic	   rest	  period	  ascertained	   from	   the	   cine	   images	  was	  used	   to	   define	   the	   acquisition	   window	   for	   the	   subsequent	   coronary	   lumen	   and	  vessel	  wall	  scans.	  Targeted	   coronary	   bright-­‐blood	   Magnetic	   Resonance	   Angiography	   (CMRA)	   was	  performed	   with	   a	   previously	   described	   navigator-­‐gated	   free-­‐breathing	   and	  cardiac-­‐triggered	   T2-­‐prepared	   three-­‐dimensional	   (3D)	   steady-­‐state	   free	  precession	  sequence	  allowing	  visualisation	  of	  the	  anatomy	  of	  the	  coronary	  artery	  lumen.146	   Adaptations	   of	   the	   technique	   for	   imaging	   in	   children	   have	   also	   been	  described	   and	   implemented	   here.90,	   92,	   101	   First,	   a	   rapid	   whole-­‐heart	   CMRA	   was	  performed	  as	  a	  roadmap	  for	  a	  subsequent	  3-­‐point	  plan-­‐scan	  for	  a	  targeted	  double-­‐oblique	  CMRA	  parallel	  to	  the	  native	  left	  coronary	  artery	  system.145	  Then,	  using	  an	  identical	   imaging	  plane	   and	   spatial	   resolution	   as	   the	   targeted	  CMRA,	   a	   coronary	  late	   gadolinium	   enhancement	   (LGE)	   sequence	   was	   performed.	   This	   was	  performed	  30-­‐40	  minutes	  after	  the	  administration	  of	  gadolinium.	  This	  sequence	  is	  a	  navigator-­‐gated,	  vector	  ECG-­‐triggered,	  fat-­‐suppressed	  T1-­‐weighted	  3D	  gradient-­‐echo	   inversion-­‐recovery	   sequence.135,	   166,	   167	   Imaging	   parameters	   included	   the	  following:	   field	   of	   view	   =	   270x270	   mm,	   matrix	   =	   216x216,	   acquired	   in-­‐plane	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resolution	   =	   1.25x1.25	   mm,	   reconstructed	   slice	   thickness	   =	   1.5	   mm	   (acquired	  thickness	  =	  3	  mm),	  acquisition	  window	  =	  80	  to	  100	  ms,	  repetition	  time/echo	  time	  =	  4.9	  ms/1.6	  ms,	   flip	  angle	  =	  30°;	  start-­‐up	  cycles	  =	  5,	  and	  number	  of	  slices	  =	  20.	  The	   patient-­‐specific	   inversion	   time	   was	   adjusted	   to	   null	   blood	   signal	   with	   a	  preceding	  Look	  Locker	  sequence.168	  	  Typical	  inversion	  times	  were	  180	  to	  240ms.	  	  
4.1.3.2. MR	  Image	  Analysis	  CMRA	   images	  were	   analysed	   using	   a	   semi-­‐automatic	   vessel	   analysis	   tool	   (Soap-­‐Bubble,	   Release	   5.0).147	   This	   was	   used	   to	   measure	   the	   mean	   coronary	   artery	  diameter	  and	   the	  combined	   length	  of	   left	  main	  and	   left	  anterior	  descending	   that	  was	   imaged.	   LGE	   has	   been	   used	   to	   quantify	   atrial	   scar	   burden	   in	   the	   setting	   of	  atrial	   fibrillation.169	   The	   technique	   described	   by	   Oakes	   at	   al169	   for	   atrial	   wall	  enhancement	  was	   adapted	   for	   coronary	   vessel	   wall	   quantification.	   Visualisation	  and	  segmentation	  of	  the	  MRI	  were	  performed	  with	  OsiriX	  version	  3.9.1.	  LGE	  was	  defined	  as	  areas	  in	  the	  vessel	  wall	  with	  a	  signal	   intensity	  that	   is	  significantly	  (>2	  standard	   deviations	   (SD))	   higher	   than	   normal	   non-­‐enhancing	   vessel	   wall.	   The	  ascending	  aorta	  (distal	   to	  anastomosis	  site)	  or	  the	  descending	  aorta	  was	  used	  as	  the	   reference	   for	   normal	   vessel	   wall.	   A	   threshold	   filter	   (mean	   signal	   of	   normal	  vessel	  +	  2	  SD)	   is	   then	  applied	   to	   the	  LGE	   images.	  Using	   the	  coronary	  MRA	  as	  an	  overlay	   roadmap,	   the	   volume	   of	   coronary	   vessel	   wall	   enhancement	   was	   then	  measured	   (Figure	  26).	  Using	   this	  volume	  and	  Soap-­‐Bubble	  measurements,	  mean	  enhancement	   area	   (=volume/length	   imaged),	   enhancement	   diameter	   (assuming	  circular	  area)	  and	  mean	  enhancement	  index	  (=enhancement	  area/coronary	  mean	  cross	   sectional	   area)	   were	   derived	   and	   recorded.	   As	   well	   as	   quantifying	   the	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volume	   of	   enhancement,	   the	   position	   of	   areas	   of	   vessel	   wall	   enhancement	   was	  recorded,	  as	  the	  distance	  from	  major	  branches.	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Figure	  26.	  Anatomical	  Correlation	  of	  Late	  Gadolinum	  Enhancement	  and	  
Intravascular	  Ultrasound	  
A	  –	  Coronary	  Magnetic	  Resonance	  Angiogram	  showing	  left	  mainstem	  
coronary	  artery	  (LM)	  and	  left	  anterior	  descending	  (LAD)	  
B	  –	  Late	  Gadolinium	  Enhancement	  of	  same	  slice	  as	  image	  A.	  Double	  arrows	  
show	  areas	  of	  marked	  enhancement	  occurring	  in	  the	  coronary	  vessel	  wall.	  
Single	  arrows	  show	  enhancement	  in	  a	  pulmonary	  vein	  as	  it	  enters	  the	  left	  
atrium	  (This	  area	  may	  show	  enhancement	  also,	  either	  because	  of	  the	  
presence	  of	  an	  anastamosis	  line	  in	  the	  left	  atrium	  close	  to	  the	  pulmonary	  
vein	  ostium	  or	  due	  to	  venous	  labelling	  as	  explained	  in	  the	  text	  above).	  
C	  –	  Late	  Gadolinium	  Enhancement	  images	  after	  threshold	  applied.	  Double	  
arrows	  show	  areas	  of	  marked	  enhancement	  occurring	  in	  the	  coronary	  vessel	  
wall.	  Single	  arrows	  show	  enhancement	  in	  the	  left	  upper	  pulmonary	  vein	  as	  it	  
enters	  the	  left	  atrium	  	  
D	  –	  Overlay	  of	  image	  C	  on	  image	  A.	  Overlay	  shows	  how	  areas	  of	  enhancement	  
pertaining	  to	  the	  coronary	  vessel	  wall	  can	  be	  clearly	  identified	  and	  
differentiated	  from	  pulmonary	  vein	  or	  left	  atrial	  enhancement.	  
E	  –	  Image	  D	  showing	  positions	  of	  intravascular	  ultrasound	  images	  (i)	  to	  (vi)	  
Intravascular	  ultrasound	  images	  (i)	  to	  (vi)	  show	  intimal	  thickness	  
corresponding	  to	  areas	  on	  image	  E.	  The	  white	  rectangles	  in	  images	  (i)	  to	  (vi)	  
represent	  the	  maximal	  thickness	  of	  the	  intimal	  layer.	  In	  this	  particular	  case	  
there	  is	  good	  anatomical	  correlation	  between	  areas	  of	  enhancement	  and	  
areas	  of	  intimal	  thickening	  as	  shown	  in	  the	  sample	  of	  intravascular	  
ultrasound	  images	  
All	   LGE	  measurements	  were	   repeated	   to	   calculate	   the	   intra-­‐observer	   and	   inter-­‐observer	   variability	   in	   analysis.	   Two	   observers,	   experienced	   in	   cardiovascular	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MRI,	  (GG	  and	  TH	  (both	  >3yrs	  cardiovascular	  MRI	  experience)	  analysed	  data	  in	  an	  independent	  manner,	  blinded	  to	  the	  angiography	  and	  IVUS	  results.	  
	  
4.1.3.3. Conventional	  X-­‐ray	  Angiography	  and	  Intravascular	  Ultrasound	  Conventional	  Angiography	  and	  IVUS	  was	  undertaken	  on	  the	  day	  following	  the	  MRI	  scan.	   Catheterisation	   is	   performed	   under	   general	   anaesthesia	   for	   children	   and	  adolescents,	  according	  to	  institutional	  protocol,	  but	  for	  older	  adolescents	  or	  young	  adults,	   performance	   under	   local	   anaesthesia	   is	   encouraged.	   Catheterisation	   and	  IVUS	   were	   only	   performed	   as	   clinically	   indicated	   for	   annual	   review.	   CAV	   on	  angiography	   is	   defined	   as	   mild,	   moderate	   or	   severe	   according	   to	   published	  criteria.7	   Angiograms	   were	   reported	   by	   a	   single	   experienced	   observer	   but	   any	  abnormalities	  were	  confirmed	  by	  a	  second	  experienced	  observer.	  IVUS	   was	   performed	   in	   the	   left	   anterior	   descending	   coronary	   artery	   with	  automated	  pullback	  at	  0.5mm/s.	  Typically,	  the	  imaging	  has	  a	  temporal	  resolution	  of	  30	  frames/second.	  A	  suitable	  length	  of	  vessel	  was	  imaged	  to	  allow	  analysis	  of	  at	  least	  30	  cross-­‐sectional	  images	  evenly	  spaced	  (at	  approximately	  1.5mm	  intervals)	  over	  the	  same	  segment	  of	  left	  anterior	  descending	  artery	  that	  was	  analysed	  at	  the	  previous	   annual	   review	   (identified	   by	   branch	   points).	   Additionally,	   the	   images	  analysed	  were	  always	  taken	  during	   the	  mid-­‐diastolic	  rest	  period	  for	  consistency.	  Maximal	  intimal	  thickness,	  mean	  intimal	  index,	  and	  Stanford	  Grading	  score	  (Table	  12)	  were	  recorded.10	  Mean	  intimal	  index	  is	  defined	  as	  the	  ratio	  of	  the	  mean	  intimal	  area	   to	   the	   sum	   of	   the	   mean	   intimal	   and	   luminal	   areas.	   In	   addition,	   a	   semi-­‐automatic	   interactive	   edge-­‐detection	   software	  was	   used	   (QIVUS	   Clinical	   Edition,	  Medis	  medical	   imaging	   systems)	   to	   improve	   reproducibility	   of	  measurements.27	  Finally,	   the	  position	  of	   the	  most	  affected	  regions	   (regions	  with	   thickness	  greater	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than	   twice	   the	   mean	   intimal	   thickness	   for	   that	   patient)	   of	   the	   left	   main	   and	  anterior	   descending	   coronary	   artery	   were	   recorded,	   using	   distance	   from	  major	  side	  branches.	  	  
	  
Table	  12.	  Stanford	  score	  table	  	  
Severity	  is	  graded	  based	  on	  the	  site	  with	  the	  most	  severe	  disease.	  
	  
4.1.3.4. Data	  Analysis	  First	  an	  anatomical	  comparison	  was	  made	  between	  areas	  of	  enhancement	  on	  MRI	  and	   the	   location	   of	   prominent	   thickening	   on	   IVUS.	   Variables	   are	   then	   formally	  assessed	   for	   normality	   of	   distribution	   using	   the	  Kolmogorov-­‐Smirnov	   test.	   Then	  specific	   bivariate	   correlation	  was	  performed	  between	   enhancement	   index	   (MRI)	  and	   intimal	   index	   (IVUS).	   Further	   bivariate	   correlation	   was	   made	   between	  enhancement	  diameter	  and	  maximal	  intimal	  thickness.	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Finally,	  sensitivity	  and	  specificity	  for	  LGE	  for	  the	  detection	  of	  CAV	  compared	  with	  IVUS	   and	   conventional	   angiography	   were	   calculated.	   For	   these	   purposes,	  significant	   CAV	   is	   defined	   as	   that	   present	   on	   X-­‐ray	   angiogram	   or	   scored	   as	  Stanford	  grade	  IV	  on	  IVUS.	  Inter-­‐	  and	  intra-­‐observer	  variability	  in	  enhancement	  scoring	  are	  further	  assessed	  by	  Bland-­‐Altman	   analyses.	   Comparison	   against	   control	   enhancement	   scores	  was	  further	  performed	  using	  independent	  t-­‐tests.	  	  
4.1.4. Results	  Twelve	  children	  (5	  male)	  took	  part	  in	  this	  study	  with	  a	  mean	  age	  of	  15	  years	  and	  1	  month	  (range	  12	  to	  17	  years).	  Mean	  follow-­‐up	  time	  was	  4.5	  years	  post-­‐transplant	  (range	  6	  months	  to	  12	  years).	  On	  IVUS,	  Maximal	  Intimal	  Thickness	  (MIT)	  was	  0.50	  
±	   0.29mm	   and	   Mean	   Intimal	   Index	   (MII)	   was	   17.5	   ±	   5.7%.	   On	   MRI,	   mean	  enhancement	   diameter	  was	   5.38	  ±	   2.39	  mm	   and	  mean	   enhancement	   index	  was	  0.53	  ±	  0.42.	  All	   four	  variables	   (MIT,	  MII,	  Enhancement	  diameter	  &	  Enhancement	  index)	   were	   assessed	   visually	   with	   frequency	   plots	   and	   were	   further	   formally	  tested	   for	  normality	  using	   the	  Kolmogorov-­‐Smirnov	  test	   (p=	  0.56,	  0.47,	  0.19	  and	  0.23	  respectively).	  Based	  on	  this	  assessment,	  all	  four	  variables	  were	  assumed	  to	  be	  normally	  distributed.	  Eleven	   patients	   underwent	   angiography	   and	   IVUS	   within	   48	   hours	   of	   the	   MRI	  procedure.	  One	  patient	  had	  their	  procedure	  delayed	  by	  eight	  weeks	  due	  to	  initial	  technical	   failure.	   No	   patient	   had	   angiographic	   evidence	   of	   CAV	   but	   two	   had	  Stanford	  grade	  4	  disease	  on	  IVUS.	  
4.1.4.1. Anatomical	  Assessment	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For	   the	  12	  patients,	   there	  were	  17	   coronary	   artery	   segments	   classified	   as	   being	  the	   most	   affected	   regions	   on	   IVUS.	   Similarly,	   17	   regions	   of	   enhancement	   were	  identified	   on	   MRI.	   In	   11	   regions	   (mean	   intimal	   thickness	   0.51mm),	   there	   was	  anatomical	   correlation	   (to	  within	   1mm	   for	   location	   from	   a	  major	   branch-­‐point)	  between	   areas	   of	   IVUS	   depicted	   thickening	   and	   enhancement	   noted	   in	   the	  MRI	  (Figure	   26).	   6	   IVUS	   regions	   classified	   as	  worst	   affected	   areas	   had	   no	   reciprocal	  enhancement	  on	  MRI.	  The	  mean	   intimal	   thickness	  of	   those	  6	   regions	   (0.44	  mm)	  was	  not	  significantly	  different	  to	  the	  11	  matched	  areas	  (p=0.69	  by	  independent	  t-­‐test).	  Conversely,	   there	  were	  6	  areas	  of	   late	   enhancement	  on	  MRI	   that	  were	  not	  reciprocally	  identified	  by	  IVUS.	  The	  mean	  intimal	  thickness	  on	  IVUS	  corresponding	  to	   those	   areas	   (0.28	   mm)	   was	   significantly	   less	   than	   the	   11	   matched	   areas	  (p=0.04).	  	  	  
4.1.4.2. Quantitative	  assessment	  Enhancement	   diameter	   on	   MRI	   showed	   a	   significant	   positive	   correlation	   with	  Maximal	   Intimal	   Thickness	   on	   IVUS	   (Pearson’s	   Correlation	   coefficient	   0.81,	  p=0.001)	  (Figure	  27).	  Similarly,	  the	  enhancement	  index	  on	  MRI	  showed	  significant	  positive	   correlation	  with	   the	  Mean	   Intimal	   Index	  on	   IVUS	   (Pearson’s	  Correlation	  coefficient	  0.62,	  p=0.03)	  (Figure	  28).	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Figure	   27.	   Scatter	   plot	   for	   Correlation	   of	   Enhancement	   Diameter	   on	   MRI	  
against	  Maximal	  Intimal	  Thickness	  on	  IVUS.	  	  
It	   shows	   individual	   values	   and	   regression	   line.	   Pearson’s	   Correlation	  
coefficient	  0.81,	  p=0.001	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Figure	   28.	   Scatter	   plot	   for	   Correlation	   of	   Enhancement	   Diameter	   on	   MRI	  
against	  Mean	  Intimal	  Index	  on	  IVUS.	  	  
It	   shows	   individual	   values	   and	   regression	   line.	   Pearson’s	   Correlation	  
coefficient	  0.62,	  p=0.03	  
No	  patient	  had	  angiographic	  evidence	  of	  disease.	  Two	  patients	  had	  Stanford	  grade	  4	  Coronary	  Allograft	  Vasculopathy	  on	  IVUS.	  If	  disease	  on	  MRI	  was	  defined	  as	  enhancement	  diameter	  >	  7.5mm,	  sensitivity	  and	  specificity	  values	  of	  100%	  are	  obtained	  for	  the	  detection	  of	  CAV	  as	  defined	  by	  IVUS	  &	  angiography.	  Similarly,	  an	  enhancement	  index	  of	  >1	  again	  gives	  identical	  sensitivity	  and	  specificity	  values	  (Figure	  29	  shows	  example	  cases).	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Figure	  29.	  Coronary	  Allograft	  Vasculopathy	  MR	  Image	  
Two	   cases	   are	   shown	   for	   comparison.	   The	   first,	   left-­‐hand,	   column	   shows	  
images	   from	  a	  patient	  with	  mild	  (Stanford	  Grade	  2)	  CAV.	  The	  second,	  right	  
hand,	   column	   shows	   a	   patient	   with	   severe	   (Grade	   4)	   CAV.	   Row	   (a)	  
demonstrates	   that	   both	   patients	   have	   normal	   conventional	   angiography	  
showing	   how	   poorly	   angiography	   detects	   CAV.	   	   Row	   (b)	   shows	   the	   IVUS	  
images	   showing	   a	   small	   rim	   of	   intimal	   thickening	   in	   the	   first	   patient	  
compared	  to	  severe	  intimal	  thickening	  in	  the	  second	  patient.	  Row	  (c)	  shows	  
the	   segmentation	   of	   the	   intimal	   layer	   on	   the	   IVUS	   picture	   for	   clarification	  
(bright	  white	   rendered	   area).	   Row	   (d)	   shows	   the	   quality	   of	   coronary	  MRA	  
routinely	   achieved	   (Soapbubble	   reformat).	   Row	   (e)	   shows	   overlay	   of	   LGE	  
(arrows)	  on	  a	  multiplanar	  reformat	  of	  the	  coronary	  artery.	  A	  much	  greater	  
volume	  of	   LGE	   (arrows)	   is	   seen	   in	   the	   second	  patient	   (140mm3/cm	  vessel	  
imaged)	  than	  the	  first	  patient	  (20mm3/cm	  vessel	  imaged).	  
	  
4.1.4.3. Inter-­‐observer	  and	  Intra-­‐observer	  variability	  All	  enhancement	  measures	  were	  measured	  twice	   in	  a	  blinded	  and	  random	  order	  by	  the	  first	  observer	  and	  once	   independently	  by	  the	  second	  observer	   in	  order	  to	  calculate	   inter-­‐observer	   and	   intra-­‐observer	   variability	   in	   scoring	   LGE.	   For	  presentation	  of	  results,	  the	  observation	  set	  with	  the	  worst	  correlation	  was	  chosen.	  For	  example,	  this	  study	  quotes	  a	  correlation	  coefficient	  of	  0.81	  (p=0.001)	  for	  MIT	  against	   enhancement	   diameter,	   whereas	   observation	   set	   2	   and	   observer	   2	   had	  coefficients	  of	  0.88	  (p<0.001)	  and	  0.87	  (p<0.001)	  respectively.	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The	  Bland–Altman	  analyses	  indicate	  that	  there	  was	  no	  significant	  bias	  between	  the	  two	   sets	   of	   repeated	   enhancement	   diameter	  measurements	   (+0.1	  mm	   for	   intra-­‐observer	  error	  (p=0.83)	  and	  -­‐1.3	  mm	  for	  inter-­‐observer	  error	  (p=0.13)).	  However,	  although	  intra-­‐observer	  agreement	  was	  acceptable	  with	  95%	  limits	  of	  agreement	  ranging	   from	   +2.8	   to	   -­‐2.6	   mm	   (Figure	   30),	   inter-­‐observer	   agreement	   was	   less	  acceptable	  at	  +4.0	  to	  −6.5	  mm	  (Figure	  31).	  
	  
Figure	   30.	   Bland-­‐Altman	   Plots	   for	   intra-­‐observer	   agreement	   for	   Late	  
Gadolinium	  Enhancement	  scoring.	  	  
Half-­‐dashed	   line	   represents	   95%	   level	   of	   agreement	   and	   solid	   line	   centre-­‐
line	  represents	  the	  mean	  bias.	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Figure	   31.	   Bland-­‐Altman	   Plots	   for	   inter-­‐observer	   agreement	   for	   Late	  
Gadolinium	  Enhancement	  Scoring.	  	  
Half-­‐dashed	   line	   represents	   95%	   level	   of	   agreement	   and	   solid	   line	   in-­‐
between	  represents	  the	  mean	  bias.	  
	  
4.1.4.4. Control	  Group	  The	  control	  group	  consisted	  of	  ten	  volunteers	  (6	  male)	  with	  a	  mean	  age	  of	  23yrs	  and	   11	   months.	   They	   were	   significantly	   older	   than	   the	   transplant	   patients	  (p=0.007	  by	  independent	  samples	  t-­‐test).	  However,	  they	  were	  of	  a	  similar	  age	  to	  the	  donor	  heart	  age	  (mean	  donor	  age	  23yrs	  and	  3months,	  p=0.88	  by	  independent	  samples	   t-­‐test).	   In	   general	   terms,	   the	   volunteers	   had	   very	   little	   coronary	   late	  enhancement.	   Four	   volunteers	   had	   no	   discernible	   late	   enhancement.	   The	   mean	  enhancement	  diameter	  was	  0.27	  mm	  ±	  0.09mm.	  This	  was	  significantly	  lower	  than	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the	   transplant	  recipients,	  who	  had	  a	  mean	  enhancement	  diameter	  of	  5.38	  ±	  2.39	  mm	  (p<0.001).	  Similarly,	  enhancement	  index	  of	  the	  volunteers	  (0.02	  ±	  0.03)	  was	  significantly	  lower	  than	  the	  transplant	  patients	  (0.53	  ±	  0.42)	  (p=0.002).	  	  
4.1.5. Discussion	  In	  this	  study,	  we	  have	  demonstrated	  the	  possibility	  of	  direct	  non-­‐invasive	  imaging	  for	   CAV.	   Late	   gadolinium	   enhancement	   scores	   appear	   to	   correlate	   well	   with	  traditional	  IVUS	  measures	  of	  MIT	  and	  MII	  	  (Pearson’s	  coefficient	  respectively	  0.81,	  p=0.001	   and	   0.62	   p=0.03).	   The	   sensitivity	   and	   specificity	   of	   MRI	   to	   detect	  significant	  disease	   appears	  promising.	  An	  enhancement	  diameter	  >	  7.5mm,	  gave	  sensitivity	  and	  specificity	  values	  of	  100%	  for	  the	  detection	  of	  significant	  CAV.	  There	  was	   very	   little	   late	   enhancement	   in	   the	   controls	   and	   although	   they	  were	  older	  than	  the	  transplant	  patients,	  the	  age	  was	  almost	  identical	  to	  the	  donor	  heart	  age	  for	  our	  patients.	  The	  non-­‐invasive	  nature	  of	  MRI,	  would	  allow	  closer	  follow-­‐up	  for	  CAV	  than	  has	  been	  previously	  possible,	  especially	  in	  children.	  Earlier	  detection	  may	  therefore	  result	  in	  better	  prevention.	  There	  are	  several	   issues	   that	  need	  to	  be	  raised,	  however.	  The	  study	   is	  small	  and	  we	  must	  remain	  circumspect	  regarding	  its	  conclusions.	  Although	  the	  feasibility	  of	  LGE	   to	   directly	   image	   and	   grade	  CAV	   in	   children	  has	   been	   shown	  here,	   a	   larger	  study	  would	  confirm	  the	  utility	  of	  this	  technique.	  	  Quantitative	   assessment	   was	   encouraging.	   If	   disease	   on	   MRI	   was	   defined	   as	  enhancement	   diameter	   >	   7.5mm,	   sensitivity	   and	   specificity	   values	   of	   100%	   are	  obtained	  for	  the	  detection	  of	  CAV	  as	  defined	  by	  IVUS	  &	  angiography.	  Similarly,	  an	  enhancement	  index	  of	  >1	  again	  gives	  identical	  sensitivity	  and	  specificity	  values.	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  In	   addition	   to	   the	   quantitative	   assessment,	   the	   majority	   of	   cases	   also	  demonstrated	  good	  anatomical	  correlation	  between	  areas	  of	  enhancement	  on	  MRI	  and	  thickening	  on	  IVUS,	  (to	  within	  1mm	  for	  location	  from	  a	  major	  branch-­‐point).	  	  However,	  there	  were	  a	  significant	  number	  (6/17)	  of	  areas	  showing	  enhancement	  on	  MRI	  that	  were	  not	  markedly	  thickened	  on	  IVUS.	  This	  finding	  may	  be	  congruent	  with	   an	   earlier	   study	   into	   atherosclerosis,135	   which	   suggested	   that	   it	   is	   not	   the	  plaque	   itself	   that	   is	   imaged	  by	  Gadolinium	  deposition,	  but	   it	   is	  particular	  plaque	  compositions	   that	   result	   in	   a	   predilection	   to	   Gadolinium	   deposition.	   Previous	  studies	   note	   that	   arterial	   inflammation	   (both	   acute	   and	   chronic)	   and	   fibrosis	  enhance	   on	   late	   Gadolinium	   images.170-­‐172	   One	   possible	   explanation	   for	   our	  anatomical	   correlate	   findings,	   therefore,	   is	   that	  only	  areas	  of	  CAV	  with	  a	  greater	  inflammatory	   or	   fibrous	   component	   will	   enhance	   on	   LGE	   imaging.	   Therefore,	  acute	   inflammation	  without	   the	   same	   degree	   of	   intimal	   thickening,	  may	   also	   be	  imaged	   on	   LGE.	   Conversely,	   some	   areas	   of	   intimal	   thickening	   (especially,	   for	  example,	  donor	  atherosclerosis),	  may	  not	  have	   the	  same	  degree	  of	   inflammation	  or	  fibrosis	  to	  give	  enhancement	  on	  LGE	  images.	  If	  this	  is	  the	  case,	  then	  there	  may	  be	  even	  greater	  potential	  prognostic	  significance	  of	  coronary	  enhancement	  on	  LGE	  MRI.	  If	  coronary	  inflammation	  can	  be	  imaged	  before	  intimal	  proliferation	  occurs,	  then	   the	   potential	   for	   tailoring	   preventative	   therapy	   (antiviral	   or	  immunosuppressive	  therapy)173,	  174	  may	  be	  realised.	  Currently,	  the	  inter-­‐observer	  variability	  for	  measuring	  coronary	  LGE	  remains	  high	  and	   future	  work	   should	   concentrate	  on	   improvements	   in	   image	  quality,	   analysis	  and	  observer	  experience.	  It	  should	  be	  noted,	  however,	  that	  this	  is	  a	  new	  technique	  and	  that	  there	  will	  be	  a	  learning	  curve	  for	  acquisition,	  analysis	  and	  interpretation.	  Interestingly,	   (Figure	   26)	   also	   shows	   enhancement	   in	   the	   area	   of	   one	   of	   the	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pulmonary	  veins	  as	  it	  enters	  the	  left	  atrium.	  This	  was	  a	  relatively	  common	  finding.	  This	  may	  represent	  scarring	  near	  the	  pulmonary	  vein	  ostia	  in	  the	  left	  atrium	  from	  the	   transplantation	   suture	   line.	   Alternatively,	   it	   may	   represent	   labeling	   of	   the	  venous	  blood	  from	  the	  navigator,	  as	  has	  been	  previously	  described.175	  Despite	  this,	  overlaying	   the	  LGE	  and	  CMRA	   images,	   as	   shown	   in	   (Figure	  26)	   can	  differentiate	  this	  enhancement	  from	  coronary	  vessel	  wall	  enhancement.	  LGE	  has	  previously	  been	  shown	  to	  be	  useful	  for	  risk	  stratification	  in	  carotid	  vessel	  wall	   disease.176	   Gadolinium	   has	   also	   been	   shown	   to	   accumulate	   in	   the	   coronary	  vessel	  wall	   in	   the	  setting	  of	  damaged	  endothelium	  after	  myocardial	   infarction.136	  Recently,	   an	   elastin-­‐specific	   magnetic	   resonance	   contrast	   agent	   has	   been	  identified.177	   Such	   specific	   magnetic	   resonance	   binding	   agents	   would	   be	   much	  more	  suitable	  for	  the	  purposes	  of	  imaging	  and	  grading	  CAV.	  However,	  it	  will	  take	  time	  before	  these	  contrast	  agents	  can	  be	  used	  clinically	  in	  children.	  	  Finally,	   there	   are	   implications	   from	   this	   study	   for	   conventional	   atherosclerosis	  imaging.	  CAV	  is	  thought	  to	  be	  a	  largely	  autoimmune-­‐mediated	  vasculopathy	  with	  a	  clear	   inflammatory	   component.3	   As	   such,	   the	   strong	   correlation	   in	   this	   study	  between	   disease	   severity,	   as	   demonstrated	   by	   IVUS,	   and	   LGE	   measures	   adds	  weight	  to	  the	  argument	  that	  late	  gadolinium	  enhancement	  may	  be	  able	  to	  identify	  atherosclerotic	  plaque	  with	  an	  inflammatory	  component.	  	  	  
4.1.6. Conclusion	  	  This	   study	   has	   shown	   that	   imaging	   CAV	   with	   MRI	   is	   possible	   in	   paediatric	  transplant	  recipients.	  The	  late	  gadolinium	  enhancement	  scores	  correlate	  well	  with	  traditional	   IVUS	  measures.	  Non-­‐invasive	   coronary	   imaging	   is	   highly	   desirable	   in	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children,	  but	  the	  greatest	  potential	  of	  this	  technique	  may	  be	  in	  the	  identification	  of	  areas	  of	  inflammation	  and	  targeted	  therapy.	  	  
4.2. Diagnosis	  of	  Post-­‐Transplant	  Coronary	  Artery	  Disease	  using	  Contrast-­‐
Enhanced	  Coronary	  Vessel	  Wall	  imaging	  at	  3.0	  Tesla.	  	  
4.2.1. Abstract	  Coronary	  plaque	  characterisation	  at	  3.0	  Tesla	  holds	  great	  potential	  for	  clinical	  benefit.	  Coronary	  allograft	  vasculopathy	  (CAV)	  occurs	  after	  heart	  transplantation	  and	  is	  an	  immune-­‐mediated	  diffuse	  coronary	  intimal	  disease.	  We	  demonstrate	  the	  use	  of	  contrast-­‐enhanced	  inversion-­‐recovery	  prepared	  coronary	  vessel	  wall	  MRI	  at	  3T	  for	  diagnosis.	  We	  further	  validate	  the	  technique	  in	  23	  patients	  with	  intravascular	  ultrasound	  (IVUS),	  showing	  an	  accuracy	  of	  91%.	  Direct	  non-­‐invasive	  imaging	  has	  great	  potential	  benefit	  for	  screening	  and	  prevention	  in	  these	  patients.	  The	  study	  has	  further	  significant	  implications	  for	  conventional	  coronary	  atherosclerosis.	  
	  
4.2.2. Introduction	  Coronary	   Allograft	   Vasculopathy	   (CAV)	   remains	   the	   leading	   cause	   of	   late	   death	  after	   heart	   transplantation	   in	   children6	   but	   is	   poorly	   detected	   by	   X-­‐ray	  angiography.8	   Intravascular	   ultrasound	   (IVUS)	   has	   been	   proven	   to	   be	   able	   to	  detect	   rapid	   early	   progression	   of	   CAV	   and	   this	   has	   proven	   prognostic	  significance.25	  However,	   it	   is	   invasive	   and	   costly.	  This	  precludes	   close	   follow-­‐up,	  especially	  in	  children.	  We	  have	  previously	  demonstrated	  the	  feasibility	  of	  MRI	  late	  gadolinium	   enhancement	   (LGE)	   in	   the	   coronary	   vessel	  wall	   to	   detect	   and	   grade	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4.2.3.1. Subjects	  Patients	   older	   than	   10	   years	   undergoing	   annual	   review	   after	   orthotopic	   heart	  transplantation	  were	  invited	  to	  take	  part	  in	  the	  study.	  Written,	  informed	  consent	  was	   obtained	   from	   the	   patient	   and/or	   parent	   accordingly.	   This	   study	   has	  appropriate	   Institutional	   Review	   Board	   approval	   (Research	   Ethics	   Committee	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reference	   number	   09/H0713/53).	   Participants	   underwent	   cardiac	  MRI	   followed	  by	  their	  routine	  conventional	  X-­‐ray	  angiography	  and	  IVUS,	  one	  day	  later.	  	  
4.2.3.2. MRI	  Cardiac	  Magnetic	  Resonance	  was	  performed	  using	  a	  3.0	  Tesla	  Achieva	  clinical	  MR	  scanner	  with	   parallel	   transmit	   technology	   (Philips	  Healthcare,	   Best,	  NL	   gradient	  amplitude	  30	  mT/m	  and	  slew	  rate	  200	  mT/m/sec).	  Images	  were	  obtained	  using	  a	  32-­‐element	  cardiac	  phased-­‐array	  receiver	  coil.	  Prior	  to	  entering	  the	  scan	  room,	  0.2	  mmol/kg	   body	  weight	   of	   a	  Gadolinium-­‐based	   contrast	  medium	   (Gadovist,	   Bayer	  Schering,	   Berlin,	   Germany)	   was	   administered	   intravenously.	   Subsequently,	   an	  initial	  survey	  and	  reference	  scan	  were	  acquired	  to	  obtain	  coil	  sensitivity	  maps.	  An	  additional	  B1	  calibration	  scan	  was	  performed	  between	   the	  survey	  and	  reference	  scans	   in	   order	   to	   calculate	   the	   patient-­‐specific	   absorption	   rate	   and	   allow	   for	  B1	  volume	   shimming	   by	   utilising	   parallel	   transmit	   technology.	   Following	   this,	   the	  cardiac	   rest	   period	  was	   ascertained	   using	   a	   high	   temporal	   resolution,	   balanced-­‐SSFP,	   two-­‐dimensional	   cine	   MR	   sequence	   in	   a	   four-­‐chamber	   view	   orientation.	  (Imaging	  parameters	   included:	   repetition	   time	  =	  2.4	  ms,	  echo	   time	  =	  1.2	  ms,	   flip	  angle	  =	  60°	  at	  1.5T	  and	  40°	  at	  3T,	  slice	  thickness	  =	  10mm,	  FOV	  =	  300-­‐350	  mm,	  80	  cardiac	  phases,	  echo	  train	  length	  =	  11	  at	  1.5T	  and	  22	  at	  3.0T,	  temporal	  resolution	  =	  10	   to	   16	   ms/	   frame).	   The	   mid-­‐diastolic	   rest	   period,	   ascertained	   from	   the	   cine	  images,	  was	  used	   to	  define	   the	  acquisition	  window	   for	   the	   subsequent	   coronary	  lumen	  and	  vessel	  wall	  scans.	  First,	   a	   rapid	   whole-­‐heart	   cardiac	   magnetic	   resonance	   angiogram	   (CMRA)	   was	  performed	  as	  a	  roadmap	  for	  a	  subsequent	  3-­‐point	  plan-­‐scan	  for	  a	  targeted	  double-­‐oblique	  CMRA	  parallel	  to	  the	  native	  left	  coronary	  artery	  system.145	  Targeted	  CMRA	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was	   performed	   with	   a	   previously	   described	   navigator-­‐gated	   free-­‐breathing	   and	  cardiac-­‐triggered	  T2-­‐prepared	  three-­‐dimensional	  (3D)	  balanced	  steady-­‐state	  free-­‐precession	  (SSFP)	  sequence	  allowing	  visualisation	  of	  the	  anatomy	  of	  the	  coronary	  artery	   lumen.146	   A	   volume	   B1	   shim	   was	   applied	   utilising	   the	   parallel	   transmit	  technology.	   Imaging	   parameters	   included	   the	   following:	   FOV	   =	   320x320	   mm,	  matrix	  =	  320x320,	  acquired	  in-­‐plane	  resolution	  =	  1x1	  mm	  (reconstructed	  0.5x0.5	  mm),	   reconstructed	   slice	   thickness	   =	   1.5	   mm	   (acquired	   thickness	   =	   3	   mm	  overcontiguous	  slices),	   acquisition	  window	  =	  80	   to	  100	  ms,	   repetition	   time	  (TR)	  /echo	  time	  (TE)	  =	  5.2	  ms/2.6	  ms,	  flip	  angle	  =	  70°;	  start-­‐up	  cycles	  =	  5,	  and	  number	  of	  slices	  =	  20.	  	  Finally,	   using	   an	   identical	   imaging	   plane	   and	   spatial	   resolution	   as	   the	   targeted	  CMRA,	  a	  coronary	   late	  gadolinium	  enhancement	  (LGE)	  sequence	  was	  performed.	  This	  was	   performed	  30-­‐40	  minutes	   after	   the	   administration	   of	   gadolinium.	   This	  time	  delay	  is	  longer	  than	  that	  used	  for	  clinical	  myocardial	  late	  enhancement.	  This	  approach	  ensures	  that	  most	  of	  the	  contrast	  medium	  had	  been	  cleared	  renally	  and	  that	   most	   of	   the	   physiologic	   uptake	   of	   contrast	   medium	   in	   healthy	   tissues	   had	  been	  washed	  out.	  This	  allows	   for	  greater	  contrast	  between	  diseased	  and	  healthy	  tissues.	  This	  approach	  is	  less	  favourable	  for	  clinical	  myocardial	  imaging	  as	  residual	  blood-­‐pool	   contrast	   agent	   enables	   distinction	   of	   the	   physiological	   blood-­‐pool	   to	  myocardial	  boundary	  and	  makes	  image	  analysis	  for	  myocardial	  gadolinium	  uptake	  easier.	   In	   contrast,	   for	   coronary	   LGE,	   it	   is	   helpful	   to	   null	   signal	   from	   both	  myocardium	  and	  blood-­‐pool.	  This	  delayed	  imaging	  approach	  has	  been	  previously	  used	  for	  the	  depiction	  of	  coronary	  atherosclerosis.135	  This	  sequence	  is	  a	  navigator-­‐gated,	   vector	   ECG-­‐triggered,	   fat-­‐suppressed	   T1-­‐weighted	   3D	   gradient-­‐echo	  inversion-­‐recovery	   sequence.135,	   166,	   167	   Again,	   a	   volume	   B1	   shim	   was	   applied	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utilising	   the	   parallel	   RF	   transmit	   technology.	   Imaging	   parameters	   included	   the	  following:	   field	   of	   view	   =	   320x320	   mm,	   matrix	   =	   320x320,	   acquired	   in-­‐plane	  resolution	  =	  1x1	  mm,	  reconstructed	  slice	  thickness	  =	  1.5	  mm	  (acquired	  thickness	  =	  3	   mm),	   acquisition	   window	   =	   80	   to	   100	   ms,	   repetition	   time/echo	   time	   =	   5.7	  ms/1.7	  ms,	   flip	   angle	   =	   30°;	   start-­‐up	   cycles	   =	   5,	   and	  number	   of	   slices	   =	   20.	   The	  patient-­‐specific	  inversion	  time	  was	  adjusted	  to	  null	  blood	  signal	  with	  a	  preceding	  Look	  Locker	  sequence.168	  	  Typical	  inversion	  times	  were	  180	  to	  240ms.	  Data	   from	  the	  previous	   feasibility	  study	  at	  1.5	  Tesla	  was	  used	   for	  comparison	  of	  imaging	  and	  to	  calculate	  overall	  sensitivity	  and	  specificity	  of	  the	  technique.178	  	  
4.2.3.3. Conventional	  Angiography	  and	  IVUS	  	  Cardiac	  catheterisation	  was	  performed	  under	  general	  anesthesia	  for	  children	  and	  adolescents,	  according	  to	  institutional	  protocol,	  but	  for	  older	  adolescents	  or	  young	  adults,	   performance	   under	   local	   anesthesia	   is	   encouraged.	   Catheterisation	   and	  IVUS	   were	   only	   performed	   as	   clinically	   indicated	   for	   annual	   review.	   CAV	   on	  angiography	   is	   defined	   as	   mild,	   moderate	   or	   severe	   according	   to	   published	  criteria.7	   A	   single	   experienced	   observer	   reported	   angiograms	   but	   a	   second	  experienced	  observer	  confirmed	  any	  abnormalities.	  IVUS	   was	   performed	   in	   the	   left	   anterior	   descending	   coronary	   artery	   with	  automated	   pullback	   at	   0.5mm/s.	   This	   imaging	   has	   a	   temporal	   resolution	   of	   30	  frames/second.	  A	  suitable	  length	  of	  vessel	  was	  imaged	  to	  allow	  analysis	  of	  at	  least	  30	  cross-­‐sectional	  images	  evenly	  spaced	  (at	  approximately	  1.5mm	  intervals)	  over	  the	   same	   segment	   of	   left	   anterior	   descending	   artery	   that	   was	   analysed	   at	   the	  previous	   annual	   review	   (identified	   by	   branch	   points).	   Additionally,	   the	   images	  analysed	  were	  always	  taken	  during	  the	  mid-­‐diastolic	  rest	  period	  for	  consistency.	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Maximal	  intimal	  thickness	  (MIT),	  mean	  intimal	  index,	  (MII)	  and	  Stanford	  Grading	  score	   were	   recorded.10	   Mean	   intimal	   index	   is	   defined	   as	   the	   ratio	   of	   the	   mean	  intimal	  area	  to	  the	  sum	  of	  the	  mean	  intimal	  and	  luminal	  areas.	  In	  addition,	  a	  semi-­‐automatic	   interactive	   edge-­‐detection	   software	  was	   used	   (QIVUS	   Clinical	   Edition,	  Medis	  medical	   imaging	   systems)	   to	   improve	   reproducibility	   of	  measurements.27	  Finally,	   the	  position	  of	   the	  most	  affected	  regions	   (regions	  with	   thickness	  greater	  than	   twice	   the	   mean	   intimal	   thickness	   for	   that	   patient)	   of	   the	   left	   main	   and	  anterior	   descending	   coronary	   artery	   were	   recorded,	   using	   distance	   from	  major	  side	  branches.	  	  
4.2.3.4. MR	  Image	  analysis	  Magnetic	  resonance	  LGE	  images	  were	  scored	  as	  previously	  described.	  Briefly,	  LGE	  was	  defined	  as	  areas	  in	  the	  vessel	  wall	  with	  a	  signal	  intensity	  that	  is	  significantly	  (>2	  standard	  deviations	  (SD))	  higher	  than	  normal	  non-­‐enhancing	  vessel	  wall.	  The	  ascending	  aorta	  (distal	   to	  anastomosis	  site)	  or	  the	  descending	  aorta	  was	  used	  as	  the	   reference	   for	   normal	   vessel	   wall.	   Using	   the	   coronary	   MRA	   as	   an	   overlay	  roadmap,	   the	   volume	   of	   coronary	   vessel	  wall	   enhancement	  was	   then	  measured.	  Using	   this	   volume	   and	   quantitative	   coronary	   lumen	   measurements,	   mean	  enhancement	   area	   (=volume/length	   imaged),	   enhancement	   diameter	   (ED)	   and	  mean	   enhancement	   index	   (Ei	   =enhancement	   area/coronary	   lumen	   mean	   cross	  sectional	  area)	  were	  derived	  and	  recorded.	  Location	  of	  areas	  of	  coronary	  wall	  LGE	  on	  MRI	  was	  also	  recorded	  for	  comparison.	  	  Finally,	  a	  qualitative	  analysis	  was	  undertaken	  by	  means	  of	  a	  consensus	  reading	  for	  image	  quality	  scoring	  on	  all	  the	  LGE	  images	  in	  a	  blinded	  and	  random	  order	  by	  two	  readers	   (T.H.	   and	   G.F.G.	   (>3	   years	   and	   >10	   years	   respectively	   of	   CMRA	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experience)).	   The	   two	   readers	   first	   reviewed	   the	   images	   independently	   and	   any	  disagreement	  was	  then	  discussed	  before	  the	  final	  grade	  was	  given.	  The	  following	  scoring	  system	  was	  used:	  0	  indicates	  that	  the	  coronary	  vessel	  wall	  was	  not	  visible;	  1	   visible	   but	  with	  markedly	   blurred	   borders;	   2	   visible	  with	  moderately	   blurred	  borders;	  3	  visible	  with	  mildly	  blurred	  borders	  and	  4	  visible	  with	  sharply	  defined	  borders.111	  	  	  
4.2.3.5. Statistical	  Methods	  First	   an	   anatomical	   comparison	   was	   made	   between	   the	   location	   of	   areas	   of	  enhancement	   on	   MRI	   and	   the	   location	   of	   prominent	   thickening	   on	   IVUS	   using	  distance	   (mm)	   from	   the	   nearest	  major	   side-­‐branch.	   Variables	   are	   then	   formally	  assessed	   for	   normality	   of	   distribution	   using	   the	  Kolmogorov-­‐Smirnov	   test.	   Then	  specific	   bivariate	   correlation	  was	  performed	  between	   enhancement	   index	   (MRI)	  and	   intimal	   index	   (IVUS).	   Further	   bivariate	   correlation	   was	   made	   between	  enhancement	  diameter	  and	  maximal	  intimal	  thickness.	  	  A	   receiver-­‐operating	   characteristic	   (ROC)	   curve	   is	   constructed	   to	   choose	   the	  optimal	   cut-­‐off	   for	   the	   sensitivity	   and	   specificity	   of	   LGE	   for	   the	   detection	   of	  significant	  CAV.	  Significant	  CAV	  is	  defined	  as	  that	  present	  on	  X-­‐ray	  angiogram	  or	  scored	  as	  Stanford	  grade	  IV	  on	  IVUS.	  Associations	  with	  known	  risk	  factors	  were	  further	  explored	  by	  forward	  stepwise	  multivariate	   linear	  regression.	  Donor	  age,	   cytomegalovirus	   (CMV)	   infection,	   time	  post-­‐transplant,	   occurrence	   of	   severe	   or	   recurrent	   rejection	   and	   blood	   pressure	  are	  the	  risk	  factors	  that	  were	  assessed.6,	  173,	  179	  Included	  variables	  were	  only	  kept	  in	  the	  analysis	  if	  they	  improved	  model	  fit.	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Image	   Quality	   was	   compared	   between	   1.5	   and	   3T	   using	   a	   Mann-­‐Whitney	   test.	  Statistical	   analyses	   were	   performed	   on	   SPSS	   version	   19	   (Release	   19.0.0,	   IBM	  Software	  Group,	  New	  York,	  USA).	  
	  
4.2.4. Results	  24	  adolescents	  participated	  in	  the	  study	  in	  total	  (patient	  characteristics	  (Table	  13)).	  This	  included	  12	  at	  1.5T	  and	  12	  at	  3.0T.	  One	  MRI	  at	  3.0T	  failed	  due	  to	  patient	  discomfort.	  Overall,	  there	  was	  excellent	  correlation	  of	  MRI	  with	  IVUS.	  Pearson’s	  correlation	  for	  ED	  with	  MIT	  was	  0.80	  (p<0.001)	  and	  for	  Ei	  with	  MII	  was	  0.92	  (p<0.001).	  Correlation	  coefficients	  at	  3T	  were	  comparable	  to	  1.5T	  (0.77	  &	  0.96	  versus	  0.81	  &	  0.62	  respectively	  (all	  p<0.05)).	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Table	  13.	  Descriptive	  Summary	  of	  Heart	  Transplant	  Patient	  Characteristics.	  	  
Variables	  are	  reported	  separately	  for	  3.0T	  and	  1.5T	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  At	  1.5T,	  although	  intra-­‐observer	  agreement	  was	  acceptable	  with	  95%	  limits	  of	  agreement	  ranging	  from	  +2.8	  to	  -­‐2.6,	  inter-­‐observer	  agreement	  was	  less	  acceptable	  at	  +4.0	  to	  −6.5	  mm.	  However,	  this	  was	  improved	  at	  3.0T,	  with	  95%	  limits	  of	  agreement	  for	  intra-­‐observer	  agreement	  ranging	  from	  +1.7	  to	  -­‐2.3	  and	  for	  inter-­‐observer	  from	  +3.5	  to	  −2.5	  mm.	  This	  improvement	  in	  repeatability	  was	  likely	  due	  to	  an	  increase	  in	  LGE	  image	  quality	  at	  3.0T	  (median=3)	  compared	  to	  1.5T	  (median=2;	  p=0.019	  by	  Mann-­‐Whitney	  test).	  Furthermore,	  at	  1.5T	  only	  11	  out	  of	  17	  areas	  of	  enhancement	  on	  MRI	  were	  associated	  with	  corresponding	  significant	  disease	  on	  IVUS	  (i.e.	  location	  match	  to	  within	  1mm	  from	  a	  major	  branch-­‐point).	  At	  3T,	  however,	  11	  of	  13	  enhancing	  lesions	  had	  exact	  and	  anatomical	  match	  (	  Figure	  32).	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Figure	  32.	  3.0	  vs.	  1.5	  Tesla	  imaging	  for	  CAV.	  
A)	  Patient	  1	  Left	  Coronary	  system	  CMRA	  at	  3T.	  	  
B)	  Patient	  1	  LGE	  at	  3T.	  	  
C)	  Patient	  2	  Left	  coronary	  CMRA	  at	  1.5T.	  	  
D)	  Patient	  2	  LGE	  at	  1.5T	  
E)	   Overlay	   of	   Patient	   1	   LGE	   on	   CMRA	   at	   3T.	   Arrows	   show	   corresponding	  
positions	  for	  IVUS	  pictures	  G	  &	  H.	  	  
F)	  Overlay	   of	   Patient	   2	   LGE	   on	   CMRA	   at	   1.5T.	   Arrows	   show	   corresponding	  
positions	  for	  IVUS	  pictures	  I	  &	  J.	  
G	  &	   I)	   IVUS	   images.	  White	  box	   illustrates	   intimal	   thickening	  corresponding	  
to	  enhancement	  on	  overlay	  picture	  above	  
J	  &	  H)	  IVUS	  images.	  No	  significant	  intimal	  thickening	  corresponding	  to	  areas	  
without	  enhancement	  on	  overlay	  picture	  above	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  Overall,	  the	  receiver	  operating	  characteristics	  curve	  demonstrates	  that	  a	  cut-­‐off	  of	  7.5	  mm	  ED	  on	  MRI	  has	  86%	  sensitivity	   and	  94%	  specificity	   for	   the	  detection	  of	  significant	  (Stanford	  grade	  4	  on	  IVUS)	  CAV.	  This	  gives	  a	  positive	  predictive	  value	  of	  86%,	  negative	  predictive	  value	  of	  94%	  and	  accuracy	  of	  91%.	  In	   the	  multivariate	   analysis,	   donor	   age,	   length	   of	   time	   post	   transplant	   and	  MRI	  (ED)	   were	   the	   only	   significant	   independent	   predictors	   of	   maximum	   intimal	  thickness	   on	   IVUS	   (model	   R2=	   0.79;	   p<0.001).	   Standardised	   correlation	  coefficients	  were	  0.69	  for	  ED	  (p<0.001);	  0.65	  for	  donor	  age	  (p=0.002)	  and	  0.42	  for	  time	   post-­‐transplant	   (p=0.048).	   There	   were	   no	   significant	   correlations	   between	  ED	  and	  donor	  age	  or	  between	  ED	  and	  time	  post-­‐transplant.	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4.2.5. Discussion	  We	   have	   demonstrated	   that	   coronary	   vessel	   wall	   late	   gadolinium	   enhancement	  has	  91%	  accuracy	  in	  the	  detection	  of	  significant	  coronary	  allograft	  vasculopathy	  as	  defined	   by	   intravascular	   ultrasound.	   We	   have	   further	   demonstrated	   improved	  coronary	  vessel	  wall	  LGE	  image	  quality	  at	  3.0	  Tesla.	  This	  is	  likely	  to	  be	  responsible	  for	   the	   improved	  anatomical	  correlation	  with	  IVUS	  at	  3.0	  Tesla	   in	  comparison	  to	  1.5	  Tesla	  imaging.	  Due	  to	  time	  constraints,	  we	  did	  not	  perform	  LGE	  imaging	  at	  3.0	  Tesla	  without	  the	  use	   of	   parallel	   transmit	   technology	   for	   comparison	   and	   so	   it	   is	   difficult	   to	   infer	  specific	  benefits	   from	   its	  use.	   It	   is	   known	   that,	   at	   higher	   field	   strengths,	   there	   is	  difficulty	  in	  achieving	  uniform	  radiofrequency	  (RF)	  excitation	  over	  the	  entire	  field	  of	   view	   (FOV).	   This	   results	   in	   a	   reduction	   of	   image	   quality	   (e.g.	   B1	   attenuation	  artefacts).	   	   Parallel	   radiofrequency	   transmission	   can	   be	   used	   to	   improve	   the	  radiofrequency	   (B1	   field)	   homogeneity	   in	   high-­‐field	   MRI.142	   More	   accurate	  knowledge	  of	  the	  local	  B1	  field	  also	  allows	  for	  improved	  management	  of	  the	  local	  specific	  absorption	  rate	   (SAR),	   thereby	  enabling	  shorter	  repetition	   times	  (TR)	   to	  be	   employed.143	   This	  may	   be	   responsible	   for	   the	   overall	   improvement	   in	   image	  quality	   by	   reducing	   artefact	   levels,	   as	   demonstrated	   recently	   in	   a	   small	   study	  comparing	  cine	  images	  with	  and	  without	  the	  use	  of	  parallel	  transmission.144	  In	  this	  study,	  we	  demonstrate	  a	  non-­‐invasive	  but	  direct	  means	  by	  which	  to	  image	  CAV.	  In	  order	  to	  do	  this	  reliably,	  we	  have	  made	  use	  of	  recently	  applied	  technology	  including	  parallel	   radiofrequency	   transmission	  at	  3.0	  Tesla.	  Non-­‐invasive	   follow-­‐up	   with	   MRI	   would	   allow	   more	   frequent	   screening	   for	   CAV;	   would	   limit	   the	  number	  of	  invasive	  procedures;	  would	  reduce	  exposure	  to	  ionising	  radiation;	  may	  allow	   earlier	   detection	   and	   allow	   earlier	   therapeutic	   intervention.	   Future	   study	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should	  focus	  on	  the	  prognostic	  significance	  of	  LGE	  in	  the	  setting	  of	  CAV	  and	  on	  the	  implementation	  of	  MRI	  into	  a	  clinical	  trial	  to	  prevent	  CAV.	  	  
4.2.6. Conclusion	  	  Coronary	   vessel	  wall	   delayed	   enhancement	  MRI	   is	   a	   valuable	   and	   accurate	   non-­‐invasive	   method	   to	   quantify	   CAV.	   Improved	   image	   quality	   at	   3.0	   Tesla	   further	  ameliorates	  the	  accuracy	  of	  this	  technique.	  	  	  
4.3. Contrast-­‐Enhanced	  Inversion	  Prepared	  Coronary	  Vessel	  Wall	  Imaging	  
for	  Kawasaki	  Disease	  	  
4.3.1. Introduction	  Aside	   from	   CAV,	   Kawasaki	   Disease	   is	   the	   other	   main	   coronary	   vasculopathy	  encountered	  in	  childhood.	  Hence,	  the	  technique	  of	  contrast-­‐enhanced	  vessel	  wall	  imaging	  described	  for	  CAV	  may	  have	  important	  implications	  for	  Kawasaki	  Disease.	  Indeed,	  2d	  cross-­‐sectional	  Dual-­‐Inversion-­‐Recovery	  (DIR)	  black-­‐blood	  imaging	  of	  the	   coronary	   arteries	   has	   been	   previously	   used	   to	   assess	   Kawasaki	   Disease	  (KD).180	  Hence,	   in	  this	  thesis	  the	  utility	  of	  a	  3d	  coronary	  black-­‐blood	  approach	  is	  examined.	  This	  3d	  black-­‐blood	  approach	  has	  been	  shown	  to	  give	  better	  coverage	  of	  the	  coronary	  tree.97	  Furthermore,	  uptake	  of	  gadolinium	  contrast	  agent	  has	  been	  shown	   to	   indicate	   inflammation	   (both	   acute	   and	   chronic)	   or	   fibrosis	   in	   other	  pathological	   processes.	   170-­‐172	   Therefore,	  we	   also	   sought	   to	   investigate	   coronary	  vessel	  wall	  uptake	  of	  gadolinium	  after	  Kawasaki	  Disease	  to	  see	  if	  any	  inference	  can	  be	  drawn	  regarding	  the	  pathological	  processes	  involved.	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4.3.2. Aim	  To	  investigate	  whether	  in-­‐plane	  3d	  coronary	  vessel	  wall	  imaging	  utilising	  a	  local-­‐inversion	   technique	   and	   spiral	   image	   acquisition,	   in	   combination	  with	   contrast-­‐enhanced	   inversion-­‐recovery	   (IR)	   imaging	   allows	   more	   comprehensive	  assessment	  of	  KD.	  	  
4.3.3. Method	  	  Patients	  with	   previous	   coronary	   aneurysms	   due	   to	   KD	   undergoing	   routine	   CMR	  evaluation	   had	   additional	   vessel	   wall	   imaging	   before	   and	   after	   contrast	  administration	  (0.2	  mmol/kg	  gadopentetate	  dimeglumine).	  All	  examinations	  were	  performed	  on	  a	  1.5T	  MR-­‐system	  and	  the	  coil	  was	  selected	  according	  to	  patient	  size	  (two-­‐element/five-­‐element).	   Coronary	   MRA	   was	   followed	   by	   a	   targeted,	   free-­‐breathing,	  ECG-­‐triggered	  3d	  vessel	  wall	  sequence	  using	  local	  inversion	  and	  spiral	  image	   acquisition	   (spatial	   resolution=0.76x0.76x2mm;	  TE/TR=2/29ms,	   FA=90°).	  Areas	  of	  vessel	  wall	   thickening	  on	   in-­‐plane	   imaging	  were	   then	   further	  evaluated	  with	  through-­‐plane	  2d	  DIR	  technique.	  Post-­‐contrast	  imaging	  was	  performed	  using	  a	  free-­‐breathing,	  ECG-­‐triggered,	  3d-­‐IR	  segmented	   gradient-­‐echo	   sequence	   (spatial	   resolution=1.25x1.25x3mm,	  TE/TR=1.4/3.5ms,	  FA=30°	  &	  TI	  chosen	  to	  null	  blood	  using	  Look-­‐Locker).	  	  
4.3.4. Results	  	  13	   CMR	   examinations	   were	   performed	   in	   12	   children	   (7	   male,	   age=2-­‐19yrs;	  HR=60-­‐110bpm;	   6	   weeks-­‐18	   years	   post-­‐acute	   KD).	   6	   cases	   showed	   persistent	  aneurysms;	  4	  cases	  had	  coronary	  ectasia	  and	   the	  remaining	  resolved	  aneurysms	  had	  a	  normal	  lumen.	  	  One	  case	  showed	  a	  mild	  LAD	  stenosis	  shown	  on	  CMRA	  and	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confirmed	   on	   conventional	   angiography.	   Complete	   black	   blood	   coverage	   of	   the	  affected	  portions	  of	  the	  coronary	  arteries	  was	  achieved	  using	  the	  new	  3d	  in-­‐plane	  local-­‐inversion	   technique.	   Targeted	   2d	   cross-­‐sectional	   imaging	   showed	   that	  aneurismal	   segments	   had	   greater	   wall	   thickness	   (mean	   0.87mm)	   than	   ectatic	  segments	   (0.42mm)	   or	   resolved	   aneurysms	   (0.31mm).	   Delayed	   enhancement	   of	  the	  coronary	  vessel	  wall	  was	  only	  present	  in	  three	  cases	  (all	  of	  whom	  had	  recent	  KD	  <2yrs	  ago).	  	  	  
4.3.5. Conclusion	  Our	  data	  suggests	  that	  late	  gadolinium	  enhancement	  of	  the	  coronary	  vessel	  wall	  in	  Kawasaki	   Disease	   may	   persist	   for	   up	   to	   2	   years	   post-­‐acute	   insult.	   This	   may	  represent	   inflammation	   and	   subsequent	   resolution.	   This	   type	   of	   imaging	   may	  therefore	  be	  helpful	   for	  confirmatory	  evidence	  of	  disease	   in	  atypical	  cases	  or	   for	  follow-­‐up	  purposes	  to	  show	  resolution	  of	  pathology.	  We	   have	   further	   shown	   that	   vessel	   wall	   remodeling	   seems	   to	   have	   occurred	  effectively	   in	   the	   resolved	   aneurysms	   studied	   here.	   3d	   in-­‐plane	   local-­‐inversion	  black-­‐blood	   imaging	   gives	   more	   complete	   coverage	   of	   affected	   segments	   and	  allows	   targeting	   of	   cross-­‐sectional	   imaging	   on	   thickened	   portions.	   This	   type	   of	  vessel	   wall	   imaging	   has	   the	   potential	   to	   allow	   pathophysiological	   insights	   into	  disease	  or	  to	  be	  an	  imaging	  biomarker	  for	  future	  therapeutic	  trials.	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5. Aortic	  Imaging	  and	  Correlates	  with	  Cardiovascular	  Disease	  
	  
5.1. Aortic	   Pulse	   Wave	   Velocity	   as	   a	   marker	   for	   coronary	   allograft	  
vasculopathy	  
	  
5.1.1. Abstract	  Background:	   Pulse	   wave	   velocity	   (PWV),	   a	   marker	   for	   intrinsic	   stiffness	   of	   the	  aortic	  wall,	  has	  been	  shown	  to	  be	  highly	  predictive	  for	  cardiovascular	  events	  in	  the	  setting	   of	   atherosclerosis.	   The	   purpose	   of	   this	   study	   is	   to	   investigate	   whether	  central	   arterial	   stiffness	   in	   children	   relates	   to	   the	   degree	   of	   coronary	   intimal	  disease	  after	  heart	  transplantation.	  	  Method:	   10	   children	   (5	   male)	   underwent	   cardiac	   magnetic	   resonance	   (CMR)	  followed	   by	   X-­‐ray	   angiography	   and	   intravascular	   ultrasound	   (IVUS).	   Published	  normal	  values	  were	   taken	   for	  age-­‐matched	  controls.	  PWV	  was	  measured	  using	  a	  VCG-­‐gated	   gradient-­‐echo	   pulse	   sequence	   with	   velocity	   encoding	   (temporal	  resolution	   5	   to	   7ms).	   Magnitude	   images	   were	   used	   to	   give	   an	   image-­‐based	  assessment	   of	   central	   aortic	   stiffness	   (β	   index).	   Total	   peripheral	   vascular	  resistance	  (TPR)	  was	  calculated,	  using	  ascending	  aorta	  flux	  as	  cardiac	  output.	  IVUS	  was	  performed	  in	  the	  left	  anterior	  descending	  coronary	  artery.	  Maximal	  and	  mean	  intimal	  thicknesses	  were	  recorded	  as	  measures	  of	  CAV	  burden.	  	  Results:	   PWV	   in	   transplant	   patients	   was	   significantly	   higher	   than	   normal	  volunteers	  (4.5	  vs.	  3.3	  m/s;	  p=0.002).	  β	  index	  was	  not	  raised	  significantly	  (3.2	  vs.	  2.5	  in	  normal	  volunteers;	  p=0.17)	  and	  neither	  was	  TPR	  (1245	  vs.	  1144	  dyn.sec.cm-­‐
5	  in	  normal	  volunteers;	  p=0.08).	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PWV	   was	   significantly	   positively	   correlated	   with	   CAV	   burden	   as	   measured	   by	  maximal	   intimal	   thickness	   (Pearson’s	   Coefficient	   =	   0.66;	   p=0.036)	   and	   by	  mean	  intimal	   thickness	   (Pearson’s	   Coefficient	   =	   0.71;	   p=0.02).	   β	   index	   was	   also	  positively	   correlated	   with	   these	   indices	   of	   CAV	   burden	   (Coefficient	   =	   0.74	   and	  0.78;	   p=0.014	   and	   0.008	   respectively).	   TPR	   does	   not,	   however,	   correlate	   with	  these	  measures	  of	  CAV	  (Coefficients	  =	  -­‐0.015	  and	  -­‐0.001;	  p>0.9).	  	  BP	   parameters;	   age;	   time	   post-­‐transplant;	   and	   PWV	   were	   added	   into	   the	  multivariate	   linear	  regression	  model	   for	  mean	   intimal	   thickness	  prediction.	  Only	  PWV	  remained	  in	  the	  model	  after	  forward	  stepwise	  exclusions.	  PWV	  was	  the	  only	  independent	  predictor	  of	  CAV	  burden	  (model	  R2=0.51;	  p=0.02).	  	  Conclusions:	   	   In	   this	   study	   we	   demonstrate	   that	   central	   arterial	   stiffness,	  measured	  by	  pulse	  wave	  velocity	  correlates	  with	  coronary	  allograft	  vasculopathy	  independently	  of	  closely	  related	  parameters	  such	  as	  blood	  pressure.	  PWV	  may	  be	  a	   potential	   surrogate	   marker	   for	   adverse	   vascular	   modeling	   after	   heart	  transplantation.	  	  	  
5.1.2. Introduction	  Pulse	  wave	  velocity	  (PWV)	  is	  a	  marker	  for	  the	  intrinsic	  stiffness	  of	  the	  aortic	  wall,	  which	   has	   been	   shown	   to	   be	   highly	   predictive	   for	   cardiovascular	   events	   in	   the	  setting	   of	   atherosclerosis.69-­‐74	   The	   precise	   relationship	   between	   PWV	   and	   CV	  disease	   is	   unknown	   but	   one	   explanation	   is	   that	   PWV	   is	   a	   marker	   of	   advanced	  plaque	   burden.75	   Furthermore,	   increased	   aortic	   stiffness	   signifies	   adverse	  myocardial	   haemodynamic	   conditions	   including	   an	   increase	   in	   systolic	   blood	  pressure	   and	   pulse	   pressure	   with	   increased	   systolic	   load	   and	   decreased	  myocardial	  perfusion	  pressure.76-­‐78	  	  Coronary	  Allograft	  Vasculopathy	  (CAV)	  is	  the	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leading	  cause	  of	  late	  death	  or	  graft	  loss	  after	  heart	  transplantation	  in	  children	  6.	  A	  small	   study	   performed	   in	   children	   above	   5	   years	   of	   age	   showed	   a	   significant	  correlation	  between	  length	  of	  time	  since	  transplantation	  and	  PWV.	  However,	  this	  study	  fell	  short	  of	  correlating	  PWV	  with	  direct	  measurements	  of	  CAV.	  The	  relative	  ease	  of	  measurement	  would	  make	  it	  an	  attractive	  adjunct	  to	  the	  clinic	  if	  its	  utility	  can	  be	  shown	  in	  the	  setting	  of	  CAV.	  It	  would	  be	  particularly	  beneficial	  in	  children	  for	  whom	  quick	  non-­‐invasive	  markers	  are	  more	  acceptable.	  	  	  The	  purpose	  of	  this	  study	  is	  to	  see	  if	  central	  arterial	  stiffness	  in	  children	  is	  related	  to	   the	   degree	   of	   coronary	   intimal	   disease	   after	   heart	   transplantation.	   Cardiac	  Magnetic	   Resonance	   (CMR)	   is	   used	   in	   this	   exploratory	   study	   as	   it	   affords	   the	  ability	  to	  image	  aortic	  vessel	  changes	  through	  the	  cardiac	  cycle,	  measure	  PWV,	  and	  calculate	  cardiac	  output	  within	  a	  single	  imaging	  modality.	  	  	  
5.1.3. Method	  
	  
5.1.3.1. Subjects	  	  	  Children	   over	   10	   years	   of	   age	   attending	   for	   routine	   annual	   review	   for	   heart	  transplantation	   were	   invited	   to	   participate	   in	   this	   study.	   Ten	   children	   (5	  male)	  participated	  in	  the	  study.	  Institutional	  Review	  Board	  approval	  was	  obtained	  prior	  to	   commencing	   the	   study	   (Research	   Ethics	   Committee	   reference	   number	  09/H0713/53).	  Written,	  informed	  consent	  was	  obtained	  from	  the	  patient	  and/or	  parent	  accordingly.	  Participants	  underwent	  cardiac	  MRI	  followed	  by	  their	  routine	  conventional	  X-­‐ray	  angiography	  and	  IVUS,	  one	  day	  later.	  Normal	  values	  for	  arterial	  stiffness	  were	  taken	  from	  published	  literature	  for	  age-­‐matched	  controls.181,	  182	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5.1.3.2. Blood	  Pressure	  Recordings	  	  In	  clinic,	  routine	  blood	  pressure	  recordings	  are	  taken	  with	  the	  child	  seated	  and	  for	  five	  minutes	  before	  conventional	  BP	  measurement.	  Measurements	  are	  taken	  in	  the	  right	   arm	   with	   an	   appropriate-­‐sized	   cuff.	   The	   mean	   of	   3	   sphygmomanometer	  readings	  is	  taken	  as	  the	  conventional	  (clinical)	  BP	  measurement.	  Hypertension	  is	  classified	   as	   recordings	   on	   three	   separate	   occasions	   being	   higher	   than	   the	   95th	  centile	  for	  height	  and	  age.183-­‐185	  Prior	  to	  commencement	  of	  therapy,	  hypertension	  is	   further	   classified	   and	   confirmed	   according	   to	   24-­‐hour	   ambulatory	   blood	  pressure	   measurements.	   Classification	   of	   hypertension	   and	   antihypertensive	  medications	  were	  recorded	  from	  the	  clinical	  records.	  Finally,	  a	  blood	  pressure	   is	  also	   taken	   at	   the	   time	   of	   the	   MRI	   using	   an	   automated	   cuff	   (Datex	   Ohmeda	  oscillometric	   blood	   pressure	   device,	   GE	   Healthcare,	   WI,	   USA)	   with	   an	  appropriately	   sized	   cuff.	   This	   blood	   pressure	   is	   used	   for	   reference	   of	   indices	   of	  arterial	  stiffness.	  	  
5.1.3.3. MRI	  &	  Arterial	  Stiffness	  Indices	  	  	  Cardiac	  Magnetic	  Resonance	  was	  performed	  using	  a	  1.5	  Tesla	  Achieva	  clinical	  MR	  scanner	  (Philips	  Healthcare,	  Best,	  NL).	   Images	  were	  obtained	  using	  a	  32-­‐element	  cardiac	  phased-­‐array	  receiver	  coil.	  Pulse-­‐wave	  velocity	  is	  recorded	  according	  to	  a	  previously	   validated	   method.186	   In	   this	   study,	   PWV	  was	   measured	   between	   the	  ascending	   aorta	   and	   the	   descending	   aorta	   at	   the	   level	   of	   the	   diaphragm.	   A	  retrospectively	   VCG-­‐gated	   gradient-­‐echo	   pulse	   sequence	   with	   velocity	   encoding	  was	   applied	   at	   these	   levels	   to	   measure	   through-­‐plane	   flow.	   This	   sequence	   was	  performed	   free-­‐breathing	   and	   imaging	   parameters	   included:	   Echo	   Time	   2.9ms,	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Repetition	  Time	  5	  ms,	  Slice	  Thickness	  8	  mm;	  Acquired	  resolution	  2.2x2.2	  mm;	  2	  to	  3	  signal	  averages;	  125	  cardiac	  phases	  and	  temporal	  resolution	  5.1	  to	  6.9	  ms.	  	  PWV	  was	   subsequently	   calculated	   as	  Δx/Δt	   (expressed	   in	  m/s),	  where	  Δx	   is	   the	  aortic	  path	  length	  between	  2	  imaging	  levels	  and	  Δt	  is	  the	  time	  delay	  between	  the	  arrival	  of	  the	  foot	  of	  the	  pulse	  wave	  at	  these	  levels.	  Flow	  analysis	  was	  performed	  using	  commercially	  available	  analysis	   software	   (View	  Forum;	  Philips	  Healthcare,	  Best,	  The	  Netherlands).	  Arrival	  of	  the	  foot	  of	  the	  pulse	  wave	  was	  calculated	  using	  the	  method	  of	  intersecting	  tangents.	  Matlab	  Release	  2009b	  (version	  7.9)	  is	  used	  to	  identify	   the	   inflection	   point	   (using	   change	   of	   sign	   of	   the	   second	   derivative)	   to	  centre	   the	   first	   tangent.	  The	   intersection	   this	   tangent	  and	   the	  second	   line	  drawn	  horizontal	   to	   the	  minimum	  diastolic	   flow,	   identified	   the	   foot	  of	   the	  wave	  (Figure	  33).	  	  
	  
Figure	  33.	  Pulse	  Wave	  Velocity	  Calculation	  
a)	   Shows	   sagittal	   view	   of	   the	   ascending	   aorta,	   aortic	   arch	   and	   descending	  
aorta.	   Δx	   is	   calculated	   using	   a	   centre-­‐line	   plot	   from	  point	   (1)	   to	   point	   (3).	  
White	   lines	   represent	   location	   of	   cross-­‐sectional	   axial	   views	   b)	   and	   c)	   for	  
flow	  measurements.	  Position	  (1)	   in	  the	  ascending	  aorta;	  position	  (2)	   in	  the	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proximal	  descending	   aorta	   and	  position	   (3)	   in	   the	  descending	   aorta	   at	   the	  
level	  of	  the	  diaphragm.	  Position	  (2)	  is	  taken	  for	  image-­‐based	  assessment	  of	  
diastolic	  and	  systolic	  diameters.	  d)	  shows	  offline	  analysis	  of	  flow	  to	  calculate	  
Δt,	  the	  time	  delay	  between	  the	  pulse	  wave	  arrival	  at	  different	  levels	  (“foot”	  
method).	   Arrival	   of	   the	   foot	   of	   the	   pulse	   wave	   was	   calculated	   using	   the	  
method	  of	  intersecting	  tangents.	  Matlab	  Release	  2009b	  (version	  7.9)	  is	  used	  
to	  identify	  the	  inflection	  point	  (using	  change	  of	  sign	  of	  the	  second	  derivative)	  
to	  centre	  the	  first	  tangent.	  The	  intersection	  this	  tangent	  and	  the	  second	  line	  
drawn	   horizontal	   to	   the	  minimum	  diastolic	   flow,	   identified	   the	   foot	   of	   the	  
wave.	  Tangents	   for	  positions	  (1)	  and	  (3)	  are	   labeled.	  Pulse	  wave	  velocity	  =	  
Δx/Δt.	  	  Magnitude	  images	  of	  the	  velocity-­‐encoded	  cine	  of	  the	  proximal	  descending	  aorta	  were	  used	   to	   give	   image-­‐based	   traditional	   assessment	  of	   central	   aortic	   stiffness.	  Diameter	   changes	   were	   quantified	   using	   a	   semi-­‐automatic	   tool	   (View	   Forum;	  Philips	   Healthcare,	   Best,	   The	   Netherlands)	   taking	   values	   to	   the	   nearest	   mm2.	  Maximum	   and	  minimum	   diameters	  were	   taken	   as	   an	   average	   of	   three	   readings	  and	  all	  values	  were	  confirmed	  manually.	  The	  Aortic	  stiffness	  β	  index	  was	  given	  as:	  β	  =	  ln	  (SBP/DBP)	  /	  [(As-­‐Ad)/Ad]	  Where	   ln	   =	   natural	   logarithm;	   SBP	   =	   systolic	   blood	   pressure	   (mmHg);	   DBP	   =	  diastolic	  blood	  pressure	  (mmHg);	  As	  =	  maximum	  systolic	  aortic	  area	  (mm2)	  and	  Ad	  =	  minimum	  diastolic	  area	  (mm2).182	  Finally,	  total	  peripheral	  vascular	  resistance	  (TPR)	  was	  calculated,	  using	  net	  flux	  in	  the	  ascending	  aorta	  as	  the	  cardiac	  output,	  as:	  TPR	  =	  (MBP/CO)	  x	  80	  Where	  TPR	  is	  measured	  in	  dyn.sec.cm-­‐5;	  MBP	  =	  mean	  blood	  pressure	  (mmHg);	  CO	  is	  cardiac	  output	  (l/min).181	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5.1.3.4. Intravascular	  Ultrasound	  	  Intravascular	   Ultrasound	   (IVUS)	   was	   undertaken	   on	   the	   day	   following	   the	   MRI	  scan.	   Catheterisation	   is	   performed	   under	   general	   anaesthesia	   for	   children	   and	  adolescents,	  according	  to	  institutional	  protocol,	  but	  for	  older	  adolescents	  or	  young	  adults,	   performance	   under	   local	   anaesthesia	   is	   encouraged.	   Catheterisation	   and	  IVUS	   were	   only	   performed	   as	   clinically	   indicated	   for	   annual	   review.	   IVUS	   was	  performed	   in	   the	   left	   anterior	   descending	   coronary	   artery	   with	   automated	  pullback	   at	   0.5mm/s.	   Typically,	   the	   imaging	   has	   a	   temporal	   resolution	   of	   30	  frames/second.	  A	  suitable	  length	  of	  vessel	  was	  imaged	  to	  allow	  analysis	  of	  at	  least	  30	   evenly	   spaced	   cross-­‐sectional	   images	   (at	   approximately	   1.5mm	   intervals).	  Maximal	   and	   mean	   intimal	   thicknesses	   were	   recorded	   as	   measures	   of	   CAV	  burden.23,	  25	  In	  addition,	  a	  semi-­‐automatic	  interactive	  edge-­‐detection	  software	  was	  used	   (QIVUS	   Clinical	   Edition,	   Medis	   medical	   imaging	   systems,	   Leiden,	  Netherlands)	  to	  improve	  reproducibility	  of	  measurements.27	  	  	  
5.1.3.5. Data	  analysis	  	  First,	   measures	   of	   central	   arterial	   stiffness	   and	   TPR	   were	   tested	   using	   single	  sample	  t-­‐test	  against	  known	  normal	  mean	  values	  for	  adolescents	  (β	  index	  of	  2.5;	  PWV	  of	  3.3	  m/s	  and	  TPR	  of	  1144	  dyn.sec.cm-­‐5).181,	  182	  Then,	  bivariate	  correlation	  between	   indices	   of	   coronary	   intimal	   disease	   on	   IVUS	   and	   measures	   of	   central	  arterial	  stiffness	  or	  TPR	  was	  performed.	  PWV	   associations	   were	   further	   explored	   by	  multivariate	   linear	   regressions	   and	  forward	   stepwise	   addition	   of	   blood	   pressure	   indices,	   age	   and	   time	   since	  transplant.	   These	   variables	   were	   chosen	   due	   to	   the	   known	   interdependence	   of	  stiffness,	  blood	  pressure	  and	  age.	  Furthermore,	  a	  previous	  study	  in	  children	  after	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heart	   transplantation	   identified	   time	   since	   transplantation	   as	   a	   predictor	   of	  PWV.187	  Only	  these	  important	  variables	  were	  included,	  as	  the	  study	  size	  would	  not	  allow	   more	   variables.	   Furthermore,	   included	   variables	   were	   only	   kept	   in	   the	  analysis	  if	  they	  improved	  model	  fit.	  	  Statistical	   analysis	   was	   performed	   on	   SPSS	   version	   19	   (Release	   19.0.0,	   IBM	  Software	  Group,	  New	  York,	  USA).	  Results	  are	  quoted	  as	  mean	  ±	  standard	  deviation	  and	  a	  p	  value	  of	  <0.05	  was	  considered	  significant.	  	  	  
5.1.4. Results	  	  
	  
5.1.4.1. Subjects	  	  	  Ten	  children	  (5	  male)	  participated	  in	  this	  study.	  Mean	  age	  was	  16	  ±	  2	  years	  (range	  12	  to	  17	  years)	  and	  mean	  time	  since	  transplant	  was	  4	  ±	  4	  years	  (range	  0.3	  to	  13	  years).	   Mean	   intimal	   thickness	   was	   0.22	   ±	   0.12	   mm	   and	   maximum	   intimal	  thickness	  was	  0.66	  ±	  0.42	  mm.	  Seven	  children	  were	  diagnosed	  as	  hypertensive	  and	  were	  on	  treatment.	  Of	  these,	  four	  were	  diagnosed	  with	  isolated	  systolic	  hypertension.	  All	  seven	  children	  were	  on	   calcium	   channel	   antagonists	   and	   two	   were	   additionally	   taking	   angiotensin	  converting	   enzyme	   inhibitors	   for	   blood	   pressure	   control.	   During	   MRI,	   diastolic	  blood	  pressures	  were	  normal	  (i.e.	  below	  95th	  centile	  for	  age	  and	  height;	  mean	  72	  ±	  10	  mmHg;	   range	   50	   to	   82	  mmHg)	  whereas	   three	   systolic	   blood	   pressures	  were	  raised	  (mean	  123	  ±	  11	  mmHg;	  range	  101	  to	  137	  mmHg).	  A	  descriptive	  summary	  of	  variables	  is	  given	  in	  (Table	  14).	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Table	  14.	  Descriptive	  summary	  of	  variables	  for	  pulse	  wave	  velocity	  study	  
5.1.4.2. Comparisons	  	  	  Pulse	   wave	   velocity	   was	   significantly	   higher	   when	   compared	   to	   previously	  published	   reference	   population	   of	   similar	   age	   (4.5	   vs.	   3.3	   m/s;	   p=0.002).	   Beta	  index	  was	  not	   raised	  significantly	   (3.2	  vs.	  2.5	   in	  normal	  volunteers;	  p=0.17)	  and	  neither	   was	   TPR	   significantly	   raised	   (1245	   vs.	   1144	   dyn.sec.cm-­‐5	   in	   normal	  volunteers;	  p=0.08)	  Bivariate	   Correlation:	   PWV	   was	   significantly	   positively	   correlated	   with	   CAV	  burden	  as	  measured	  by	  maximal	   intimal	   thickness	   (Pearson’s	  Coefficient	  =	  0.66;	  p=0.036)	   and	   by	  mean	   intimal	   thickness	   (Pearson’s	   Coefficient	   =	   0.71;	   p=0.02).	  Arterial	   stiffness	   β	   index	   also	   has	   significant	   positive	   correlations	   with	   these	  indices	   of	   CAV	   burden	   (Coefficient	   =	   0.74	   and	   0.78;	   p=0.014	   and	   0.008	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respectively).	   TPR	   does	   not,	   however,	   correlate	   with	   these	   measures	   of	   CAV	  (Coefficients	  =	  -­‐0.015	  and	  -­‐0.001;	  p=0.97	  and	  0.98	  respectively).	  	  
5.1.4.3. Multivariate	  regression	  	  As	  explained	  above,	  blood	  pressure	  parameters	  at	   the	   time	  of	   imaging,	  age,	   time	  post-­‐transplant	   and	   PWV	   were	   added	   into	   the	   linear	   model	   for	   mean	   intimal	  thickness	   prediction	   in	   a	   forward	   stepwise	  manner.	   Only	   PWV	   remained	   in	   the	  model	   after	   exclusions	   of	   variables	   not	   improving	  model	   fit.	   PWV	  was	   the	   only	  independent	  predictor	  of	  CAV	  burden	  (R2=0.51;	  p=0.02).	  The	  result	  is	  not	  changed	  if	   previous	   clinic	   blood	   pressures	   are	   used	   for	   the	  model	   (prior	   to	   initiation	   of	  antihypertensives).	  	  
5.1.5. Discussion	  	  We	  have	  demonstrated	   in	   this	  study	  that	  central	  arterial	  stiffness	   is	   increased	   in	  patients	  after	  heart	  transplantation.	  Furthermore,	  PWV	  correlates	  with	  CAV	  in	  the	  multivariate	  analysis	   independently	  of	  closely	  related	  variables	  such	  as	  age,	  time	  post-­‐transplant	  and	  blood	  pressure.	  TPR	  is	  a	  measure	  of	  arteriolar	  constriction	  or	  disease	   and	   does	   not	   have	   a	   direct	   relationship	   with	   central	   aortic	   stiffness.188	  Congruent	  with	  this	  fact,	  we	  did	  not	  demonstrate	  a	  significant	  increase	  in	  TPR	  in	  these	   patients,	   nor	   did	   we	   find	   a	   relationship	   between	   TPR	   and	   CAV.	   The	  implications	  and	  insights	  from	  these	  findings	  deserve	  attention.	  Arterial	   stiffness,	   as	   measured	   by	   PWV,	   is	   a	   well-­‐documented	   predictor	   of	  cardiovascular	  events	  in	  the	  setting	  of	  conventional	  atherosclerosis.69-­‐74	  The	  use	  of	  PWV	  as	  a	  predictor	  for	  coronary	  allograft	  vasculopathy	  has	  been	  suggested	  but	  not	  well	   investigated.189	   Our	   study	   demonstrates	   PWV	   does	   have	   a	   moderate	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correlation	  with	  extent	  of	  CAV.	  However,	  we	  cannot	  extrapolate	  whether	  central	  arterial	  stiffness	  is	  a	  cause	  or	  effect	  of	  CAV.	  We	   know	   that,	   in	   adults,	   hypertension	   has	   been	   significantly	   associated	   with	  angiographic	   onset	   of	   CAV.179	   Furthermore,	   Calcium	   channel	   antagonists	   have	  been	  shown	  to	  prevent	  CAV.190	  If	  taken	  in	  combination	  with	  our	  findings	  regarding	  central	   arterial	   stiffness,	  we	  may	  be	   lead	   to	  believe	   that	   stiffness	   is	   a	  modifiable	  risk	  factor	  in	  the	  pathogenesis	  of	  CAV.	  However,	   we	   should	   also	   note	   that	   certain	   insults	   such	   as	   cytomegalovirus	  infection	   result	   in	   coronary	   endothelial	   insult191	   and,	   in	   children,	   could	   cause	  chronic	   systemic	   inflammatory	   endothelial	   insult.192	   It	   may	   be	   that	   increased	  arterial	  stiffness	  results	  from	  these	  types	  of	  systemic	  inflammatory	  insults	  that	  are	  also	   related	   to	   CAV.	   	   In	   support	   of	   this,	   systemic	   inflammation	   in	   the	   general	  population	   is	   associated	   with	   increased	   arterial	   stiffness.193	   Furthermore,	   our	  results	  may	  not	   be	   due	   to	   any	   direct	   relationship	   between	  CAV	   and	   arterial	   but	  rather	  because	  another	  risk	  factor	  such	  as	  rejection	  or	  CMV	  influences	  both	  PWV	  and	  CAV.	  A	  wider	  study	  may	  help	  answer	  such	  questions.	  Isolated	  systolic	  hypertension	  is	  usually	  found	  in	  elderly	  patients	  and	  is	  the	  typical	  pattern	  of	  blood	  pressure	  increase	  seen	  with	  increased	  arterial	  stiffness.194,	  195	  In	  our	   study,	  4	  out	  of	  7	  of	   the	  patients	  with	  hypertension	  did	   in	   fact	   show	   isolated	  systolic	   hypertension.	   	   In	   comparison,	   a	   previous	   study	   in	   children	   showed	   that	  diastolic	  blood	  pressure	  increase	  after	  heart	  transplantation	  was	  more	  common	  in	  children	   whereas	   isolated	   systolic	   hypertension	   was	   relatively	   uncommon.79	  However,	   the	   cohort	   described	   in	   our	   study	   is	   older	   (median	   16.5	   years	   vs.	   6.3	  years	   in	   previous	   study)	   and	   this	   may	   explain	   the	   difference.	   Indeed	   older	  recipient	  age	  has	  been	  previously	   found	   to	  be	   the	  major	   recipient	   risk	   factor	   for	  
Chapter	  5:	  Aortic	  Imaging	  and	  Correlates	  with	  Cardiovascular	  Disease	  
	   	   168	  
the	   development	   of	   CAV	   in	   children.6	   If	   isolated	   systolic	   hypertension	   is	   indeed	  more	   common	   in	   older	   recipients,	   this	  may	   be	   one	   factor	   related	   to	   the	   earlier	  development	   of	   CAV.	   There	   is	   some	   support	   for	   that	   theory	   from	   another	   PWV	  study	   in	   children,	   by	   Klinge	   et	   al,	   which	   showed	   that	   children	   after	   heart	  transplantation	   had	   increased	   arterial	   stiffness	   which	  was	   associated	  with	   both	  age	  and	  length	  of	  time	  since	  transplant.187	  	  Another	  important	  point	  to	  note	  from	  the	  multivariate	  analysis	  was	  that	  PWV	  had	  an	   independent	   and	   even	   more	   important	   relationship	   to	   CAV	   than	   blood	  pressure.	  Indeed,	  a	  recent	  study	  in	  healthy	  volunteers	  showed	  that	  increased	  PWV	  in	  volunteers	  could	  predict	  an	  increase	  in	  blood	  pressure	  over	  time	  and	  the	  onset	  of	  future	  hypertension.196	  Hence,	  another	  potential	  future	  study	  would	  be	  to	  trial	  the	  treatment	  of	  raised	  arterial	  stiffness	  to	  prevent	  the	  onset	  of	  both	  hypertension	  and	  CAV.	  However,	   in	   this	   study,	   TPR	  was	   not	   significantly	   raised	   in	   children	   after	   heart	  transplantation	   compared	   to	   previously	   published	   reference	   population.	   Raised	  TPR	   is	   often	   found	   in	   young	   adult	   hypertensives	   causing	   upstream	   increase	   in	  transmural	  pressure	  resulting	  in	  stretching	  and	  stiffening	  of	  large	  central	  arteries	  and	  typically	  presents	  with	  elevated	  diastolic	  BP.194	  This	  type	  of	  hypertension	  may	  better	  explain	  the	  rise	  in	  arterial	  stiffness	  and	  diastolic	  blood	  pressure	  seen	  in	  the	  younger	  heart	  transplant	  recipients	  described	  by	  Klinge	  et	  al.187	  Our	   study	   was	   an	   exploratory	   study	   to	   investigate	   the	   relationship	   between	  arterial	  stiffness	  and	  CAV.	  The	  use	  of	  MRI	  in	  this	  regard	  is	  invaluable	  offering	  rapid	  assessment	   of	   numerous	   physiological	   variables.	   PWV	   is	   now	   regarded	   as	   the	  gold-­‐standard	  measure	  of	  arterial	  stiffness.197	  In	  the	  clinic	  setting,	  it	  can	  be	  rapidly	  acquired	   in	   a	   non-­‐invasive	   &	   child-­‐friendly	   manner	   using	   carotid-­‐femoral	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tonometry.	  Given	  the	  ease	  of	  acquisition,	  this	  study	  clearly	  demonstrates	  the	  need	  for	  further	  investigation	  of	  the	  utility	  of	  PWV	  in	  heart-­‐transplant	  medicine.	  We	   took	   care	   in	   the	   acquisition	   and	   analysis	   of	   this	   data.	   This	   was	   the	   reason	  behind	   adding	   a	   traditional	   independent	   image-­‐based	  method	   to	   assess	   arterial	  stiffness,	  the	  β	  index.	  Analyses	  using	  this	  variable	  may	  lend	  support	  to	  our	  findings	  further	  because	  the	  β	  index	  was	  higher	  in	  our	  study	  patients	  compared	  to	  normal	  volunteers	  (although	  not	  significantly	  perhaps	  due	  to	  study	  size)	  and	  because	  the	  β	   index	  also	  showed	  significant	  positive	  correlation	  with	  CAV	  disease	  burden	  on	  IVUS.	   Further	   care	   was	   taken	   to	   limit	   the	   multivariate	   analysis	   to	   specific	  important	  variables	   in	  a	   stepwise	  approach.	  Nevertheless,	   this	   study	   remains	  an	  exploratory	   one	   demonstrating	   only	   moderate	   correlation.	   Further	   study	   is	  warranted	   to	   confirm	   this	   observation.	   In	   addition,	   it	   is	   difficult	   to	   draw	  conclusions	   from	   our	   study	   regarding	   resistance	   at	   the	   arteriolar	   level	   due	   to	  concomitant	  use	  of	  vasodilators.	  Potentially,	   PWV	   is	   not	   only	   a	   biomarker	   but	   also	   a	   means	   by	   which	   to	   better	  understand	  the	  contribution	  of	  hypertension	  to	  CAV.	  The	  methodology	  described	  here	  helps	  us	   to	  non-­‐invasively	   classify	  hypertension	  and	  arterial	   stiffness	  using	  MRI.	   This	   will	   not	   only	   help	   to	   tailor	   therapy	   but	   will	   give	   us	   a	   better	  understanding	  of	  the	  pathophysiology	  of	  endothelial	  damage	  in	  CAV.	  	  Conclusion:	   In	   this	   study	  we	  observe	   that	   central	   arterial	   stiffness,	  measured	  by	  pulse	   wave	   velocity,	   correlates	   with	   coronary	   allograft	   vasculopathy	  independently	   of	   age,	   blood	   pressure	   or	   length	   of	   time	   since	   transplant.	   We	  believe	   that	   central	   PWV	   may	   have	   potential	   as	   an	   early	   biomarker	   or	   as	   a	  modifiable	  risk	  factor	  in	  the	  setting	  of	  coronary	  allograft	  vasculopathy.	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5.2. Zoom	   Imaging	   for	   Rapid	   Aortic	   Vessel	   Wall	   Imaging	   and	  
Cardiovascular	  Risk	  Assessment	  	  
	  In	  sub-­‐chapter	  5.1,	  we	  discussed	  the	  potential	  value	  of	  measuring	  central	  arterial	  stiffness	  as	  a	  marker	  for	  CAV.	  For	  future	  study	  of	  central	  arterial	  stiffness,	  it	  is	  important	  to	  investigate	  the	  mechanism	  of	  the	  increase	  in	  this	  stiffness	  that	  occurs	  in	  these	  patients.	  In	  order	  to	  this	  this,	  rapid	  anatomical	  aortic	  vessel	  wall	  imaging	  is	  required	  to	  assess	  vessel	  wall	  thickness	  and	  plaque	  formation	  is	  desirable.	  In	  this	  sub-­‐chapter,	  we	  consider	  the	  use	  of	  ‘zoom	  imaging’	  to	  accelerate	  anatomical	  black-­‐blood	  imaging	  of	  the	  aorta.	  The	  further	  potential	  implication	  for	  this	  sequence	  in	  the	  wider	  setting	  of	  atherosclerosis	  is	  discussed	  in	  detail.	  	  
5.2.1. ABSTRACT	  
Purpose:	  To	   demonstrate	   the	   utility	   of	   a	   ‘reduced	   field-­‐of-­‐view’	   (zoom	   imaging)	  technique	   to	   accelerate	   free-­‐breathing,	   ECG-­‐triggered,	   turbo-­‐spin-­‐echo	   black-­‐blood	  sequences,	  which	  have	  been	  previously	  described	  to	  detect	  subclinical	  aortic	  atherosclerosis.	  Materials	  and	  Methods:	  Fifteen	  healthy	  volunteers	  underwent	  MRI	  of	   the	   thoracic	   and	  abdominal	   aorta.	   Imaging	  with	   the	   conventional	   full	   field-­‐of-­‐view	  sequence	  was	  compared	  to	  zoom	  imaging.	  Total	  scan	  time,	  image	  quality	  (i.e.	  contrast-­‐to-­‐noise	  ratio	  and	  vessel	  wall	  sharpness)	  and	  vessel	  wall	  thickness	  were	  analysed.	   A	   subgroup	   of	   ten	   volunteers	   also	   underwent	   acceleration	   of	   imaging	  using	   sensitivity	   encoding	   (SENSE)	   for	   comparison.	   Results:	   Zoom	   imaging	  significantly	   reduced	   imaging	   time	   from	   a	  mean	   of	   41±9	  minutes	   (conventional	  imaging)	   to	   15±0.5	  minutes	   (p<0.01).	   There	  was	   no	   difference	   in	   image	   quality	  between	  conventional	  and	  zoom	  imaging	  with	  respect	  to	  CNR	  (10.1±6	  vs.	  10.1±6)	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or	  vessel	  wall	   sharpness	   	   (38±4%	  vs.	  39±4%).	  Furthermore,	  Bland	  Altman	  plots	  showed	  excellent	  agreement	  in	  vessel	  wall	  thickness	  measurements	  using	  the	  two	  methods.	   In	   comparison,	   SENSE	   not	   only	   reduced	   CNR	   but	   also	   resulted	   in	  underestimation	  of	  vessel	  wall	  thickness	  compared	  to	  the	  conventional	  sequence.	  
Conclusion:	   Zoom	   imaging	   allows	   accurate	   and	   time-­‐efficient	   imaging	   of	   the	  abdominal	   and	   thoracic	   aorta	   for	   cardiovascular	   risk	   prediction.	   In	   this	  application,	  it	  is	  preferable	  to	  SENSE.	  
	  
5.2.2. INTRODUCTION	  Atherosclerosis	  remains	  the	  leading	  cause	  of	  mortality	  and	  morbidity	  in	  developed	  countries.127,	   128	   Appropriate	   therapy	   in	   asymptomatic	   individuals	   has	   the	  potential	   to	   reduce	   risk	   at	   the	   population	   level	   but	   there	   remains	   significant	  concerns	   about	   the	   applicability	   of	   currently	   available	   risk	   scores	   to	   guide	   such	  therapy.198	  A	  more	  acceptable	  approach	  would	  be	  to	   identify	   individuals	  with	  an	  appreciable	  atherosclerotic	  burden	  at	  an	  asymptomatic	  stage	  and	   to	   target	   them	  for	  treatment.	  Thoracic	  aortic	  plaque	  burden	  correlates	  closely	  with	  the	  coronary	  arterial	  plaque	  burden.199	  The	  extent	  of	  thoracic	  atherosclerosis	  may	  be	  a	  stronger	  predictor	  of	  coronary	  artery	  disease	  than	  conventional	  risk	  factors	  200	  and	  may	  be	  a	   stronger	   predictor	   than	   even	   carotid	   or	   femoral	   artery	   plaque	   burden	   as	  detected	  by	  ultrasound.201	  For	  this	  reason,	  a	  free-­‐breathing	  ECG	  triggered,	  turbo-­‐spin-­‐echo	   (TSE)	   black-­‐blood	   sequence	   has	   been	   described	   to	   detect	   subclinical	  aortic	  atherosclerosis	  and	  the	  value	  of	  this	  sequence	  to	  stratify	  cardiovascular	  risk	  has	   been	   demonstrated	   in	   more	   than	   2000	   participants	   recruited	   from	   the	  Framingham	   population.202-­‐204	   Routine	   use	   of	   this	   sequence	   for	   aortic	   plaque	  screening	  is	  challenging	  due	  to	  the	  relatively	  long	  imaging	  time.	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Oyama	  et	  al	  described	   this	  aortic	  wall	   cardiovascular	  magnetic	   resonance	   (CMR)	  imaging	   sequence	   encompassing	   the	   aorta	   from	   the	   arch	   to	   the	   aortoiliac	  bifurcation	  using	  5mm	  slices	  imaged	  in	  the	  transverse	  plane.	  Total	  aortic	  imaging	  time	  is	  stated	  as	  less	  than	  twenty	  minutes.204	  In	  order	  to	  achieve	  this,	  however,	  24	  slices	   were	   obtained	   with	   a	   slice	   gap	   of	   10mm.	   It	   is	   acknowledged	   that	   denser	  sampling	  of	  the	  aorta	  was	  not	  possible	  due	  to	  time	  constraints.	  	  Previous	   studies	   have	   demonstrated	   how	   zoom	   imaging	   can	   be	   used	   for	   rapid	  small	   field	   of	   view	   (FOV)	   imaging	   during	   percutaneous	   interventions.205	   Zoom	  imaging	   is	   implemented	   for	   TSE	   techniques	   by	   having	   the	   slice-­‐selection	   and	  refocusing	   gradients	   perpendicular	   to	   each	   other.	   By	   doing	   this,	   refocusing	   of	  spins	  only	  occurs	  in	  the	  section	  that	  is	  crossed	  by	  both	  gradients	  and	  so,	  a	  narrow	  field	  of	  view	  can	  be	  imaged	  without	  wraparound	  artefacts.	  Hence,	  imaging	  time	  is	  substantially	  reduced	  (Figure	  34).	  This	  study	  seeks	  to	  demonstrate	  the	  use	  of	  the	  ‘reduced	   FOV’	   or	   more	   recently	   renamed	   ‘zoom	   imaging’,	   technique	   for	  accelerating	  aortic	  vessel	  wall	   imaging.	  This	  would	  allow	  denser	  sampling	  of	   the	  aorta	  with	  a	  reduced	  imaging	  time.	  In	  this	  study,	  we	  sought	  to	  investigate	  how	  the	  use	  of	  zoom	  imaging	  compares	  with	  the	  standard	  non-­‐accelerated	  black	  blood	  TSE	  technique	  with	  respect	  to	  image	  quality	  and	  image	  analysis	  and	  how	  it	  compares	  with	  rapid	  black	  blood	  imaging	  with	  SENSE	  reconstruction.	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Figure	  34.	  Zoom	  Pulse	  Sequence	  
At	  the	  top	  of	  this	  diagram,	  the	  zoom	  TSE	  pulse	  sequence	  timing	  to	  the	  ECG	  is	  
shown.	  The	  bottom	  panel	  in	  the	  figure	  shows	  more	  detail	  of	  the	  TSE	  block	  for	  
zoom	   imaging.	   In	   the	   zoom	   TSE	   sequence,	   the	   excitation	   and	   refocusing	  
pulses	  are	  in	  orthogonal	  planes,	  allowing	  a	  small	  FOV	  without	  wrap-­‐around	  
artifact.	   This	   bottom	   TSE	   panel	   only	   shows	   the	   first	   90-­‐degree	   and	   180-­‐
degree	   pulse:	   Subsequent	   180-­‐degree	   pulses	   are	   not	   shown	   but	   are	   just	   a	  
copy	   of	   the	   first	   180-­‐degree	   pulse.	   (RF	   =	   radiofrequency	   pulse;	   S	   =	   slice	  
selection;	  P	  =	  phase	  encoding).	  
	  
5.2.3. MATERIALS	  AND	  METHODS	  Institutional	  Review	  Board	  Approval	  was	  obtained	  prior	  to	  commencing	  this	  study	  (Local	  Research	  Ethics	  Committee	  Ref	  EC04/015).	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5.2.3.1. MR	  Imaging	  Fifteen	   healthy	   volunteers	   underwent	   CMR	   of	   the	   thoracic	   and	   abdominal	   aorta	  using	   a	   1.5T	   Achieva	   clinical	   MR	   scanner	   (Philips	   Healthcare,	   Best,	   NL).	   Aortic	  vessel	   wall	   images	   were	   obtained	   using	   a	   five-­‐element	   cardiac	   phased-­‐array	  receiver	   coil.	   An	   initial	   survey	   and	   reference	   scan	   were	   acquired	   to	   obtain	   coil	  sensitivity	   maps.	   Subsequently,	   sixty-­‐six	   transverse	   slices	   encompassing	   the	  thoracic	   and	   abdominal	   aorta	   down	   to	   the	   aorto-­‐iliac	   bifurcation	  were	   obtained	  using	  a	  free-­‐breathing	  ECG-­‐triggered,	  black-­‐blood	  2D	  TSE	  sequence.	  The	  66	  slices	  were	  acquired	  in	  2	  slabs	  consisting	  of	  33	  slices.	  The	  echo-­‐train	  length	  was	  12	  and	  the	  acquired	  matrix	  was	  224	  x	  208	  (acquired	  resolution	  0.98	  x	  1.06mm).	  Thoracic	  imaging	   was	   respiratory	   navigator-­‐gated	   using	   an	   8mm	   navigator	   window	  whereas,	   for	   abdominal	   aorta	   imaging,	   respiratory	   motion	   correction	   was	   not	  used.	   The	   receiver	   coil	  was	   repositioned	   after	   the	   thoracic	   aorta	  was	   imaged	   to	  allow	   abdominal	   aorta	   imaging.	   A	   5mm	   slice-­‐thickness	   was	   used	   and	   partial	  Fourier	   imaging	   (factor	   =	   0.75)	   was	   used	   to	   further	   shorten	   scan	   time.	   Other	  imaging	  parameters	   included:	  pixel	  bandwidth	  416,	   repetition	   time	  of	   two	  heart	  beats,	  one	   signal	  average,	   shortest	   trigger	  delay	   (~500	  ms),	   echo	   time	  of	  5.0	  ms	  and	  60ms	  acquisition	  window.	  Imaging	  was	  performed	  with	  zoom	  imaging	  (FOV	  =	  220mm	  x	  67mm).	  The	  five	  central	  abdominal	  and	  thoracic	  slices	  within	  each	  of	  the	  respective	  two	  slabs	  of	  33	  slices	  were	  then	  repeated	  without	  zoom	  imaging	  (FOV	  =	  220mm	  x	  220mm)	  for	  comparison.	  	  	  Use	  of	  sensitivity-­‐encoding	  (SENSE)	  acceleration	  would	  be	  an	  alternative	  method	  to	   shorten	   imaging	   time.	   Hence,	   ten	   of	   the	   fifteen	   volunteers	   also	   underwent	  repeat	   TSE	   black	   blood	   imaging	   of	   the	   same	   5	   central	   abdominal	   and	   thoracic	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slices	   using	   undersampled	   data	   acquisition	   and	   SENSE	   reconstruction	   with	   an	  acceleration	  factor	  of	  2.	  	  	  
5.2.3.2. Image	  Analysis	  Scan	   times,	   signal-­‐to-­‐noise	   ratios	   (SNR)	  and	   contrast-­‐to-­‐noise	   ratios	   (CNR)	  were	  analysed	   for	   conventional	   non-­‐accelerated	   TSE	   black	   blood	   imaging	   and	   for	   the	  zoom	   imaging	   sequence.	   For	   accelerated	   TSE	   black	   blood	   imaging	   using	   SENSE	  reconstruction,	   only	   scan	   times	   and	   CNR	  were	   analysed.	   The	   full	   sixty-­‐six	   slices	  were	   acquired	   for	   the	   zoom	   imaging	   sequence	   whilst	   only	   central	   slices	   were	  acquired	   for	   the	   non-­‐	   and	   SENSE	   accelerated	   full	   FOV	   sequences.	   Hence,	   the	  corresponding	   respective	   central	   imaging	   slices	   were	   identified	   and	   used	   for	  image	  quality	  analyses.	  Additionally,	  image	  analysis	  of	  aortic	  vessel	  wall	  sharpness	  and	   vessel	   wall	   thickness	   was	   compared	   between	   the	   conventional	   and	  accelerated	  (zoom	  imaging	  and	  SENSE)	  imaging	  techniques	  using	  the	  ‘SoapBubble’	  software	   analysis	   tool.147	   Using	   this	   tool,	   the	   local	   vessel	  wall	   sharpness	   can	   be	  calculated	   in	  percent	  by	  normalising	   the	  magnitude	  of	   the	   local	   change	   in	   signal	  intensity	  (using	  a	  Deriche	  filter)	  at	  the	  selected	  vessel	  wall	  border	  to	  the	  average	  signal	   intensity	   of	   the	   centerline	   of	   the	   selected	   vessel	   wall.147,	   148	   In	   brief,	   this	  algorithm	   calculates	   an	   edge	   image	   using	   a	   first-­‐order	   derivative	   of	   the	   input	  image.	  A	  vessel	  sharpness	  of	  100%	  refers	  to	  a	  maximum	  signal	  intensity	  change	  at	  the	  vessel	  wall	  border.	  Sharpness,	   as	  a	  measure	  of	  edge	  detection,	   is	  useful	  as	   it	  gives	  a	  measure	  of	   the	  ability	   to	  quantify	  vessel	  wall	  parameters	   such	  as	  plaque	  volume.	  The	  “Soapbubble”	  software	  permits	  application	  of	  automated	  algorithms	  for	   sharpness	  with	   standardised	   comparisons	   of	   different	   imaging	   sequences.105	  Time	   for	   imaging	  without	  zoom	  was	  calculated	  by	   taking	   the	  nominal	   time	   from	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the	  scanner	  console	  for	  all	  sixty-­‐six	  slices	  whilst	  planning	  and	  allowing	  for	  exactly	  the	  same	  navigator	  efficiency	  as	  the	  zoom	  sequence.	  SNR	  was	  defined	  according	  to	  the	  difference	  in	  repeated	  images.	  This	  SNRdiff	  in	  an	  ROI	  (region	  of	  interest	  in	  the	  aortic	  vessel	  wall)	  is	  calculated	  as	  the	  quotient	  of	  the	  mean	  value	   (with	   respect	   to	   the	  ROI)	  of	   the	   signal	   in	   the	   sum	   image	  and	   the	  SD	  (evaluated	   in	   the	  same	  ROI)	  of	   the	  signal	   in	   the	  difference	   image,	  divided	  by	   the	  factor	  √2.206	  CNR	  was	  defined	  according	  to	  the	  following	  formula:	  
CNR	   =	   Signal	  Mean	  (aortic	  vessel	  wall)	  -­‐	  Signal	  Mean	  paraspinal	  muscle	  
	   	   0.5*(SDEVaortic	  vessel	  wall	  signal	  +	  SDEVparaspinal	  muscle	  signal)	  
	  
5.2.3.3. Statistical	  Analyses	  Statistical	   analyses	   were	   performed	   using	   SPSS	   version	   18	   (IBM,	   Chicago,	   USA).	  SNR,	   CNR	   and	  Vessel	  wall	   sharpness	  were	   compared	   between	   conventional	   and	  zoom	  imaging	  techniques	  using	  paired	  t-­‐tests.	  CNR	  and	  vessel	  wall	  sharpness	  were	  compared	   between	   conventional	   and	   SENSE	   imaging	   techniques	   using	   paired	   t-­‐tests.	  	  Agreement	   between	   conventional	   and	   accelerated	   imaging	   techniques	   for	   vessel	  wall	   thickness	   analysis	   was	   investigated	   by	   the	   use	   of	   a	   Bland-­‐Altman	   plot.	  Reproducibility	   of	   vessel	  wall	   thickness	  measurements	   between	   techniques	  was	  further	  assessed	  using	  intra-­‐class	  correlation.	  
	  
5.2.4. RESULTS	  15	  healthy	  volunteers	  (4	  male)	  were	  recruited	  for	  this	  study	  with	  a	  mean	  age	  of	  33	  years	  (range	  25	  to	  75	  years)	  and	  a	  mean	  heart	  rate	  of	  72bpm	  (range	  54	  to	  95).	  In-­‐
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plane	  spatial	  image	  resolution	  was	  0.98	  x	  1.06mm	  (0.31	  x	  0.30mm	  reconstructed).	  Mean	  navigator	  efficiency	  was	  55±9%	  (range	  40	  to	  70%).	  All	  CNR,	  SNR,	  sharpness	  and	   time	   parameters	   for	   the	   different	   groups	   were	   normally	   distributed	   (as	  confirmed	  by	  the	  One-­‐Sample	  Kolmogorov-­‐Smirnov	  Test	  for	  normality).	  	  
5.2.4.1. Zoom	  Imaging	  Zoom	   imaging	   significantly	   reduced	   total	   (abdomen	   and	   thorax)	   imaging	   time	  from	  a	  mean	  of	  41±9	  minutes	  with	  conventional	  non-­‐accelerated	  full	  FOV	  imaging	  to	   a	   mean	   of	   15±0.5	  minutes	   (p<0.01).	   There	   was	   a	   trend	   towards	   higher	   SNR	  without	   zoom	   imaging	   (11.8±5.7	   vs.	   14.0±3.7;	   p=0.1).	   However,	   CNR	   was	  comparable	  at	  a	  mean	  of	  10.1±6	  with	  zoom	  imaging	  and	  10.1±6	  without	  (p=0.99).	  More	  importantly,	  aortic	  vessel	  wall	  sharpness	  was	  also	  comparable	  at	  a	  mean	  of	  39±4%	  with	  zoom	  imaging	  and	  38±4%	  at	  full	  FOV	  (p=0.21).	  	  Furthermore,	   there	   was	   no	   difference	   in	   aortic	   vessel	   wall	   thickness	   (mean	  1.70±0.14mm	   with	   zoom	   and	   1.72±0.14mm	   at	   full	   FOV;	   p=0.2).	   Aortic	   wall	  thickness	  measures	  showed	  excellent	  agreement	  on	  Bland-­‐Altman	  analysis	  with	  a	  negligible	   mean	   bias	   of	   0.02	  mm	   (Figure	   35)	   and	   the	   95%	   limits	   of	   agreement	  between	  the	  two	  methods	  ranged	  from	  -­‐0.09	  (95%	  CI	  -­‐0.31,	  0.14)	  to	  0.13	  (95%	  CI	  -­‐0.10,	   0.35)	   mm.	   Good	   reproducibility	   of	   measurements	   between	   the	   two	  techniques	  is	  shown	  by	  the	  Intraclass	  Correlation	  (ICC	  =	  0.91,	  95%	  CI	  (0.82,	  0.96)).	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Figure	  35.	  Bland-­‐Altman	  plot	  (zoom)	  
Aortic	  wall	  thickness	  using	  standard	  TSE	  imaging	  minus	  thickness	  using	  
Zoom	  TSE	  imaging.	  Image	  slice	  thickness	  used	  was	  5	  mm	  and	  the	  in-­‐	  plane	  
resolution	  was	  0.98	  x	  1.06	  mm.	  
5.2.4.2. SENSE	  acceleration	  Parallel	  imaging	  with	  SENSE	  reconstruction	  and	  a	  reduction	  factor	  of	  2	  in	  the	  phase	  encoding	  direction	  was	  used	  for	  ten	  of	  the	  volunteers.	  This	  technique	  also	  significantly	  reduced	  imaging	  time	  (26	  ±	  7	  minutes	  vs.	  39	  ±	  10	  minutes	  for	  conventional	  full	  FOV;	  p<0.01),	  although	  this	  was	  still	  substantially	  longer	  than	  with	  the	  zoom	  imaging	  sequence.	  Furthermore,	  CNR	  using	  SENSE	  (5.4	  ±	  3.5)	  was	  also	  significantly	  lower	  than	  for	  conventional	  full	  FOV	  imaging	  (9.8±3.5)	  (p	  =0.007).	  Vessel	  wall	  sharpness	  was	  comparable	  between	  the	  two	  techniques	  (39±5%	  using	  SENSE	  and	  38±5%	  for	  conventional).	  However,	  Bland-­‐Altman	  plots	  for	  vessel	  wall	  thickness	  showed	  a	  significant	  mean	  bias	  of	  0.06mm	  (mean	  vessel	  wall	  thickness	  using	  SENSE:	  1.68	  ±	  0.14mm	  vs.	  1.74	  ±	  0.16mm	  for	  standard	  full	  FOV,	  p=0.02).	  95%	  limits	  of	  agreement	  are	  also	  wider	  than	  for	  zoom	  imaging	  (-­‐0.08	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(95%	  CI	  -­‐0.4,	  0.25)	  to	  0.20	  (95%	  CI	  -­‐0.13,	  0.52)	  mm)	  (Figure	  36).	  Reproducibility	  of	  measurements	  between	  the	  two	  techniques	  is	  shown	  by	  the	  Intraclass	  Correlation	  (ICC	  =	  0.82,	  95%	  CI	  (0.59,	  0.93)),	  which	  was	  not	  as	  good	  as	  for	  zoom	  imaging.	  	  
	  
Figure	  36.	  Bland-­‐Altman	  plot	  (traditional)	  
Aortic	  wall	  thickness	  using	  standard	  TSE	  imaging	  minus	  thickness	  using	  TSE	  
imaging	  with	  SENSE.	  Image	  slice	  thickness	  used	  was	  5	  mm	  and	  the	  in-­‐plane	  
resolution	  was	  0.98x1.06	  mm	  
Wraparound	  artefact	  was	  intermittently	  problematic	  for	  both	  conventional	  full	  FOV	  TSE	  and	  TSE	  with	  SENSE.	  Foldover	  suppression	  using	  saturation	  bands	  or,	  in	  the	  case	  of	  SENSE	  imaging,	  increase	  of	  the	  oversampling	  factor	  in	  the	  phase	  encoding	  direction	  during	  reconstruction	  was	  used	  to	  overcome	  this	  artefact.	  A	  sample	  of	  images	  is	  given	  in	  (Figure	  37)	  to	  show	  how	  lack	  of	  wraparound	  artefact	  with	  zoom	  imaging	  is	  a	  particular	  advantage	  of	  the	  technique.	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Figure	  37.	  Sample	  Images	  
Column	   A	   shows	   TSE	   black	   blood	   images	   using	   zoom.	   Column	   B	   Shows	  
conventional	   TSE	   Black	   Blood	   Images.	   Column	   C	   shows	   equivalent	   using	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SENSE	  acceleration.	  Row	  10	  displays	  one	  of	  the	  advantages	  of	  Zoom	  imaging,	  
i.e.,	   lack	   of	   problems	   associated	   with	   wrap-­‐around	   artifact.	   This	   is	   more	  
problematic	  with	  SENSE	  acceleration,	  as	  is	  shown	  in	  C10.	  FOV	  =	  field	  of	  view;	  
TSE	  =	  turbo	  spin	  echo.	  
	  
5.2.5. DISCUSSION	  It	   has	   previously	   been	   demonstrated	   that	   zoom	   imaging	   can	   be	   used	   for	   rapid	  small	   field	   of	   view	   imaging	   during	   percutaneous	   interventions.205	   This	   study	  demonstrates	   the	   use	   of	   zoom	   imaging	   to	   reduce	   imaging	   time	   for	   diagnostic	  cardiovascular	  aortic	  vessel	  wall	  imaging.	  We	  were	  able	  to	  reduce	  imaging	  time	  by	  63%	  with	   zoom	   imaging	  without	   loss	   of	   contrast-­‐to-­‐noise	   ratio	   (CNR)	   or	   vessel	  sharpness	   compared	   to	   previously	   used	   full	   FOV	   TSE	   imaging	   techniques.202-­‐204	  There	  was	   a	   trend	   towards	   lower	   SNR	  without	   affecting	   image	  quality	   or	   image	  analysis	  (in	  particular	  in	  the	  assessment	  of	  vessel	  wall	  thickness).	  	  In	   comparison	   to	   SENSE	   data	   acquisition	   acceleration,	   zoom	   imaging	   reduced	  imaging	   time	   more	   effectively	   and	   did	   not	   reduce	   CNR.	   However,	   most	  importantly,	   SENSE	   not	   only	   reduced	   CNR	   but	   also	   resulted	   in	   a	   small	   but	  significant	  underestimation	  of	  vessel	  wall	  thickness	  compared	  to	  the	  conventional	  non-­‐accelerated	  full	  FOV	  technique.202-­‐204	  The	  technique	  of	  zoom	  imaging,	  as	  described,	  achieves	  a	  reduction	  in	  the	  field	  of	  view	  by	  implementing	  excitation	  and	  refocusing	  pulses	  in	  orthogonal	  planes.	  As	  a	  result	  signal	  is	  produced	  only	  from	  the	  volume	  at	  the	  intersection	  of	  these	  pulses.	  Hence,	  a	  narrow	  field	  of	  view	  can	  be	  achieved	  without	  concerns	  regarding	  image	  aliasing.	   The	   acceleration	   achieved	   can	   be	   used	   to	   improve	   image	   resolution	   or	  acquire	  more	   slices.	   This	   technique,	   also	   known	   as	   ‘inner	   volume	   imaging’,	   was	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first	   described	   by	   Feinberg	   et	   al.207	   The	   theory	   has	   also	   been	   applied	   for	   other	  sequence	   designs,	   including	   echo-­‐planar	   imaging	   and	   3D	   fast	   spin	   echo	  imaging.208-­‐210	   The	   study	   described	   here,	   is	   therefore	   a	   novel	   application	   of	   this	  well	  described	  imaging	  approach.	  Another	  theoretical	  approach	  would	  have	  been	  to	  use	  a	  local	  excitation	  pulse,	  hence	  giving	  an	  alternative	  way	  of	  minimizing	  signal	  from	  outside	  the	  region	  of	  interest.	  This	  technique	  would	  also	  achieve	  an	  effective	  reduction	   of	   the	   field	   of	   view	   without	   concerns	   regarding	   image	   aliasing.	   This	  alternative	  approach	  has	  also	  been	  well-­‐described.211-­‐213	  The	  main	  concern	  about	  using	  a	  selective	  excitation	  pulse	  approach	  is	  the	  relatively	  long	  duration	  of	  the	  RF	  waveform	  and	  the	  resulting	  prolonged	  acquisition	  window	  duration.	  It	  is	  acknowledged	  that	  there	  was	  a	  low	  aortic	  plaque	  burden	  in	  our	  cases	  due	  to	  mostly	  healthy	  volunteers	  with	  a	  low	  cardiovascular	  risk	  profile.	  However,	  (Figure	  38)	   shows	   an	   area	   of	   abdominal	   aortic	   plaque	   in	   a	   66	   year-­‐old	   volunteer	  demonstrating	   the	   ability	   of	   this	   technique	   for	   plaque	   quantification,	   as	  demonstrated	   with	   the	   conventional	   technique	   previously	   in	   more	   than	   2000	  cases.202-­‐204	   Zoom	   imaging	   enables	   comparable	   data	   quality	   in	   shorter	   time	  compared	  to	  the	  conventional	  technique.	  This	  time	  saving	  can	  be	  used	  to	  improve	  coverage	  of	  the	  anatomic	  region	  of	  interest.	  It	  should	  also	  be	  noted	  that	  this	  study	  used	   a	   relatively	   narrow	   acquisition	  window	  of	   60ms	   to	   reduce	  motion	   artefact	  but,	   in	   clinical	   practice,	   acquisition	   times	  of	   120	   to	  150ms	  are	   routinely	  used	   in	  aortic	  imaging.	  Therefore	  the	  whole	  aorta	  can	  be	  imaged	  in	  less	  than	  10	  minutes	  and	   cardiovascular	   risk	   prediction	   using	   just	   the	   thoracic	   aorta	   could	   be	  completed	   within	   5	   minutes.	   Previously	   gaps	   of	   10	   mm	   were	   accepted	   but,	   in	  doing	   so,	   plaque	   burden	   was	   probably	   underestimated.	   It	   is	   likely	   that	   future	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studies	   using	   complete	   coverage,	   as	   in	   this	   study,	   will	   give	   more	   accurate	  cardiovascular	  risk	  prediction.	  
	  
Figure	  38.	  Sample	  Plaque	  Images	  
Among	  the	  healthy	  volunteers,	  the	  plaque	  burden	  was	  low	  but	  these	  images	  
indicate	   the	  presence	  of	   aortic	  plaque	   (arrows).	   Zoom	   imaging	  depicts	   this	  
well.	   Again,	   column	   A	   shows	   TSE	   black	   blood	   images	   using	   zoom	   imaging;	  
column	  B	  shows	  conventional	  TSE	  black	  blood	  images,	  and	  column	  C	  shows	  
equivalent	  full	  FOV	  images	  using	  SENSE	  acceleration.	  FOV	  =	  field	  of	  view;	  TSE	  
=	  turbo	  spin	  echo.	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  Aortic	  plaque	  burden	  has	  been	  shown	  in	  autopsy	  studies	  to	  predict	  the	  amount	  of	  coronary	  atherosclerosis.199	  Furthermore,	  measurement	  of	   thoracic	  aortic	  plaque	  burden	  by	  MRI	  has	  been	  shown	  to	  be	  an	  independent	  risk	  factor	  for	  the	  severity	  of	  coronary	  atherosclerosis	  demonstrated	  by	  coronary	  angiography.214	  This	  evidence	  forms	   the	   basis	   of	   recommendations	   for	   screening	   atherosclerotic	   disease	   by	  imaging	  the	  aorta.203	  Currently,	  this	  approach	  is	  simpler	  and	  less	  time-­‐consuming	  than	  direct	  non-­‐invasive	   imaging	  for	  coronary	  atherosclerotic	  burden	  using	  high-­‐resolution	  MR	   coronary	   vessel	  wall	   imaging.97,	  99,	  215	   It	   also	   offers	   advantages	   for	  screening	   in	   terms	   of	   lack	   of	   ionising	   radiation	   exposure	   when	   compared	   to	  Computed	   Tomography	   screening	   for	   cardiovascular	   disease	   by	   imaging	   of	   the	  aorta216	   or	   coronary	   arteries.217	   Furthermore,	   using	   ultrasound,	   thoracic	   aortic	  atherosclerosis	   has	   been	   shown	   to	   be	   a	   stronger	   correlate	   of	   cardiovascular	  disease	  than	  screening	  of	  carotid	  arteries	  or	  femoral	  arteries.218	  The	  use	  of	  aortic	  imaging	  to	  guide	  primary	  prevention	  would	  obviate	  the	  concerns	  regarding	   the	   applicability,	   accuracy	   and	   ethical	   dilemmas	   surrounding	   use	   of	  currently	   available	   risk	   scoring	   alone	   to	   guide	   such	   therapy.198	   Furthermore,	   it	  provides	   patients	   with	   a	   goal-­‐directed	   prevention	   therapy	   with	   the	   ability	   to	  monitor	   disease	   progress	   and	   should	   therefore	   improve	   compliance	   and	  acceptability	  of	  therapy.	  In	   the	   clinical	   setting,	   carotid-­‐femoral	   pulse	   wave	   velocity	   is	   much	   easier	   to	  perform	   than	   aortic	   imaging	   and	   has	   been	   shown	   to	   be	   predictive	   of	  cardiovascular	   events,	   although	   the	   incremental	   value	   for	   risk	   prediction	   still	  needs	  to	  be	  ascertained.219	  Undoubtedly,	  aortic	  atherosclerosis	  is	  a	  determinant	  of	  arterial	   stiffness	   but	   the	   lack	   of	   consistent	   association	   between	   pulse	   wave	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velocity	   and	   many	   conventional	   atherosclerotic	   risk	   factors	   warrants	   further	  evaluation.220	   In	   this	   respect,	   the	   zoom	   TSE	   black	   blood	   imaging	   sequence	  described	   here	  would	   also	   allow	  better	   evaluation	   of	   the	   determinants	   of	   aortic	  stiffness.	  In	   conclusion,	   we	   propose	   that	   use	   of	   the	   zoom	   imaging	   sequence	   will	   allow	  accurate	  and	  more	  time-­‐efficient	  imaging	  of	  the	  abdominal	  and	  thoracic	  aorta	  for	  cardiovascular	   risk	  prediction.	  By	   reducing	   imaging	   time,	   the	   sequence	  becomes	  more	   applicable	   for	   future	   studies	   of	   cardiovascular	   risk	   stratification	   and	  monitoring	  of	  treatment	  effects	  in	  those	  individuals.	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“A	  discipline	  that	  increases	  the	  efficiency	  of	  determining	  the	  relevance	  of	  novel	  
discoveries	   in	   the	   biological	   sciences	   to	   human	   disease	   and	   helps	   clinical	  
researchers	   identify,	   through	   direct	   human	   observation,	   alternative	  
hypotheses	   relevant	   to	   human	   disease.	   A	   further	   goal	   is	   to	   accelerate	   the	  
rational	   transfer	   of	   new	   insights	   and	   knowledge	   into	   clinical	   practice	   for	  
improving	  patients’	  outcomes	  and	  public	  health.”1	  	  Referring	  once	  more	  to	  Littman’s	  original	  definition	  of	  translational	  research,1	  this	  thesis	   has	   succeeded	   in	   determining	   ‘the	   relevance	   of	   novel	   discoveries’	  including	   contrast-­‐enhanced	   vessel	   wall	   imaging,	   dual	   phase	   imaging,	   parallel	  transmit	   technology	  at	  3.0	  Tesla,	   i-­‐T2	  prep	  and	   ‘zoom	   imaging’.	   In	  attempting	   to	  address	   the	   pressing	   need	   for	   non-­‐invasive	   imaging	   for	   Coronary	   Allograft	  Vasculopathy	  (CAV),	  this	  thesis	  has	  not	  only	  accelerated	  ‘the	  rational	  transfer	  of	  
new	  insights	  and	  knowledge’	  into	  imaging	  for	  CAV	  but	  also	  for	  Congenital	  Heart	  Disease,	  Kawasaki	  Disease	  and	  Atherosclerosis.	  	  	  Chapter	  2	  describes	  optimisation	  of	  the	  whole-­‐heart	  sequence	  for	  coronary	  artery	  lumen	   imaging	   using	   dual	   phase	   approach.	   It	   further	   describes	   the	   use	   of	   this	  approach	  in	  children	  to	  develop	  of	  normal	  reference	  values	  for	  coronary	  magnetic	  resonance	   angiography	   (CMRA).	   This	   development	   enables	   the	   use	   of	   CMRA	   for	  follow-­‐up	  of	  both	  CAV	  and	  Kawasaki	  disease.	  	  Use	  of	  the	  dual	  phase	  technique	  for	  this	  thesis,	  allowed	  formation	  and	  subsequent	  proof	  of	  an	  ‘alternative	  hypothesis	  relevant	  to’	  Congenital	  Heart	  Disease.	  That	  is	  to	  say	  that	  this	  dual	  phase	  approach	  is	  not	  only	  relevant	  to	  coronary	  imaging	  but	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that	  it	  is	  shown	  to	  improve	  the	  overall	  success	  rate	  in	  achieving	  diagnostic	  image	  quality,	  and	  is	  further	  shown	  to	  be	  particularly	  useful	  for	  interventional	  planning.	  	  	  Despite	  the	  advance	  of	  dual	  phase	  imaging,	  CMRA	  remains	  challenging.	  Chapter	  3	  goes	  on	  to	  investigate	  the	  relevance	  to	  CMRA	  of	  the	  novel	  discoveries	  of	  i-­‐T2	  prep	  and	   parallel	   transmit	   technology	   at	   3.0	   Tesla.	   i-­‐T2prep,	   has	   great	   potential	   for	  future	   use	   in	   patients	   to	   image	   coronary	   lumen	   and	   vessel	   wall	   using	   a	   single	  sequence.	   Image	   quality	   from	   the	   volunteers	   in	   Chapter	   3	   demonstrates	   this	  potential.	  In	  this	  study,	  it	  is	  shown	  that	  an	  approach	  using	  sublingual	  nitroglycerin	  (NTG)	  prior	  to	  imaging	  would	  improve	  image	  quality.	  This	  may	  therefore	  allow	  a	  non-­‐invasive	   evaluation	   of	   the	   influence	   of	   CAV,	   atherosclerotic	   plaque	   or	  calcification	   on	   endothelium-­‐independent	   vasodilatation.	   Chapter	   3	   also	  demonstrates	   that	   lumen	   imaging	   is	   still	   preferable	   at	   1.5	   Tesla	   field	   strength.	  However,	   the	   use	   of	   novel	   parallel	   transmission	   technology	   at	   3.0	   Tesla	   gave	  acceptable	  image	  quality.	  	  	  The	   central	   study	   of	   this	   thesis	   was	   the	   demonstration	   and	   grading	   of	   CAV	   in	  children	   using	   LGE	   MRI.	   An	   accuracy	   of	   91%	   is	   shown	   for	   the	   detection	   of	  significant	   CAV	   as	   corroborated	   by	   invasive	   coronary	   intravascular	   ultrasound	  (IVUS).	  The	  advantage	  of	  3.0	  Tesla	  field	  strength	  for	  the	  detection	  of	  CAV	  was	  also	  shown.	   It	   is	   unclear	   whether	   LGE	   MRI	   images	   acute	   inflammation	   or	   chronic	  fibrosis.	   However,	   the	   strong	   correlation	   with	   IVUS	   suggests	   that	   it	   may	   be	   a	  combination	   of	   both.	   Further	   longitudinal	   studies	   may	   help	   to	   elucidate	   this.	   If	  acute	   inflammation	  can	  be	   imaged,	   the	  potential	   for	   tailoring	   therapy	   to	  prevent	  CAV	  may	  be	  realised.	   Ideally,	  a	  randomised	  control	   trial	  using	  LGE	  MRI	   to	  direct	  changes	   in	   therapy	  and	  using	   intravascular	  ultrasound	  to	  assess	  response	  would	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be	  the	  future	  direction	  of	  this	  research.	  Such	  a	  study	  would	  hopefully	  demonstrate	  how	   these	  novel	   technologies	   could	  directly	   become	   responsible	   ‘for	   improving	  
patients’	  outcomes’.	  	  Chapter	   5	   demonstrates	   that	   pulse	   wave	   velocity,	   a	   marker	   for	   central	   aortic	  stiffness,	   is	   increased	   in	  children	  after	  heart	   transplantation.	  The	  mechanism	   for	  this	  is	  unclear.	  Chapter	  5	  goes	  on	  to	  describe	  a	  rapid	  aortic	  vessel	  wall	  assessment,	  which	   can	   be	   performed	   using	   ‘zoom	   imaging’.	   This	   sequence	   could	   be	   used	   in	  future	   studies	   to	   see	   if	   the	   increase	   in	   aortic	   stiffness	   associated	   with	   CAV	   is	  actually	   due	   to	   an	   increase	   in	   aortic	   vessel	   wall	   thickness.	   Indeed,	   if	   a	   causal	  mechanism	   is	   proven,	   then	   applanation	   tonometry,	   a	   rapid	   method	   to	   quantify	  pulse	  wave	  velocity,	  could	  be	  performed	  in	  the	  clinic	  to	  routinely	  screen	  for	  CAV.	  	  In	  summary,	  this	  thesis	  has	  indeed	  generated	  a	  myriad	  of	  ‘alternative	  hypotheses	  
relevant	  to	  human	  disease”.	  In	  the	  setting	  of	  CAV,	  we	  could	  hypothesise	  that	  LGE	  MRI	  can	  be	  used	  to	  direct	  therapy	  in	  clinical	  trials	  aiming	  to	  improve	  outcome.	  In	  the	  setting	  of	  Kawasaki	  Disease,	  we	  could	  hypothesise	   that	  LGE	  MRI	   is	  a	  marker	  for	   outcome,	   including	   death	   or	   infarction.	   In	   the	   setting	   of	   CAV	   or	   traditional	  atherosclerosis,	   we	   could	   hypothesise	   that	   native	   vessel	   wall	   imaging	   with	   i-­‐T2prep	   could	   reveal	   the	   disease-­‐specific	   relevance	   of	   impaired	   endothelium-­‐independent	   vasodilatation.	   Regarding	   the	   observation	   of	   raised	   central	   arterial	  stiffness	  after	  heart	  transplantation,	  we	  could	  hypothesise	  that	  aortic	  thickness	  is	  increased	   due	   to	   systemic	   inflammatory	   insults	   and	   this	   could	   be	   investigated	  using	  ‘zoom	  imaging’.	   	  The	  methods	  required	  to	  investigate	  these	  hypotheses	  are	  detailed	   in	   this	   thesis.	   The	   future	   direction	   of	   this	   work	   will	   be	   to	   establish	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coronary	  vessel	  wall	   imaging	   into	   routine	  practice	   in	   the	   follow-­‐up	  of	  paediatric	  heart	  transplantation.	  The	  first	  step	  would	  be	  to	  conduct	  larger	  multi-­‐centre	  trials	  to	  confirm	  the	  diagnostic	  ability	  of	  the	  technique	  and	  ensure	  that	  the	  technique	  is	  robust	  from	  centre	  to	  centre	  and	  across	  imaging	  platforms.	  Once	  this	  is	  achieved,	  the	  technique	  should	  be	  implemented	  into	  a	  clinical	  trial	  looking	  to	  direct	  therapy	  using	  this	  imaging	  as	  a	  biomarker	  of	  disease.	  The	  endpoint	  of	  the	  research	  would	  be	  to	  reduce	  the	  incidence	  of	  clinically	  significant	  CAV	  by	  instituting	  a	  programme	  of	  increased	  imaging	  surveillance.	  The	  objectives	  as	  set	  out	  in	  the	  introduction	  to	  this	  thesis	  have	  been	  fulfilled:	  The	  thesis	   demonstrates	   improvements	   in	   coronary	   lumen	   imaging;	   describes	   the	  clinical	  relevance	  of	  contrast-­‐enhanced	  vessel	  wall	  imaging	  to	  paediatric	  coronary	  vasculopathies	   and	   explores	   aortic	   imaging	   as	   a	   correlate	   for	   coronary	   disease.	  The	   structure	   of	   this	   thesis	   has	   been	   guided	   by	   the	   discipline	   of	   translational	  research.	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